Document:

EX-10.4

 Exhibit 10.4 

[FORM OF NON-AFFILIATE] SUBSCRIPTION AGREEMENT 

This SUBSCRIPTION AGREEMENT (this “Subscription Agreement”) is entered into this 13th day of September, 2018, by and among
Saban Capital Acquisition Corp., a Cayman Islands exempted company limited by shares (the “Issuer”), which shall domesticate as a Delaware corporation prior to the Subscription Closing (as defined below), and [•]
(“Subscriber”). 
 RECITALS 

WHEREAS, the Issuer intends to enter into a Business Combination Agreement (as it may be amended or supplemented from time to time, the
“Business Combination Agreement”), by and among the Issuer, Panavision Inc., a Delaware corporation (“Panavision”), SIM Video International Inc., an Ontario corporation (together with Panavision, the
“Companies”), solely in its capacity as the initial Panavision Holder Representative (as defined therein), Cerberus PV Representative, LLC, and the other parties thereto, in substantially the from previously provided to Subscriber;

 WHEREAS, in connection with the transactions contemplated by the Business Combination Agreement (collectively, the
“Transactions”), Subscriber desires to subscribe for and purchase from the Issuer that number of shares of common stock, par value $0.0001 per share (the “Common Shares”), of the Issuer set forth on the signature
page hereto (the “Acquired Shares”) for a purchase price of $10.00 per share, or the aggregate purchase price set forth on the signature page hereto (the “Purchase Price”), and the Issuer desires to issue and sell
to Subscriber the Acquired Shares in consideration of the payment of the Purchase Price by or on behalf of Subscriber to the Issuer on or prior to the Subscription Closing; and 

WHEREAS, in connection with the Transactions, certain other “accredited investors” (as such term is defined in Rule 501 under
the Securities Act of 1933, as amended (the “Securities Act”)), have entered into separate subscription agreements with the Issuer substantially similar to this Subscription Agreement (except that the subscription agreement entered
into by Saban Sponsor II LLC, a Delaware limited liability company and an affiliate of Saban Sponsor LLC, is in substantially the form of the draft attached hereto as Annex A), pursuant to which such investors have, together with Subscriber
pursuant to this Subscription Agreement, agreed to purchase on the Closing Date an aggregate of 5,500,000 Common Shares at the per share Purchase Price (the “Other Subscription Agreements”). 

NOW, THEREFORE, in consideration of the foregoing and the mutual representations, warranties and covenants, and subject to the
conditions, herein contained, and intending to be legally bound hereby, the parties hereto hereby agree as follows: 
 1.
Subscription. Pursuant to the terms and subject to the conditions set forth herein, Subscriber hereby agrees to subscribe for and purchase, and the Issuer hereby agrees to issue and sell to Subscriber, upon the payment of the Purchase Price,
the Acquired Shares (such subscription and issuance, the “Subscription”). 

 2. Subscription Closing. 

(a) The closing of the Subscription contemplated hereby (the “Subscription Closing”) is contingent upon the substantially
concurrent consummation of the Transactions and shall occur immediately prior thereto. Not less than five (5) business days prior to the scheduled closing date of the Transactions (the “Closing Date”), the Issuer shall provide
written notice to Subscriber (the “Closing Notice”) of such Closing Date; provided that the Issuer may delay the scheduled Closing Date up to five (5) business days following the original scheduled Closing Date
identified in the Closing Notice by written notice to Subscriber if it provides Subscriber with notice of the revised Closing Date no later than 24 hours prior to the then scheduled Closing Date. On the Closing Date, (i) the Issuer shall
deliver to Subscriber (x) the Acquired Shares in book entry form, free and clear of any liens or other restrictions whatsoever (other than those arising under state or federal securities laws or as set forth herein), in the name of Subscriber
(or its nominee in accordance with its delivery instructions) or to a custodian designated by Subscriber, as applicable and (y) a copy of the records of the Issuer’s transfer agent (the “Transfer Agent”) showing Subscriber
(or such nominee or custodian) as the owner of the Acquired Shares on and as of the Closing Date and (ii) Subscriber shall deliver to the Issuer the Purchase Price for the Acquired Shares by wire transfer of U.S. dollars in immediately
available funds to the account specified by the Issuer in the Closing Notice no later than 9:00am New York City time (unless a later time on the Closing Date is otherwise agreed by the Issuer). In the event the Closing (as defined in the Business
Combination Agreement) does not occur within one (1) business day of the Closing Date, the Issuer shall, unless the Closing occurs prior thereto, promptly (but not later than two (2) business days thereafter) return the Purchase Price to
Subscriber by wire transfer of U.S. dollars in immediately available funds to the account specified by Subscriber, and any book entries shall be deemed cancelled; provided that the return of the funds shall not terminate this Subscription
Agreement or otherwise relieve either party of any of its obligations hereunder (including the obligation to purchase the Acquired Shares at the Subscription Closing). 

(b) The Subscription Closing shall be subject to the conditions that, on the Closing Date: 

(i) no suspension of the qualification of the Acquired Shares for offering or sale or trading in the United States, or
initiation or threatening of any proceedings for any of such purposes, shall have occurred; 
 (ii) all conditions precedent
to the closing of the Transactions shall have been satisfied or waived (other than (A) those conditions that by their nature may only be satisfied at the closing of the Transactions, but subject to the satisfaction of such conditions as of the
closing of the Transactions and provided that any such waiver does not materially adversely affect Subscriber, and (B) the condition pursuant to Section 11.1(g) of the Business Combination Agreement); 

(iii) the terms of the Business Combination Agreement shall not have been amended in a manner that materially adversely affects
any of Subscriber’s rights hereunder; 

  
 2 

 (iv) all representations and warranties made by the Issuer and Subscriber in
this Subscription Agreement shall be true and correct in all material respects as of the Closing Date (other than those representations and warranties expressly made as of an earlier date, which shall be true and correct in all material respects as
of such date), in each case without giving effect to the consummation of the Transactions; 
 (v) solely with respect to
Subscriber, the Issuer shall have performed, satisfied and complied in all material respects with all covenants, agreements and conditions required by this Subscription Agreement to be performed, satisfied or complied with by it at or prior to the
Subscription Closing; and 
 (vi) no governmental authority shall have enacted, issued, promulgated, enforced or entered any
material judgment, order, law, rule or regulation (whether temporary, preliminary or permanent) which is then in effect and has the effect of making consummation of the transactions contemplated hereby illegal or otherwise preventing or prohibiting
consummation of the transactions contemplated hereby. 
 (c) At the Subscription Closing, the parties hereto shall execute and deliver such
additional documents and take such additional actions as the parties reasonably may deem to be practical and necessary in order to consummate the Subscription as contemplated by this Subscription Agreement. 

(d) For purposes of this Subscription Agreement, “business day” shall mean any day other than (i) any Saturday or Sunday
or (ii) any other day on which banks located in New York, New York are required or authorized by applicable law to be closed for business. 
 3.
Issuer Representations and Warranties. The Issuer represents and warrants that: 
 (a) The Issuer has been duly incorporated and is
validly existing as an exempted company in good standing under the laws of the Cayman Islands. Subject to obtaining all required approvals necessary in connection with the performance of the Business Combination Agreement (including, without
limitation, the approval of the Issuer’s shareholders) (collectively, the “Required Approvals”), the Issuer has all corporate power and authority to own, lease and operate its properties and conduct its business as presently
conducted and to enter into, deliver and perform its obligations under this Subscription Agreement. As of the Closing Date, the Issuer will be duly incorporated and validly existing as a corporation in good standing under the laws of the State of
Delaware, with corporate power and authority to own, lease and operate its properties and conduct its business as presently conducted and to enter into, deliver and perform its obligations under this Subscription Agreement. 

(b) As of the Closing Date, the Acquired Shares will be duly authorized and, when issued and delivered to Subscriber against full payment for
the Acquired Shares in accordance with the terms of this Subscription Agreement and registered with the Transfer Agent, the Acquired Shares will be validly issued, fully paid and non-assessable and will not
have been issued in violation of or subject to any preemptive or similar rights created under the Issuer’s certificate of incorporation and bylaws or under the Delaware General Corporation Law. 

  
 3 

 (c) This Subscription Agreement has been duly authorized, executed and delivered by the
Issuer and, assuming that this Subscription Agreement constitutes the valid and binding agreement of Subscriber, is the valid and binding obligations of the Issuer, enforceable against the Issuer in accordance with its terms, except as may be
limited or otherwise affected by (i) applicable bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium or other laws relating to or affecting the rights of creditors generally, and (ii) principles of equity, whether
considered at law or equity. 
 (d) Subject to obtaining the Required Approvals, the execution, delivery and performance of this Subscription
Agreement (including compliance by the Issuer with all of the provisions hereof), issuance and sale of the Acquired Shares, and the consummation of the other transactions contemplated herein, will not conflict with or result in a breach or violation
of any of the terms or provisions of, or constitute a default under, or result in the creation or imposition of any lien, charge or encumbrance upon any of the property or assets of the Issuer pursuant to the terms of (i) any indenture,
mortgage, deed of trust, loan agreement, lease, license or other agreement or instrument to which the Issuer is a party or by which the Issuer is bound or to which any of the property or assets of the Issuer is subject, which would reasonably be
expected to have a material adverse effect on the business, properties, financial condition, stockholders’ equity or results of operations of the Issuer (a “Material Adverse Effect”) or materially affect the validity of the
Acquired Shares or the legal authority of the Issuer to comply in all material respects with the terms of this Subscription Agreement; (ii) the organizational documents of the Issuer; or (iii) any statute or any judgment, order, rule or
regulation of any court or governmental agency or body, domestic or foreign, having jurisdiction over the Issuer or any of its properties that would reasonably be expected to have a Material Adverse Effect or materially affect the validity of the
Acquired Shares or the legal authority of the Issuer to comply in all material respects with this Subscription Agreement. 
 (e) Other than
the Issuer’s Class F ordinary shares, par value $0.0001 per share (“Class F Shares”), there are no securities or instruments issued by or to which the Issuer is a party containing anti-dilution or
similar provisions that will be triggered by the issuance of (i) the Acquired Shares or (ii) the shares to be issued pursuant to any Other Subscription Agreement that have not been or will not be validly waived on or prior to the Closing
Date; provided that the holders of the Class F Shares will waive any such anti-dilution or similar provisions in connection with the Transactions. 

(f) The Issuer is not in default or violation (and no event has occurred which, with notice or the lapse of time or both, would constitute a
default or violation) of any term, condition or provision of (i) the organizational documents of the Issuer, (ii) any loan or credit agreement, note, bond, mortgage, indenture, lease or other agreement, permit, franchise or license to
which the Issuer is now a party or by which the Issuer’s properties or assets are bound or (iii) any statute or any judgment, order, rule or regulation of any court or governmental agency or body, domestic or foreign, having jurisdiction
over the Issuer or any of its properties, except, in the case of clauses (ii) and (iii), for defaults or violations that have not had and would not be reasonably likely to have, individually or in the aggregate, a Material Adverse Effect. 

  
 4 

 (g) The Issuer is not required to obtain any consent, waiver, authorization or order of,
give any notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority, self-regulatory organization or other person in connection with the execution, delivery and performance by the
Issuer of this Subscription Agreement (including, without limitation, the issuance of the Acquired Shares), other than (i) filings with the Securities and Exchange Commission (the “Commission”), (ii) filings required by
applicable state securities laws, (iii)the filings required in accordance with Section 9(n) of this Subscription Agreement; (iv) those required by the Nasdaq Capital Market (“Nasdaq”), including with
respect to obtaining shareholder approval, and (v) the failure of which to obtain would not be reasonably likely to have, individually or in the aggregate, a Material Adverse Effect. 

(h) As of the date of this Subscription Agreement, the authorized capital stock of the Issuer consists of (i) 5,000,000 preferred shares,
par value $0.0001 per share (“Preferred Shares”), (ii) 500,000,000 Class A ordinary shares, par value $0.0001 per share, and (iii) 20,000,000 Class F Shares. As of the date hereof: (i) no shares of Preferred Stock are
issued and outstanding, (ii) 25,000,000 Class A ordinary shares, par value $0.0001 per share, are issued and outstanding, (iii) 6,243,480 Class F Shares are issued and outstanding and (iv) warrants to purchase 19,500,000 Common
Shares are outstanding. 
 (i) The Issuer has not received any written communication from a governmental entity that alleges that the Issuer
is not in compliance with or is in default or violation of any applicable law, except where such non-compliance, default or violation would not, individually or in the aggregate, be reasonably likely to have a
Material Adverse Effect. 
 (j) The issued and outstanding Class A ordinary shares are registered pursuant to Section 12(b) of the
Securities Exchange Act of 1934, as amended (the “Exchange Act”), and are listed for trading on Nasdaq under the symbol “SCAC”. There is no suit, action, proceeding or investigation pending or, to the knowledge of the
Issuer, threatened against the Issuer by Nasdaq or the Commission with respect to any intention by such entity to deregister the Class A ordinary shares or prohibit or terminate the listing of the Class A ordinary shares on Nasdaq. The
Issuer has taken no action that is designed to terminate the registration of the Common Shares under the Exchange Act. 
 (k) Assuming the
accuracy of Subscriber’s representations and warranties set forth in Section 4 of this Subscription Agreement, no registration under the Securities Act is required for the offer and sale of the Acquired Shares by the
Issuer to Subscriber. 
 (l) Neither the Issuer nor anyone acting on its behalf has offered the Common Shares or any similar securities for
sale to, or solicited any offer to buy any of the same from, or otherwise approached or negotiated in respect thereof with, any person other than Subscriber and other Institutional Accredited Investors, each of which has been offered Common Shares
at a private sale for investment. “Institutional Accredited Investor” means an institutional accredited investor as defined in Rule 501(a)(1), (2), (3) or (7) under the Securities Act. 

(m) None of the Issuer nor any of its affiliates has offered Common Shares or any similar securities during the six months prior to the date
hereof to anyone other than in connection with the Transactions and to Subscriber and other investors in connection with the Other Subscription Agreements. The Issuer has no intention to offer Common Shares or any similar security during the six
months from the date hereof other than in connection with the Transactions. 

  
 5 

 (n) Neither the Issuer nor any person acting on its behalf has offered or sold the Acquired
Shares by any form of general solicitation or general advertising, including, but not limited to, the following: (1) any advertisement, article, notice or other communication published in any newspaper, magazine, or similar media or broadcast
over television or radio; (2) any website posting or widely distributed e-mail; or (3) any seminar or meeting whose attendees have been invited by any general solicitation or general advertising.

 (o) In connection with the Transactions, the Issuer has not entered into any other agreement with any subscriber in the Other Subscription
Agreements or any other investor to purchase Common Shares on terms (economic or otherwise), taken as a whole, more favorable to such subscriber or investor than as set forth in this Subscription Agreement. 

(p) The Issuer has made available to Subscriber (via the Commission’s EDGAR system) a copy of each form, report, statement, schedule,
prospectus, proxy, registration statement and other document, if any, filed by the Issuer with the Commission since its initial registration of the Class A ordinary shares (the “SEC Documents”). None of the SEC Documents filed
under the Exchange Act contained, when filed or, if amended, as of the date of such amendment with respect to those disclosures that are amended, any untrue statement of a material fact or omitted to state a material fact required to be stated
therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading; provided, that the Issuer makes no such representation or warranty with respect to the Registration Statement on
Form S-4 and related proxy statement to be filed by the Issuer with respect to the Transactions or any other information relating to the Companies or any of their respective affiliates included in any SEC
Document or filed as an exhibit thereto. The Issuer has timely filed each report, statement, schedule, prospectus, and registration statement that the Issuer was required to file with the Commission since its inception. There are no material
outstanding or unresolved comments in comment letters from the staff of the Division of Corporation Finance (the “Staff”) of the Commission with respect to any of the SEC Documents. 

(q) Except for such matters as have not had and would not be reasonably likely to have, individually or in the aggregate, a Material Adverse
Effect, there is no (i) action, suit, claim or other proceeding, in each case by or before any governmental authority pending, or, to the knowledge of the Issuer, threatened against the Issuer or (ii) judgment, decree, injunction, ruling
or order of any governmental entity or arbitrator outstanding against the Issuer. 
 (r) Other than the Agents (as defined below), the Issuer
has not dealt with any broker, finder, commission agent, placement agent or arranger in connection with the sale of the Acquired Shares, and the Issuer is not under any obligation to pay any broker’s fee or commission in connection with the
sale of the Acquired Shares other than to the Agents. Neither the Issuer nor any of its affiliates nor any other person acting on its behalf (other than its officers acting in such capacity) has solicited offers for, or offered or sold, the Acquired
Shares other than through the Agent. 

  
 6 

 (s) The Issuer has not entered into any side letter or similar agreement with any subscriber
in the Other Subscription Agreements in connection with such subscriber’s direct or indirect investment in the Issuer other than the Other Subscription Agreements and such Other Subscription Agreement have not been amended in any material
respect following the date of this Agreement, except that the Issuer has entered into agreements with Saban Sponsor II LLC in connection with its role as an affiliate of Saban Sponsor LLC, the Issuer’s sponsor. 

4. Subscriber Representations and Warranties. Subscriber represents and warrants that: 

(a) Subscriber has been duly formed or incorporated and is validly existing in good standing under the laws of its jurisdiction of
incorporation or formation, with power and authority to enter into, deliver and perform its obligations under this Subscription Agreement. 

(b) This Subscription Agreement has been duly authorized, executed and delivered by Subscriber and, assuming that this Subscription Agreement
constitutes the valid and binding agreement of the Issuer, is the valid and binding obligations of Subscriber, enforceable against Subscriber in accordance with its terms, except as may be limited or otherwise affected by (i) applicable
bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium or other laws relating to or affecting the rights of creditors generally, and (ii) principles of equity, whether considered at law or equity. 

(c) The execution, delivery and performance by Subscriber of this Subscription Agreement and the consummation of the transactions contemplated
herein will not conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default under, or result in the creation or imposition of any lien, charge or encumbrance upon any of the property or assets of
Subscriber or any of its subsidiaries pursuant to the terms of (i) any indenture, mortgage, deed of trust, loan agreement, lease, license or other agreement or instrument to which Subscriber or any of its subsidiaries is a party or by which
Subscriber or any of its subsidiaries is bound or to which any of the property or assets of Subscriber or any of its subsidiaries is subject, which would reasonably be expected to have a material adverse effect on the business, properties, financial
condition, stockholders’ equity or results of operations of Subscriber and any of its subsidiaries, taken as a whole (a “Subscriber Material Adverse Effect”), or materially affect the legal authority of Subscriber to comply in
all material respects with the terms of this Subscription Agreement; (ii) the organizational documents of Subscriber; or (iii) any statute or any judgment, order, rule or regulation of any court or governmental agency or body, domestic or
foreign, having jurisdiction over Subscriber or any of its subsidiaries or any of their respective properties that would reasonably be expected to have a Subscriber Material Adverse Effect or materially affect the legal authority of Subscriber to
comply in all material respects with this Subscription Agreement. 
 (d) Subscriber represents that it is an Institutional Accredited
Investor, satisfying the applicable requirements set forth on Schedule A. Subscriber represents that it is purchasing the Acquired Shares for its own account or for one or more separate accounts maintained by it for the benefit of one or more
other Institutional Accredited Investors and not with a view to the distribution thereof, provided that the disposition of Subscriber’s property shall at all times be within Subscriber’s control. Subscriber understands that the Acquired
Shares have not been 

  
 7 

 
registered under the Securities Act and may be resold only if registered pursuant to the provisions of the Securities Act or if an exemption from registration is available, except under
circumstances where neither such registration nor such an exemption is required by law, and that the Issuer is not required to register the Securities other than as provided for in Section 5 of this Subscription Agreement.
Subscriber further represents and warrants that it will not sell, transfer or otherwise dispose of the Acquired Shares or any interest therein except in a transaction exempt from or not subject to the registration requirements of the Securities Act
and except in accordance with the terms and conditions of this Subscription Agreement. Subscriber acknowledges that the Acquired Shares will bear a restrictive legend substantially as set forth on Exhibit A to this Subscription Agreement. 

(e) The purchase of Acquired Shares by Subscriber has not been solicited by or through anyone other than the Issuer or the Agent. 

(f) Subscriber acknowledges that the Acquired Shares will not be eligible for resale pursuant to Rule 144A promulgated under the Securities
Act. Subscriber understands and agrees that the Acquired Shares will be subject to transfer restrictions and, as a result of these transfer restrictions, Subscriber may not be able to readily resell the Acquired Shares and may be required to bear
the financial risk of an investment in the Acquired Shares for an indefinite period of time. Subscriber understands that it has been advised to consult legal counsel prior to making any offer, resale, pledge or transfer of any of the Acquired
Shares. 
 (g) Subscriber understands and agrees that Subscriber is purchasing the Acquired Shares directly from the Issuer. Subscriber
further acknowledges that there have been no representations, warranties, covenants and agreements made to Subscriber by the Issuer or any of its officers, directors or representatives, expressly or by implication, other than those representations,
warranties, covenants and agreements included in this Subscription Agreement. 
 (h) Subscriber represents and warrants that its acquisition
and holding of the Acquired Shares will not constitute or result in a non-exempt prohibited transaction under section 406 of the Employee Retirement Income Security Act of 1974, as amended, section 4975 of the
Internal Revenue Code of 1986, as amended (the “Code”), or any applicable similar law. 
 (i) In making its decision to
purchase the Acquired Shares, Subscriber represents that it has relied solely upon independent investigation made by Subscriber. Subscriber acknowledges and agrees that Subscriber has received such information as Subscriber deems necessary in order
to make an investment decision with respect to the Acquired Shares, including with respect to the Issuer, the Transactions and the Companies. Subscriber represents and agrees that Subscriber and Subscriber’s professional advisor(s), if any,
have had the full opportunity to ask such questions, receive such answers and obtain such information as Subscriber and such Subscriber’s professional advisor(s), if any, have deemed necessary to make an investment decision with respect to the
Acquired Shares. Subscriber acknowledges and agrees that it has not relied on the Agents or any of the Agents’ affiliates with respect to its decision to purchase the Acquired Shares. 

  
 8 

 (j) Subscriber became aware of this offering of the Acquired Shares solely by means of
direct contact between Subscriber and the Issuer or by means of contact from Goldman Sachs & Co. LLC or Deutsche Bank Securities Inc., acting as placement agents for the Issuer (together, the “Agents”), and the Acquired Shares
were offered to Subscriber solely by direct contact between Subscriber and the Issuer or by contact between Subscriber and the Agent. Subscriber did not become aware of this offering of the Acquired Shares, nor were the Acquired Shares offered to
Subscriber, by any other means. Subscriber acknowledges that the Issuer represents and warrants that the Acquired Shares (i) were not offered by any form of general solicitation or general advertising and (ii) are not being offered in a
manner involving a public offering under, or in a distribution in violation of, the Securities Act, or any state securities laws. 
 (k)
Subscriber acknowledges that it is aware that there are substantial risks incident to the purchase and ownership of the Acquired Shares. Subscriber has such knowledge and experience in financial and business matters as to be capable of evaluating
the merits and risks of an investment in the Acquired Shares, and Subscriber has sought such accounting, legal and tax advice as Subscriber has considered necessary to make an informed investment decision. 

(l) Alone, or together with any professional advisor(s), Subscriber represents and acknowledges that Subscriber has adequately analyzed and
fully considered the risks of an investment in the Acquired Shares and determined that the Acquired Shares are a suitable investment for Subscriber and that Subscriber is able at this time and in the foreseeable future to bear the economic risk of a
total loss of Subscriber’s investment in the Issuer. Subscriber acknowledges specifically that a possibility of total loss exists. 

(m) Subscriber understands and agrees that no federal or state agency has passed upon or endorsed the merits of the offering of the Acquired
Shares or made any findings or determination as to the fairness of this investment. 
 (n) Subscriber represents and warrants that Subscriber
is not (i) a person or entity named on the List of Specially Designated Nationals and Blocked Persons, the Executive Order 13599 List, the Foreign Sanctions Evaders List, or the Sectoral Sanctions Identification List, each of which is
administered by the U.S. Treasury Department’s Office of Foreign Assets Control (“OFAC”), or any other Executive Order issued by the President of the United States and administered by OFAC (collectively “OFAC
Lists”), (ii) owned or controlled by, or acting on behalf of, a person, that is named on an OFAC List; (iii) organized, incorporated, established, located, resident or born in, or a citizen, national, or the government, including any
political subdivision, agency, or instrumentality thereof, of, Cuba, Iran, North Korea, Syria, the Crimea region of Ukraine, or any other country or territory embargoed or subject to substantial trade restrictions by the United States, (iv) a
Designated National as defined in the Cuban Assets Control Regulations, 31 C.F.R. Part 515, or (v) a non-U.S. shell bank or providing banking services indirectly to a
non-U.S. shell bank (collectively, a “Prohibited Investor”). Subscriber represents that if it is a financial institution subject to the Bank Secrecy Act (31 U.S.C. section 5311 et seq.) (the
“BSA”), as amended by the USA PATRIOT Act of 2001 (the “PATRIOT Act”), and its implementing regulations (collectively, the “BSA/PATRIOT Act”), that Subscriber maintains policies and procedures
reasonably designed to comply with applicable obligations under the BSA/PATRIOT Act. Subscriber also represents that, to the extent required by applicable laws, it maintains policies and procedures reasonably designed to ensure compliance with
OFAC-administered sanctions programs, including for the screening of its investors against the OFAC Lists. Subscriber further represents and warrants that, to the extent required by applicable laws, it maintains policies and procedures reasonably
designed to ensure that the funds held by Subscriber and used to purchase the Acquired Shares were legally derived. 

  
 9 

 (o) If Subscriber is or is acting on behalf of (i) an employee benefit plan that is
subject to Title I of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”), (ii) a plan, an individual retirement account or other arrangement that is subject to section 4975 of the Code, (iii) an
entity whose underlying assets are considered to include “plan assets” of any such plan, account or arrangement described in clauses (i) and (ii) (each, an “ERISA Plan”), or (iv) an employee benefit plan that is
a governmental plan (as defined in section 3(32) of ERISA), a church plan (as defined in section 3(33) of ERISA), a non-U.S. plan (as described in section 4(b)(4) of ERISA) or other plan that is not subject to
the foregoing clauses (i), (ii) or (iii) but may be subject to provisions under any other federal, state, local, non-U.S. or other laws or regulations that are similar to such provisions of ERISA or the
Code (collectively, “Similar Laws”, and together with ERISA Plans, “Plans”) (iv) , Subscriber represents and warrants that (i) neither Issuer, nor any of its respective affiliates (the “Transaction
Parties”) has provided investment advice or has otherwise acted as the Plan’s fiduciary, with respect to its decision to acquire and hold the Acquired Shares, and none of the Transaction Parties shall at any time be the Plan’s
fiduciary with respect to any decision to acquire, continue to hold, transfer or otherwise dispose of the Acquired Shares; (ii) the decision to invest in the Acquired Shares has been made at the recommendation or direction of a fiduciary (for
purposes of ERISA and/or section 4975 of the Code, or any applicable Similar Law) with respect to Subscriber’s investment in the Acquired Shares who is (A) independent of the Transaction Parties; (B) acknowledges that none of the
Transaction Parties will not provide impartial investment advice, or to give advice in a fiduciary capacity, in connection with Subscriber’s investment in the Acquired Shares and (C) its purchase of Acquired Shares will not result is non-exempt prohibited transaction under Section 406 of ERISA or Section 4975 of the Code, or any applicable Similar Law. 

(p) Subscriber has, and at the Subscription Closing will have, sufficient funds to pay the Purchase Price pursuant to
Section 2(a) of this Subscription Agreement. 
 5. Registration Rights. 

(a) The Issuer agrees that, within thirty (30) calendar days following the Closing Date (the “Filing Date”), the Issuer
will file with the Commission (at the Issuer’s sole cost and expense) a registration statement registering the resale of the Acquired Shares (the “Registration Statement”), and the Issuer shall use its commercially reasonable
efforts to have the Registration Statement declared effective as soon as practicable after the filing thereof, but no later than the earlier of (i) the 90th calendar day (or 120th calendar day if the Commission notifies the Issuer that it will
“review” the Registration Statement) following the Closing Date and (ii) the 10th business day after the date the Issuer is notified (orally or in writing, whichever is earlier) by the Commission that the Registration Statement will
not be “reviewed” or will not be subject to further review (such earlier date, the “Effectiveness Date”); provided, however, that the Issuer’s obligations to include the Acquired Shares in the Registration
Statement are contingent upon Subscriber furnishing in writing to the Issuer such information regarding Subscriber, the securities of the Issuer held by Subscriber and the intended method of disposition of the Acquired Shares as shall be reasonably
requested by the Issuer to effect the registration of the 

  
 10 

 
Acquired Shares, and Subscriber shall execute such documents in connection with such registration as the Issuer may reasonably request that are customary of a selling stockholder in similar
situations, including providing that the Issuer shall be entitled to postpone and suspend the effectiveness or use of the Registration Statement during any customary blackout or similar period or as permitted hereunder. For purposes of
clarification, any failure by the Issuer to file the Registration Statement by the Filing Date or to effect such Registration Statement by the Effectiveness Date shall not otherwise relieve the Issuer of its obligations to file or effect the
Registration Statement as set forth above in this Section 5 of this Subscription Agreement. 
 (b) The Issuer
further agrees that, in the event that (i) the Registration Statement has not been declared effective by the Commission by the Effectiveness Date, (ii) after such Registration Statement is declared effective by the Commission,
(A) such Registration Statement ceases for any reason (including by reason of a stop order, or the Issuer’s failure to update the Registration Statement in accordance with the Securities Act), to remain continuously effective as to all
Acquired Shares for which it is required to be effective pursuant to this Agreement or (B) Subscriber is not permitted to utilize the Registration Statement to resell the Acquired Shares (in each case of (A) and (B), (x) other than within
the time period(s) permitted by this Subscription Agreement and (y) excluding by reason of a post-effective amendment required in connection with the Issuer’s filing of an amendment thereto (a “Special Grace Period”)
(which Special Grace Period shall not be treated as a Registration Default (as defined below))), or (iii) after the date that is one year following the Closing Date, and only in the event the Registration Statement is not effective or available
to sell all Acquired Shares, the Issuer fails to file with the Commission any required reports under Section 13 or 15(d) of the Exchange Act such that it is not in compliance with Rule 144(c)(1) (or Rule 144(i)(2), if applicable), as a result
of which Subscriber, if Subscriber is not an affiliate of the Issuer, is unable to sell the Acquired Shares without restriction under Rule 144 (or any successor thereto) (each such event referred to in clauses (i) through (iii), a
“Registration Default” and, for purposes of such clauses, the date on which such Registration Default occurs, a “Default Date”), then in addition to any other rights Subscriber may have hereunder or under applicable
law, within five Business Days of a Default Date and on each monthly anniversary of each such Default Date (if the applicable Registration Default shall not have been cured by such date) until the applicable Registration Default is cured, the Issuer
shall pay to each Subscriber an amount in cash, as liquidated damages and not as a penalty (“Liquidated Damages”), equal to 0.5% of the aggregate Purchase Price paid by Subscriber pursuant to this Subscription Agreement for any
Acquired Shares which may not be disposed by Subscriber without restriction on the Default Date or such monthly anniversary of such Default Date, as applicable; provided, however, that if Subscriber fails to provide the Issuer with any
information or executed documents requested by the Issuer that is required to be provided in, or with respect to, such Registration Statement with respect to Subscriber as set forth herein, then, for purposes of this
Section 5 of this Subscription Agreement, the Filing Date or Effectiveness Date, as applicable, for a Registration Statement with respect to Subscriber shall be extended until five (5) business days following the date
of receipt by the Issuer of such required information or executed documents, as applicable, from Subscriber. The Liquidated Damages pursuant to the terms hereof shall apply on a daily pro-rata basis for any
portion of a month prior to the cure of a Registration Default, except in the case of the first Default Date. The Issuer shall deliver the cash payment to Subscriber with respect to any Liquidated Damages by the fifth business day after the date
payable. If the Issuer fails to pay said cash payment to Subscriber in full by the fifth business day after the date payable, the Issuer will 

  
 11 

 
pay interest thereon at a rate of 5.0% per annum (or such lesser maximum amount that is permitted to be paid by applicable law, and calculated on the basis of a year consisting of 360 days) to
such Subscriber, accruing daily from the date such Liquidated Damages are due until such amounts, plus all such interest thereon, are paid in full. The parties agree that notwithstanding anything to the contrary herein, no Liquidated Damages shall
be payable to Subscriber with respect to any period during which all of the Acquired Shares then held by Subscriber may be sold by Subscriber without volume or manner of sale restrictions under Rule 144 and the Issuer is in compliance in all
material respects with the current public information requirements under Rule 144(c)(1) (or Rule 144(i)(2), if applicable). Notwithstanding anything to the contrary in this Section 5(f) or otherwise in this Subscription
Agreement, in no event shall the Issuer be required hereunder to pay, and in no event shall its liability, to Subscriber pursuant to this Subscription Agreement be in an aggregate amount that exceeds 5.0% of the aggregate Purchase Price paid by
Subscriber for its Acquired Shares. The Liquidated Damages shall be Subscriber’s sole and exclusive remedy hereunder with respect to a Registration Default. 

(c) In the case of the registration, qualification, exemption or compliance effected by the Issuer pursuant to this Subscription Agreement, the
Issuer shall, upon reasonable request, inform Subscriber as to the status of such registration, qualification, exemption and compliance. At its expense the Issuer shall: 

(i) except for such times as the Issuer is permitted hereunder to suspend the use of the prospectus forming part of a
Registration Statement, use its commercially reasonable efforts to keep such registration, and any qualification, exemption or compliance under state securities laws which the Issuer determines to obtain, continuously effective with respect to
Subscriber, and to keep the applicable Registration Statement or any subsequent shelf registration statement free of any material misstatements or omissions, until the earlier of the following: (i) Subscriber ceases to hold any Acquired Shares
or (ii) the date all Acquired Shares held by Subscriber may be sold without restriction under Rule 144, including without limitation, any volume and manner of sale restrictions which may be applicable to affiliates under Rule 144, other than
the requirement for the Issuer to be in compliance with the current public information required under Rule 144(c)(1) (or Rule 144(i)(2), if applicable), and (iii) two years from the Effectiveness Date. The period of time during which the Issuer
is required hereunder to keep a Registration Statement effective is referred to herein as the “Registration Period”; 

(ii) advise Subscriber within five (5) business days: 

(1) when a Registration Statement or any amendment thereto has been filed with the Commission and when such Registration Statement or any
post-effective amendment thereto has become effective; 
 (2) of any request by the Commission for amendments or supplements to any
Registration Statement or the prospectus included therein or for additional information; 

  
 12 

 (3) of the issuance by the Commission of any stop order suspending the effectiveness of any
Registration Statement or the initiation of any proceedings for such purpose; 
 (4) of the receipt by the Issuer of any notification with
respect to the suspension of the qualification of the Acquired Shares included therein for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose; and 

(5) subject to the provisions in this Subscription Agreement, of the occurrence of any event that requires the making of any changes in any
Registration Statement or prospectus so that, as of such date, the statements therein are not misleading and do not omit to state a material fact required to be stated therein or necessary to make the statements therein (in the case of a prospectus,
in the light of the circumstances under which they were made) not misleading. 
 Notwithstanding anything to the contrary set forth herein,
the Issuer shall not, when so advising Subscriber of such events, provide Subscriber with any material, nonpublic information regarding the Issuer other than to the extent that providing notice to Subscriber of the occurrence of the events listed in
(1) through (5) above constitutes material, nonpublic information regarding the Issuer; 
 (iii) use its
commercially reasonable efforts to obtain the withdrawal of any order suspending the effectiveness of any Registration Statement as soon as reasonably practicable; 

(iv) upon the occurrence of any event contemplated above, except for such times as the Issuer is permitted hereunder to
suspend, and has suspended, the use of a prospectus forming part of a Registration Statement, the Issuer shall use its commercially reasonable efforts to as soon as reasonably practicable prepare a post-effective amendment to such Registration
Statement or a supplement to the related prospectus, or file any other required document so that, as thereafter delivered to purchasers of the Acquired Shares included therein, such prospectus will not include any untrue statement of a material fact
or omit to state any material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading; 

(v) use its commercially reasonable efforts to cause all Acquired Shares to be listed on each national securities exchange
(within the meaning of the Exchange Act), if any, on which the Common Shares issued by the Issuer have been listed; and 

(vi) use its commercially reasonable efforts to take all other steps necessary to effect the registration of the Acquired
Shares contemplated hereby. 
 (d) Notwithstanding anything to the contrary in this Subscription Agreement, the Issuer shall be entitled to
delay or postpone the effectiveness of the Registration Statement, and from time to time to require Subscriber not to sell under the Registration Statement or to suspend the effectiveness thereof, if the negotiation or consummation of a transaction
by the Issuer or its 

  
 13 

 
subsidiaries is pending or an event has occurred, which negotiation, consummation or event the Issuer’s board of directors reasonably believes, upon the advice of legal counsel, would
require additional disclosure by the Issuer in the Registration Statement of material information that the Issuer has a bona fide business purpose for keeping confidential and the non-disclosure of which in
the Registration Statement would be expected, in the reasonable determination of the Issuer’s board of directors, upon the advice of legal counsel, to cause the Registration Statement to fail to comply with applicable disclosure requirements
(each such circumstance, a “Suspension Event”); provided, however, that the Issuer may not delay or suspend the Registration Statement on more than two occasions, for more than sixty (60) consecutive calendar
days, or more than ninety (90) total calendar days, in each case during any twelve-month period. Upon receipt of any written notice from the Issuer of the happening of any Suspension Event during the period that the Registration Statement is
effective or if as a result of a Suspension Event the Registration Statement or related prospectus contains any untrue statement of a material fact or omits to state any material fact required to be stated therein or necessary to make the statements
therein (in the case of a prospectus, in the light of the circumstances under which they were made) not misleading, Subscriber agrees that (i) it will immediately discontinue offers and sales of the Acquired Shares under the Registration
Statement (excluding, for the avoidance of doubt, sales conducted pursuant to Rule 144) until Subscriber receives copies of a supplemental or amended prospectus (which the Issuer agrees to promptly prepare) that corrects the misstatement(s) or
omission(s) referred to above and receives notice that any post-effective amendment has become effective or unless otherwise notified by the Issuer that it may resume such offers and sales, and (ii) it will maintain the confidentiality of any
information included in such written notice delivered by the Issuer unless otherwise required by law or subpoena. If so directed by the Issuer, Subscriber will deliver to the Issuer or, in Subscriber’s sole discretion destroy, all copies of the
prospectus covering the Acquired Shares in Subscriber’s possession; provided, however, that this obligation to deliver or destroy all copies of the prospectus covering the Acquired Shares shall not apply (i) to the extent Subscriber is
required to retain a copy of such prospectus (a) in order to comply with applicable legal, regulatory, self-regulatory or professional requirements or (b) in accordance with a bona fide pre-existing
document retention policy or (ii) to copies stored electronically on archival servers as a result of automatic data back-up. 

(e) Subscriber may deliver written notice (including via email in accordance with Section 9(l) of this Subscription
Agreement) (an “Opt-Out Notice”) to the Issuer requesting that Subscriber not receive notices from the Issuer otherwise required by this Section 5; provided,
however, that Subscriber may later revoke any such Opt-Out Notice in writing. Following receipt of an Opt-Out Notice from Subscriber (unless subsequently
revoked), (i) the Issuer shall not deliver any such notices to Subscriber and Subscriber shall no longer be entitled to the rights associated with any such notice and (ii) each time prior to Subscriber’s intended use of an effective
Registration Statement, Subscriber will notify the Issuer in writing at least two (2) business days in advance of such intended use, and if a notice of a Suspension Event was previously delivered (or would have been delivered but for the
provisions of this Section 5(e)) and the related suspension period remains in effect, the Issuer will so notify Subscriber, within one (1) business day of Subscriber’s notification to the Issuer, by delivering to
Subscriber a copy of such notice of Suspension Event that would have been provided, and thereafter will provide Subscriber with the related notice of the conclusion of such Suspension Event immediately upon its availability, and Subscriber shall
comply with any restrictions on using such Registration Statement during such Suspension Event. 

  
 14 

 (f) The Issuer agrees to indemnify and hold Subscriber, each person, if any, who controls
Subscriber within the meaning of either Section 15 of the Securities Act or Section 20 of the Exchange Act, and each affiliate of Subscriber within the meaning of Rule 405 under the Securities Act harmless against any and all losses,
claims, damages and liabilities (including, without limitation, any legal or other expenses reasonably incurred in connection with defending or investigating any such action or claim) incurred by Subscriber directly that are caused by any untrue
statement or alleged untrue statement of a material fact contained in the Registration Statement (including the prospectus contained therein) or any amendment thereof (including the prospectus contained therein) or caused by any omission or alleged
omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, except insofar as the same are caused by or contained in any information or affidavit so furnished in writing to the
Issuer by Subscriber expressly for use therein. 
 6. Termination. This Subscription Agreement shall terminate and be void and of no
further force and effect, and all rights and obligations of the parties hereunder shall terminate without any further liability on the part of any party in respect thereof, upon the earlier to occur of (a) such date and time as the Business
Combination Agreement is terminated in accordance with its terms, (b) upon the mutual written agreement of each of the parties hereto to terminate this Subscription Agreement, (c) if any of the conditions to Subscription Closing set forth
in Section 2 of this Subscription Agreement are not satisfied on or prior to the Subscription Closing and, as a result thereof, the transactions contemplated by this Subscription Agreement are not consummated at the
Subscription Closing and (d) the End Date (as defined in the Business Combination Agreement); provided, that nothing herein will relieve any party from liability for any willful breach hereof prior to the time of termination, and each
party will be entitled to any remedies at law or in equity to recover losses, liabilities or damages arising from such breach. The Issuer shall promptly notify Subscriber of the termination of the Business Combination Agreement. 

7. Trust Account Waiver. Subscriber acknowledges that the Issuer is a blank check company with the powers and privileges to effect a
merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination involving the Issuer and one or more businesses. Subscriber further acknowledges that, as described in the Issuer’s prospectus relating to
its initial public offering dated September 15, 2016, available at www.sec.gov, substantially all of the Issuer’s assets consist of the cash proceeds of the Issuer’s initial public offering and private placements of its securities,
and substantially all of those proceeds have been deposited in a trust account (the “Trust Account”) for the benefit of the Issuer, its public shareholders and the underwriters of the Issuer’s initial public offering. For and
in consideration of the Issuer entering into this Subscription Agreement, the receipt and sufficiency of which are hereby acknowledged, Subscriber, on behalf of itself and its affiliates and representatives, hereby irrevocably waives any and all
right, title and interest, or any claim of any kind they have or may have in the future as a result of, or arising out of, this Subscription Agreement, in or to any monies held in the Trust Account, and agrees not to seek recourse or make or bring
any action, suit, claim or other proceeding against the Trust Account as a result of, or arising out of, this Subscription Agreement, the transactions contemplated hereby or the Acquired Shares, regardless of whether such claim arises based on
contract, tort, equity or any other theory of legal liability. Subscriber acknowledges and agrees that it shall not have any redemption rights with respect to the Acquired Shares pursuant to the Issuer’s organizational documents in connection

  
 15 

 
with the Transactions or any other business combination, any subsequent liquidation of the Trust Account or the Issuer or otherwise. In the event Subscriber has any claim against the Issuer as a
result of, or arising out of, this Subscription Agreement, the transactions contemplated hereby or the Acquired Shares, it shall pursue such claim solely against the Issuer and its assets outside the Trust Account and not against the Trust Account
or any monies or other assets in the Trust Account. 
 8. Issuer’s Covenants. With a view to making available to Subscriber the
benefits of Rule 144 promulgated under the Securities Act or any other similar rule or regulation of the Commission that may at any time permit Subscriber to sell securities of the Issuer to the public without registration, the Issuer agrees, until
the Acquired Shares are registered for resale under the Securities Act, to: 
 (a) make and keep public information available, as those terms
are understood and defined in Rule 144; 
 (b) file with the Commission in a timely manner all reports and other documents required of the
Issuer under the Securities Act and the Exchange Act so long as the Issuer remains subject to such requirements and the filing of such reports and other documents is required for the applicable provisions of Rule 144; and 

(c) furnish to Subscriber so long as it owns Acquired Shares, as promptly as practicable upon request, (x) a written statement by the
Issuer, if true, that it has complied with the reporting requirements of Rule 144, the Securities Act and the Exchange Act, (y) a copy of the most recent annual or quarterly report of the Issuer and such other reports and documents so filed by
the Issuer with the SEC and (z) such other information as may be reasonably requested to permit Subscriber to sell such securities pursuant to Rule 144 without registration. 

9. Miscellaneous. 
 (a)
Subscriber acknowledges that the Issuer and others will rely on the acknowledgments, understandings, agreements, representations and warranties contained in this Subscription Agreement. Prior to the Subscription Closing, Subscriber agrees to
promptly notify the Issuer if any of the acknowledgments, understandings, agreements, representations and warranties set forth herein are no longer accurate in all material respects. 

(b) Each of the Issuer and Subscriber is entitled to rely upon this Subscription Agreement and is irrevocably authorized to produce this
Subscription Agreement or a copy hereof to any interested party in any administrative or legal proceeding or official inquiry with respect to the matters covered hereby. 

(c) Neither this Subscription Agreement nor any rights that may accrue to Subscriber hereunder (other than the Acquired Shares acquired
hereunder, if any) may be transferred or assigned. Neither this Subscription Agreement nor any rights that may accrue to the Issuer hereunder may be transferred or assigned. 

(d) All the agreements, representations and warranties made by each party hereto in this Subscription Agreement shall survive the Subscription
Closing. 

  
 16 

 (e) The Issuer may request from Subscriber such additional information as the Issuer may
deem reasonably necessary to evaluate the eligibility of Subscriber to acquire the Acquired Shares and to comply with the Issuer’s registration obligations under Section 5(a) of this Subscription Agreement, and
Subscriber shall provide such information as may be reasonably requested, to the extent readily available and to the extent consistent with its internal policies and procedures. 

(f) This Subscription Agreement may not be modified, waived or terminated except by an instrument in writing, signed by the party against whom
enforcement of such modification, waiver, or termination is sought. 
 (g) This Subscription Agreement constitutes the entire agreement, and
supersedes all other prior agreements, understandings, representations and warranties, both written and oral, between the parties, with respect to the subject matter hereof. 

(h) Except as otherwise provided herein, this Subscription Agreement shall be binding upon, and inure to the benefit of the parties hereto and
their heirs, executors, administrators, successors, legal representatives, and permitted assigns, and the agreements, representations, warranties, covenants and acknowledgments contained herein shall be deemed to be made by, and be binding upon,
such heirs, executors, administrators, successors, legal representatives and permitted assigns. Notwithstanding anything to the contrary in this Agreement, the Panavision Holder Representative is an express third-party beneficiary of this Agreement
and shall be entitled to seek and obtain equitable relief, without proof of actual damages, including an injunction or injunctions or order for specific performance to prevent breaches of this Agreement and to enforce specifically the terms and
provisions of this Agreement to cause Issuer to cause, or directly cause, Subscriber to fund the Purchase Price and cause the Subscription Closing to occur if the conditions in Section 2(b) have been satisfied or, to the extent permitted by
applicable law, waived. Each party hereto further agrees that the Panavision Holder Representative shall not be required to obtain, furnish or post any bond or similar instrument in connection with or as a condition to obtaining any remedy referred
to in this Section 9(h), and each party hereto irrevocably waives any right it may have to require the obtaining, furnishing or posting of any such bond or similar instrument. 

(i) If any provision of this Subscription Agreement shall be invalid, illegal or unenforceable, the validity, legality or enforceability of the
remaining provisions of this Subscription Agreement shall not in any way be affected or impaired thereby and shall continue in full force and effect. 

(j) This Subscription Agreement may be executed in two (2) or more counterparts (including by electronic means), all of which shall be
considered one and the same agreement and shall become effective when signed by each of the parties and delivered to the other parties, it being understood that all parties need not sign the same counterpart. 

(k) Subscriber shall pay all of its own expenses in connection with this Subscription Agreement and the transactions contemplated herein. 

  
 17 

 (l) Notices. Any notice or communication required or permitted hereunder shall be in
writing and either delivered personally, emailed or telecopied, sent by overnight mail via a reputable overnight carrier, or sent by certified or registered mail, postage prepaid, and shall be deemed to be given and received (i) when so
delivered personally, (ii) upon receipt of an appropriate electronic answerback or confirmation when so delivered by telecopy (to such number specified below or another number or numbers as such person may subsequently designate by notice given
hereunder), (iii) when sent, with no mail undeliverable or other rejection notice, if sent by email, or (iv) five (5) business days after the date of mailing to the address below or to such other address or addresses as such person may
hereafter designate by notice given hereunder: 
 (i) if to Subscriber, to such address or addresses set forth on the signature page hereto;

 (ii) if to the Issuer, to: 

Saban Capital Acquisition Corp. 

10100 Santa Monica Boulevard, 26th Floor 

Los Angeles, California 90067 

Attention:      Adam Chesnoff 

Email: achesnoff@sabanac.com 
 with a required
copy to (which copy shall not constitute notice): 
 Skadden, Arps, Slate, Meagher & Flom LLP 

300 South Grand Avenue, Suite 3400 

Los Angeles, CA 90071 

Attention:      Jeffrey H. Cohen 

David C. Eisman 
 E-mail:          jeffrey.cohen@skadden.com 

david.eisman@skadden.com 
 (m)
This Subscription Agreement, and any claim or cause of action hereunder based upon, arising out of or related to this Subscription Agreement (whether based on law, in equity, in contract, in tort or any other theory) or the negotiation, execution,
performance or enforcement of this Subscription Agreement, shall be governed by and construed in accordance with the Laws of the State of New York. 

THE PARTIES HERETO IRREVOCABLY SUBMIT TO THE EXCLUSIVE JURISDICTION OF THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF NEW YORK, THE SUPREME
COURT OF THE STATE OF NEW YORK AND THE FEDERAL COURTS OF THE UNITED STATES OF AMERICA LOCATED IN THE STATE OF NEW YORK SOLELY IN RESPECT OF THE INTERPRETATION AND ENFORCEMENT OF THE PROVISIONS OF THIS SUBSCRIPTION AGREEMENT AND THE DOCUMENTS
REFERRED TO IN THIS SUBSCRIPTION AGREEMENT AND IN RESPECT OF THE TRANSACTIONS CONTEMPLATED HEREBY, AND HEREBY WAIVE, AND AGREE NOT TO ASSERT, 

  
 18 

 
AS A DEFENSE IN ANY ACTION, SUIT OR PROCEEDING FOR INTERPRETATION OR ENFORCEMENT HEREOF OR ANY SUCH DOCUMENT THAT IS NOT SUBJECT THERETO OR THAT SUCH ACTION, SUIT OR PROCEEDING MAY NOT BE BROUGHT
OR IS NOT MAINTAINABLE IN SAID COURTS OR THAT VENUE THEREOF MAY NOT BE APPROPRIATE OR THAT THIS SUBSCRIPTION AGREEMENT OR ANY SUCH DOCUMENT MAY NOT BE ENFORCED IN OR BY SUCH COURTS, AND THE PARTIES HERETO IRREVOCABLY AGREE THAT ALL CLAIMS WITH
RESPECT TO SUCH ACTION, SUIT OR PROCEEDING SHALL BE HEARD AND DETERMINED BY SUCH A NEW YORK STATE OR FEDERAL COURT. THE PARTIES HEREBY CONSENT TO AND GRANT ANY SUCH COURT JURISDICTION OVER THE PERSON OF SUCH PARTIES AND OVER THE SUBJECT MATTER OF
SUCH DISPUTE AND AGREE THAT MAILING OF PROCESS OR OTHER PAPERS IN CONNECTION WITH SUCH ACTION, SUIT OR PROCEEDING IN THE MANNER PROVIDED IN SECTION 9(l) OF THIS SUBSCRIPTION AGREEMENT OR IN SUCH OTHER MANNER AS MAY BE PERMITTED BY LAW SHALL
BE VALID AND SUFFICIENT SERVICE THEREOF. 
 EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS SUBSCRIPTION AGREEMENT
OR THE TRANSACTIONS CONTEMPLATED HEREBY IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE EACH SUCH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT SUCH PARTY MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION
DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS SUBSCRIPTION AGREEMENT OR THE TRANSACTIONS CONTEMPLATED BY THIS SUBSCRIPTION AGREEMENT. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (I) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER
PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER; (II) SUCH PARTY UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF THE FOREGOING WAIVER;
(III) SUCH PARTY MAKES THE FOREGOING WAIVER VOLUNTARILY AND (IV) SUCH PARTY HAS BEEN INDUCED TO ENTER INTO THIS SUBSCRIPTION AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVER AND CERTIFICATIONS IN THIS SECTION 9(m). 

(n) The Issuer shall, by 9:00 a.m., New York City time, on the first (1st) business day
immediately following the date of this Subscription Agreement, issue one or more press releases or file with the Commission a Current Report on Form 8-K (collectively, the “Disclosure
Document”) disclosing all material terms of the transactions contemplated hereby, the Transactions and any other material, nonpublic information that the Issuer has provided to Subscriber at any time prior to the filing of the Disclosure
Document. From and after the issuance of the Disclosure Document, to the Issuer’s knowledge, Subscriber shall not be in possession of any material, non-public information received from the Issuer or any
of its officers, directors or employees. Notwithstanding anything in this Subscription Agreement to the contrary, the Issuer shall not publicly disclose the name of Subscriber or any of its affiliates, or include the name of Subscriber or any of its
affiliates in any press release or in any filing with 

  
 19 

 
the Commission or any regulatory agency or trading market, without the prior written consent of Subscriber, except (i) as required by the federal securities law in connection with the
Registration Statement, (ii) the filing of this Subscription Agreement (or a form of this Subscription Agreement) with the Commission in a manner reasonably acceptable to Subscriber, (iii) the filing of the Registration Statement on Form S-4 and related proxy statement to be filed by the Issuer with respect to the Transactions in a manner reasonably acceptable to Subscriber, (iv) in a press release or marketing materials of the Issuer in
connection with the Transactions in a manner reasonably acceptable to Subscriber and (v) to the extent such disclosure is required by law, at the request of the Staff of the Commission or regulatory agency or under the regulations of Nasdaq, in
which case the Issuer shall provide Subscriber with prior written notice of such disclosure permitted under this subclause (v), to the extent permitted by the Staff of the Commission or the applicable regulatory agency. 

[Signature pages follow.] 

  
 20 

 IN WITNESS WHEREOF, each of the Issuer and Subscriber has executed or caused this Subscription
Agreement to be executed by its duly authorized representative as of the date set forth below. 
  

			
	SABAN CAPITAL ACQUISITION CORP.
		
	By:	 	  

		 	Name:
		 	Title:

 [Signature Page to Subscription Agreement] 

 SUBSCRIBER: 

[•] 
  

			
	By:	 	  

	Name:
	Title:
	(Please print. Please indicate name and capacity of person signing above)

  

					
	Business Address:	  	  
	  	
		  	  
	  	
	Facsimile:	  	  
	  	
	Email:	  	  
	  	
	Attention:	  	  
	  	
	EIN:	  	  
	  	
		
	Dated:
                                        
, 2018	  	

 Aggregate Number of Acquired Shares subscribed for:
$                     
 Aggregate Purchase
Price:
$                                       
          
 Name in which securities are to be registered (if different):Common Shares:
                                        
     
 You must pay the Purchase Price by wire transfer of United States dollars in immediately available funds to the account
specified by the Issuer in the Closing Notice. 

 SCHEDULE A 

ELIGIBILITY REPRESENTATIONS OF SUBSCRIBER 

This page should be completed by Subscriber 

and constitutes a part of the Subscription Agreement. 

A. QUALIFIED INSTITUTIONAL BUYER STATUS 
 (Please check the
applicable subparagraphs): 
  

	 	1.	 ☐ We are a “qualified institutional buyer” (as defined in Rule 144A under the Securities Act (a
“QIB”)). 

  

	 	2.	 ☐ We are subscribing for the Acquired Shares as a fiduciary or agent for one or more investor accounts,
and each owner of such account is a QIB. 

 B. INSTITUTIONAL ACCREDITED INVESTOR STATUS 

(Please check the applicable subparagraphs): 
  

	 	1.	 ☐ We are an “accredited investor” (within the meaning of Rule 501(a) under the Securities Act)
or an entity in which all of the equity holders are accredited investors within the meaning of Rule 501(a) under the Securities Act, and have marked and initialed the appropriate box on the following page indicating the provision under which we
qualify as an “accredited investor.” 

  

	 	2.	 ☐ We are not a natural person. 

C. AFFILIATE STATUS 
 (Please check the applicable box) 

SUBSCRIBER: 
  

	 	☐	 is: 

  

	 	☐	 is not: 

an “affiliate” (as defined in Rule 144 under the Securities Act) of the Issuer or acting on behalf of an affiliate of the Issuer. 

Rule 501(a), in relevant part, states that an “accredited investor” shall mean any person who comes within any of the below listed categories, or
who the issuer reasonably believes comes within any of the below listed categories, at the time of the sale of the securities to that person. Subscriber has indicated, by marking and initialing the appropriate box below, the provision(s) below which
apply to Subscriber and under which Subscriber accordingly qualifies as an “accredited investor.” 
 ☐ Any bank as defined in section 3(a)(2)
of the Securities Act, or any savings and loan association or other institution as defined in section 3(a)(5)(A) of the Securities Act whether acting in its individual or fiduciary capacity; 

 ☐ Any broker or dealer registered pursuant to section 15 of the Securities Exchange Act of 1934; 

☐ Any insurance company as defined in section 2(a)(13) of the Securities Act; 

☐ Any investment company registered under the Investment Company Act of 1940 or a business development company as defined in section 2(a)(48) of that
Act; 
 ☐ Any Small Business Investment Company licensed by the U.S. Small Business Administration under section 301(c) or (d) of the Small
Business Investment Act of 1958; 
 ☐ Any plan established and maintained by a state, its political subdivisions, or any agency or instrumentality of a
state or its political subdivisions, for the benefit of its employees, if such plan has total assets in excess of $5,000,000; 
 ☐ Any employee benefit
plan within the meaning of the Employee Retirement Income Security Act of 1974 if the investment decision is made by a plan fiduciary, as defined in section 3(21) of such act, which is either a bank, savings and loan association, insurance company,
or registered investment adviser, or if the employee benefit plan has total assets in excess of $5,000,000 or, if a self-directed plan, with investment decisions made solely by persons that are accredited investors; 

☐ Any private business development company as defined in section 202(a)(22) of the Investment Advisers Act of 1940; 

☐ Any organization described in section 501(c)(3) of the Internal Revenue Code, corporation, Massachusetts or similar business trust, or partnership, not
formed for the specific purpose of acquiring the securities offered, with total assets in excess of $5,000,000; or 
 ☐ Any trust, with total assets in
excess of $5,000,000, not formed for the specific purpose of acquiring the securities offered, whose purchase is directed by a sophisticated person as described in § 230.506(b)(2)(ii). 

 Exhibit A 

THIS SECURITY HAS BEEN ACQUIRED FOR INVESTMENT AND WITHOUT A VIEW TO DISTRIBUTION AND HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF
1933 (THE “ACT”), OR UNDER STATE SECURITIES LAWS. NO TRANSFER, SALE, ASSIGNMENT, PLEDGE, HYPOTHECATION OR OTHER DISPOSITION OF THIS SECURITY OR ANY INTEREST OR PARTICIPATION THEREIN MAY BE MADE EXCEPT (A) PURSUANT TO AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT OR (B) PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS AND, IN THE CASE OF CLAUSE (B), UNLESS THE ISSUER RECEIVES AN OPINION OF COUNSEL IN FORM AND
SUBSTANCE SATISFACTORY TO THE ISSUER TO THE EFFECT THAT REGISTRATION IS NOT REQUIRED UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS. IN ADDITION, ANY SUCH TRANSFER OR OTHER DISPOSITION IS SUBJECT TO THE CONDITIONS CONTAINED IN A SUBSCRIPTION
AGREEMENT, DATED SEPTEMBER 13, 2018. A COPY OF SUCH CONDITIONS WILL BE PROVIDED TO THE HOLDER HEREOF UPON REQUEST. 
 Any transferee of
this Security or any interest therein, by its acceptance thereof, shall be deemed to have made the representations set forth in Section 4 of the Subscription Agreement. The Issuer shall not be required to register the
transfer of any Security to any transferee unless the Issuer receives from the proposed transferee a written instrument in form and substance reasonably satisfactory to the Issuer in which such transferee makes the representations and warranties set
forth in Section 4 of the Subscription Agreement and, if the Issuer so requests, an opinion of counsel in form and substance reasonably satisfactory to the Issuer to the effect that registration under the Securities Act is
not required in connection with such transfer. 

 Exhibit A 

[See attached] 

 [FORM OF AFFILIATE] SUBSCRIPTION AGREEMENT 

This SUBSCRIPTION AGREEMENT (this “Subscription Agreement”) is entered into this 13th day of September, 2018, by and among
Saban Capital Acquisition Corp., a Cayman Islands exempted company limited by shares (the “Issuer”), which shall domesticate as a Delaware corporation prior to the Subscription Closing (as defined below), and Saban Sponsor II LLC, a
Delaware limited liability company (“Subscriber”). 
 RECITALS 

WHEREAS, the Issuer intends to enter into a Business Combination Agreement (as it may be amended or supplemented from time to time, the
“Business Combination Agreement”), by and among the Issuer, Panavision Inc., a Delaware corporation (“Panavision”), SIM Video International Inc., an Ontario corporation (together with Panavision, the
“Companies”), solely in its capacity as the initial Panavision Holder Representative (as defined therein), Cerberus PV Representative, LLC, and the other parties thereto, in substantially the from previously provided to Subscriber;

 WHEREAS, in connection with the transactions contemplated by the Business Combination Agreement (collectively, the
“Transactions”), Subscriber desires to subscribe for and purchase from the Issuer that number of shares of common stock, par value $0.0001 per share (the “Common Shares”), of the Issuer set forth on the signature
page hereto (the “Acquired Shares”) for a purchase price of $10.00 per share, or the aggregate purchase price set forth on the signature page hereto (the “Purchase Price”), and the Issuer desires to issue and sell
to Subscriber the Acquired Shares in consideration of the payment of the Purchase Price by or on behalf of Subscriber to the Issuer on or prior to the Subscription Closing; and 

WHEREAS, in connection with the Transactions, certain other “accredited investors” (as such term is defined in Rule 501 under
the Securities Act of 1933, as amended (the “Securities Act”)), have entered into separate subscription agreements with the Issuer substantially in substantially the form of the draft attached hereto as Annex A), pursuant to
which such investors have, together with Subscriber pursuant to this Subscription Agreement, agreed to purchase on the Closing Date an aggregate of 5,500,000 Common Shares at the per share Purchase Price (the “Other Subscription
Agreements”). 
 NOW, THEREFORE, in consideration of the foregoing and the mutual representations, warranties and
covenants, and subject to the conditions, herein contained, and intending to be legally bound hereby, the parties hereto hereby agree as follows: 

1. Subscription. Pursuant to the terms and subject to the conditions set forth herein, Subscriber hereby agrees to subscribe for and
purchase, and the Issuer hereby agrees to issue and sell to Subscriber, upon the payment of the Purchase Price, the Acquired Shares (such subscription and issuance, the “Subscription”). 

 2. Subscription Closing. 

(a) The closing of the Subscription contemplated hereby (the “Subscription Closing”) is contingent upon the substantially
concurrent consummation of the Transactions and shall occur immediately prior thereto. Not less than five (5) business days prior to the scheduled closing date of the Transactions (the “Closing Date”), the Issuer shall provide
written notice to Subscriber (the “Closing Notice”) of such Closing Date; provided that the Issuer may delay the scheduled Closing Date up to five (5) business days following the original scheduled Closing Date
identified in the Closing Notice by written notice to Subscriber if it provides Subscriber with notice of the revised Closing Date no later than 24 hours prior to the then scheduled Closing Date. On the Closing Date, (i) the Issuer shall
deliver to Subscriber (x) the Acquired Shares in book entry form, free and clear of any liens or other restrictions whatsoever (other than those arising under state or federal securities laws or as set forth herein), in the name of Subscriber
(or its nominee in accordance with its delivery instructions) or to a custodian designated by Subscriber, as applicable and (y) a copy of the records of the Issuer’s transfer agent (the “Transfer Agent”) showing Subscriber
(or such nominee or custodian) as the owner of the Acquired Shares on and as of the Closing Date and (ii) Subscriber shall deliver to the Issuer the Purchase Price for the Acquired Shares by wire transfer of U.S. dollars in immediately
available funds to the account specified by the Issuer in the Closing Notice no later than 9:00am New York City time (unless a later time on the Closing Date is otherwise agreed by the Issuer). In the event the Closing (as defined in the Business
Combination Agreement) does not occur within one (1) business day of the Closing Date, the Issuer shall, unless the Closing occurs prior thereto, promptly (but not later than two (2) business days thereafter) return the Purchase Price to
Subscriber by wire transfer of U.S. dollars in immediately available funds to the account specified by Subscriber, and any book entries shall be deemed cancelled; provided that the return of the funds shall not terminate this Subscription
Agreement or otherwise relieve either party of any of its obligations hereunder (including the obligation to purchase the Acquired Shares at the Subscription Closing). 

(b) The Subscription Closing shall be subject to the conditions that, on the Closing Date: 

(i) no suspension of the qualification of the Acquired Shares for offering or sale or trading in the United States, or
initiation or threatening of any proceedings for any of such purposes, shall have occurred; 
 (ii) all conditions precedent
to the closing of the Transactions shall have been satisfied or waived (other than (A) those conditions that by their nature may only be satisfied at the closing of the Transactions, but subject to the satisfaction of such conditions as of the
closing of the Transactions and provided that any such waiver does not materially adversely affect Subscriber, (B) the condition pursuant to Section 11.1(g) of the Business Combination Agreement and (C) the condition pursuant to
Section 11.1 of the Business Combination Agreement to the extent they are to be satisfied by the Issuer); 
 (iii)
[Reserved]; 
 (iv) all representations and warranties made by the Issuer and Subscriber in this Subscription Agreement shall
be true and correct in all material respects as of the Closing Date (other than those representations and warranties expressly made as of an earlier date, which shall be true and correct in all material respects as of such date), in each case
without giving effect to the consummation of the Transactions; 

  
 2 

 (v) solely with respect to Subscriber, the Issuer shall have performed,
satisfied and complied in all material respects with all covenants, agreements and conditions required by this Subscription Agreement to be performed, satisfied or complied with by it at or prior to the Subscription Closing; and 

(vi) no governmental authority shall have enacted, issued, promulgated, enforced or entered any material judgment, order, law,
rule or regulation (whether temporary, preliminary or permanent) which is then in effect and has the effect of making consummation of the transactions contemplated hereby illegal or otherwise preventing or prohibiting consummation of the
transactions contemplated hereby. 
 (c) At the Subscription Closing, the parties hereto shall execute and deliver such additional documents
and take such additional actions as the parties reasonably may deem to be practical and necessary in order to consummate the Subscription as contemplated by this Subscription Agreement. 

(d) For purposes of this Subscription Agreement, “business day” shall mean any day other than (i) any Saturday or Sunday
or (ii) any other day on which banks located in New York, New York are required or authorized by applicable law to be closed for business. 
 3.
Issuer Representations and Warranties. The Issuer represents and warrants that: 
 (a) The Issuer has been duly incorporated and is
validly existing as an exempted company in good standing under the laws of the Cayman Islands. Subject to obtaining all required approvals necessary in connection with the performance of the Business Combination Agreement (including, without
limitation, the approval of the Issuer’s shareholders) (collectively, the “Required Approvals”), the Issuer has all corporate power and authority to own, lease and operate its properties and conduct its business as presently
conducted and to enter into, deliver and perform its obligations under this Subscription Agreement. As of the Closing Date, the Issuer will be duly incorporated and validly existing as a corporation in good standing under the laws of the State of
Delaware, with corporate power and authority to own, lease and operate its properties and conduct its business as presently conducted and to enter into, deliver and perform its obligations under this Subscription Agreement. 

(b) As of the Closing Date, the Acquired Shares will be duly authorized and, when issued and delivered to Subscriber against full payment for
the Acquired Shares in accordance with the terms of this Subscription Agreement and registered with the Transfer Agent, the Acquired Shares will be validly issued, fully paid and non-assessable and will not
have been issued in violation of or subject to any preemptive or similar rights created under the Issuer’s certificate of incorporation and bylaws or under the Delaware General Corporation Law. 

(c) This Subscription Agreement has been duly authorized, executed and delivered by the Issuer and, assuming that this Subscription Agreement
constitutes the valid and binding agreement of Subscriber, is the valid and binding obligations of the Issuer, enforceable against the Issuer in accordance with its terms, except as may be limited or otherwise affected by (i) applicable
bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium or other laws relating to or affecting the rights of creditors generally, and (ii) principles of equity, whether considered at law or equity. 

  
 3 

 (d) Subject to obtaining the Required Approvals, the execution, delivery and performance of
this Subscription Agreement (including compliance by the Issuer with all of the provisions hereof), issuance and sale of the Acquired Shares, and the consummation of the other transactions contemplated herein, will not conflict with or result in a
breach or violation of any of the terms or provisions of, or constitute a default under, or result in the creation or imposition of any lien, charge or encumbrance upon any of the property or assets of the Issuer pursuant to the terms of
(i) any indenture, mortgage, deed of trust, loan agreement, lease, license or other agreement or instrument to which the Issuer is a party or by which the Issuer is bound or to which any of the property or assets of the Issuer is subject, which
would reasonably be expected to have a material adverse effect on the business, properties, financial condition, stockholders’ equity or results of operations of the Issuer (a “Material Adverse Effect”) or materially affect the
validity of the Acquired Shares or the legal authority of the Issuer to comply in all material respects with the terms of this Subscription Agreement; (ii) the organizational documents of the Issuer; or (iii) any statute or any judgment,
order, rule or regulation of any court or governmental agency or body, domestic or foreign, having jurisdiction over the Issuer or any of its properties that would reasonably be expected to have a Material Adverse Effect or materially affect the
validity of the Acquired Shares or the legal authority of the Issuer to comply in all material respects with this Subscription Agreement. 

(e) Other than the Issuer’s Class F ordinary shares, par value $0.0001 per share (“Class F
Shares”), there are no securities or instruments issued by or to which the Issuer is a party containing anti-dilution or similar provisions that will be triggered by the issuance of (i) the Acquired Shares or (ii) the shares to be
issued pursuant to any Other Subscription Agreement that have not been or will not be validly waived on or prior to the Closing Date; provided that the holders of the Class F Shares will waive any such anti-dilution or similar provisions
in connection with the Transactions. 
 (f) The Issuer is not in default or violation (and no event has occurred which, with notice or the
lapse of time or both, would constitute a default or violation) of any term, condition or provision of (i) the organizational documents of the Issuer, (ii) any loan or credit agreement, note, bond, mortgage, indenture, lease or other
agreement, permit, franchise or license to which the Issuer is now a party or by which the Issuer’s properties or assets are bound or (iii) any statute or any judgment, order, rule or regulation of any court or governmental agency or body,
domestic or foreign, having jurisdiction over the Issuer or any of its properties, except, in the case of clauses (ii) and (iii), for defaults or violations that have not had and would not be reasonably likely to have, individually or in the
aggregate, a Material Adverse Effect. 
 (g) The Issuer is not required to obtain any consent, waiver, authorization or order of, give any
notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority, self-regulatory organization or other person in connection with the execution, delivery and performance by the Issuer of
this Subscription Agreement (including, without limitation, the issuance of the Acquired Shares), other than (i) filings with the Securities and Exchange Commission (the “Commission”), (ii) filings required by applicable state

  
 4 

 
securities laws, (iii)the filings required in accordance with Section 9(n) of this Subscription Agreement; (iv) those required by the Nasdaq Capital Market
(“Nasdaq”), including with respect to obtaining shareholder approval, and (v) the failure of which to obtain would not be reasonably likely to have, individually or in the aggregate, a Material Adverse Effect. 

(h) As of the date of this Subscription Agreement, the authorized capital stock of the Issuer consists of (i) 5,000,000 preferred shares,
par value $0.0001 per share (“Preferred Shares”), (ii) 500,000,000 Class A ordinary shares, par value $0.0001 per share, and (iii) 20,000,000 Class F Shares. As of the date hereof: (i) no shares of Preferred Stock are
issued and outstanding, (ii) 25,000,000 Class A ordinary shares, par value $0.0001 per share, are issued and outstanding, (iii) 6,243,480 Class F Shares are issued and outstanding and (iv) warrants to purchase 19,500,000 Common
Shares are outstanding. 
 (i) The Issuer has not received any written communication from a governmental entity that alleges that the Issuer
is not in compliance with or is in default or violation of any applicable law, except where such non-compliance, default or violation would not, individually or in the aggregate, be reasonably likely to have a
Material Adverse Effect. 
 (j) The issued and outstanding Class A ordinary shares are registered pursuant to Section 12(b) of the
Securities Exchange Act of 1934, as amended (the “Exchange Act”), and are listed for trading on Nasdaq under the symbol “SCAC”. There is no suit, action, proceeding or investigation pending or, to the knowledge of the
Issuer, threatened against the Issuer by Nasdaq or the Commission with respect to any intention by such entity to deregister the Class A ordinary shares or prohibit or terminate the listing of the Class A ordinary shares on Nasdaq. The
Issuer has taken no action that is designed to terminate the registration of the Common Shares under the Exchange Act. 
 (k) Assuming the
accuracy of Subscriber’s representations and warranties set forth in Section 4 of this Subscription Agreement, no registration under the Securities Act is required for the offer and sale of the Acquired Shares by the
Issuer to Subscriber. 
 (l) Neither the Issuer nor anyone acting on its behalf has offered the Common Shares or any similar securities for
sale to, or solicited any offer to buy any of the same from, or otherwise approached or negotiated in respect thereof with, any person other than Subscriber and other Institutional Accredited Investors, each of which has been offered Common Shares
at a private sale for investment. “Institutional Accredited Investor” means an institutional accredited investor as defined in Rule 501(a)(1), (2), (3) or (7) under the Securities Act. 

(m) None of the Issuer nor any of its affiliates has offered Common Shares or any similar securities during the six months prior to the date
hereof to anyone other than in connection with the Transactions and to Subscriber and other investors in connection with the Other Subscription Agreements. The Issuer has no intention to offer Common Shares or any similar security during the six
months from the date hereof other than in connection with the Transactions. 

  
 5 

 (n) Neither the Issuer nor any person acting on its behalf has offered or sold the Acquired
Shares by any form of general solicitation or general advertising, including, but not limited to, the following: (1) any advertisement, article, notice or other communication published in any newspaper, magazine, or similar media or broadcast
over television or radio; (2) any website posting or widely distributed e-mail; or (3) any seminar or meeting whose attendees have been invited by any general solicitation or general advertising.

 (o) [Reserved]. 
 (p) The
Issuer has made available to Subscriber (via the Commission’s EDGAR system) a copy of each form, report, statement, schedule, prospectus, proxy, registration statement and other document, if any, filed by the Issuer with the Commission since
its initial registration of the Class A ordinary shares (the “SEC Documents”). None of the SEC Documents filed under the Exchange Act contained, when filed or, if amended, as of the date of such amendment with respect to those
disclosures that are amended, any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not
misleading; provided, that the Issuer makes no such representation or warranty with respect to the Registration Statement on Form S-4 and related proxy statement to be filed by the Issuer with respect
to the Transactions or any other information relating to the Companies or any of their respective affiliates included in any SEC Document or filed as an exhibit thereto. The Issuer has timely filed each report, statement, schedule, prospectus, and
registration statement that the Issuer was required to file with the Commission since its inception. There are no material outstanding or unresolved comments in comment letters from the staff of the Division of Corporation Finance (the
“Staff”) of the Commission with respect to any of the SEC Documents. 
 (q) Except for such matters as have not had and
would not be reasonably likely to have, individually or in the aggregate, a Material Adverse Effect, there is no (i) action, suit, claim or other proceeding, in each case by or before any governmental authority pending, or, to the knowledge of
the Issuer, threatened against the Issuer or (ii) judgment, decree, injunction, ruling or order of any governmental entity or arbitrator outstanding against the Issuer. 

(r) Other than the Agents (as defined below), the Issuer has not dealt with any broker, finder, commission agent, placement agent or arranger
in connection with the sale of the Acquired Shares, and the Issuer is not under any obligation to pay any broker’s fee or commission in connection with the sale of the Acquired Shares other than to the Agents. Neither the Issuer nor any of its
affiliates nor any other person acting on its behalf (other than its officers acting in such capacity) has solicited offers for, or offered or sold, the Acquired Shares other than through the Agent. 

(s) [Reserved]. 
 4. Subscriber
Representations and Warranties. Subscriber represents and warrants that: 
 (a) Subscriber has been duly formed or incorporated and is
validly existing in good standing under the laws of its jurisdiction of incorporation or formation, with power and authority to enter into, deliver and perform its obligations under this Subscription Agreement. 

  
 6 

 (b) This Subscription Agreement has been duly authorized, executed and delivered by
Subscriber and, assuming that this Subscription Agreement constitutes the valid and binding agreement of the Issuer, is the valid and binding obligations of Subscriber, enforceable against Subscriber in accordance with its terms, except as may be
limited or otherwise affected by (i) applicable bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium or other laws relating to or affecting the rights of creditors generally, and (ii) principles of equity, whether
considered at law or equity. 
 (c) The execution, delivery and performance by Subscriber of this Subscription Agreement and the consummation
of the transactions contemplated herein will not conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default under, or result in the creation or imposition of any lien, charge or encumbrance upon
any of the property or assets of Subscriber or any of its subsidiaries pursuant to the terms of (i) any indenture, mortgage, deed of trust, loan agreement, lease, license or other agreement or instrument to which Subscriber or any of its
subsidiaries is a party or by which Subscriber or any of its subsidiaries is bound or to which any of the property or assets of Subscriber or any of its subsidiaries is subject, which would reasonably be expected to have a material adverse effect on
the business, properties, financial condition, stockholders’ equity or results of operations of Subscriber and any of its subsidiaries, taken as a whole (a “Subscriber Material Adverse Effect”), or materially affect the legal
authority of Subscriber to comply in all material respects with the terms of this Subscription Agreement; (ii) the organizational documents of Subscriber; or (iii) any statute or any judgment, order, rule or regulation of any court or
governmental agency or body, domestic or foreign, having jurisdiction over Subscriber or any of its subsidiaries or any of their respective properties that would reasonably be expected to have a Subscriber Material Adverse Effect or materially
affect the legal authority of Subscriber to comply in all material respects with this Subscription Agreement. 
 (d) Subscriber represents
that it is an Institutional Accredited Investor, satisfying the applicable requirements set forth on Schedule A. Subscriber represents that it is purchasing the Acquired Shares for its own account or for one or more separate accounts
maintained by it for the benefit of one or more other Institutional Accredited Investors and not with a view to the distribution thereof, provided that the disposition of Subscriber’s property shall at all times be within Subscriber’s
control. Subscriber understands that the Acquired Shares have not been registered under the Securities Act and may be resold only if registered pursuant to the provisions of the Securities Act or if an exemption from registration is available,
except under circumstances where neither such registration nor such an exemption is required by law, and that the Issuer is not required to register the Securities other than as provided for in the Amended and Restated Registration Rights Agreement
to be entered into in connection with the Transactions among the Issuer, Subscriber and the other parties thereto. Subscriber further represents and warrants that it will not sell, transfer or otherwise dispose of the Acquired Shares or any interest
therein except in a transaction exempt from or not subject to the registration requirements of the Securities Act and except in accordance with the terms and conditions of this Subscription Agreement. Subscriber acknowledges that the Acquired Shares
will bear a restrictive legend substantially as set forth on Exhibit A to this Subscription Agreement. 
 (e) The purchase of Acquired Shares
by Subscriber has not been solicited by or through anyone other than the Issuer or the Agent. 

  
 7 

 (f) Subscriber acknowledges that the Acquired Shares will not be eligible for resale
pursuant to Rule 144A promulgated under the Securities Act. Subscriber understands and agrees that the Acquired Shares will be subject to transfer restrictions and, as a result of these transfer restrictions, Subscriber may not be able to readily
resell the Acquired Shares and may be required to bear the financial risk of an investment in the Acquired Shares for an indefinite period of time. Subscriber understands that it has been advised to consult legal counsel prior to making any offer,
resale, pledge or transfer of any of the Acquired Shares. 
 (g) Subscriber understands and agrees that Subscriber is purchasing the Acquired
Shares directly from the Issuer. Subscriber further acknowledges that there have been no representations, warranties, covenants and agreements made to Subscriber by the Issuer or any of its officers, directors or representatives, expressly or by
implication, other than those representations, warranties, covenants and agreements included in this Subscription Agreement. 
 (h)
Subscriber represents and warrants that its acquisition and holding of the Acquired Shares will not constitute or result in a non-exempt prohibited transaction under section 406 of the Employee Retirement
Income Security Act of 1974, as amended, section 4975 of the Internal Revenue Code of 1986, as amended (the “Code”), or any applicable similar law. 

(i) In making its decision to purchase the Acquired Shares, Subscriber represents that it has relied solely upon independent investigation made
by Subscriber. Subscriber acknowledges and agrees that Subscriber has received such information as Subscriber deems necessary in order to make an investment decision with respect to the Acquired Shares, including with respect to the Issuer, the
Transactions and the Companies. Subscriber represents and agrees that Subscriber and Subscriber’s professional advisor(s), if any, have had the full opportunity to ask such questions, receive such answers and obtain such information as
Subscriber and such Subscriber’s professional advisor(s), if any, have deemed necessary to make an investment decision with respect to the Acquired Shares. Subscriber acknowledges and agrees that it has not relied on the Agents or any of the
Agents’ affiliates with respect to its decision to purchase the Acquired Shares. 
 (j) Subscriber became aware of this offering of the
Acquired Shares solely by means of direct contact between Subscriber and the Issuer or by means of contact from Goldman Sachs & Co. LLC or Deutsche Bank Securities Inc., acting as placement agents for the Issuer (together, the
“Agents”), and the Acquired Shares were offered to Subscriber solely by direct contact between Subscriber and the Issuer or by contact between Subscriber and the Agent. Subscriber did not become aware of this offering of the
Acquired Shares, nor were the Acquired Shares offered to Subscriber, by any other means. Subscriber acknowledges that the Issuer represents and warrants that the Acquired Shares (i) were not offered by any form of general solicitation or
general advertising and (ii) are not being offered in a manner involving a public offering under, or in a distribution in violation of, the Securities Act, or any state securities laws. 

(k) Subscriber acknowledges that it is aware that there are substantial risks incident to the purchase and ownership of the Acquired Shares.
Subscriber has such knowledge and experience in financial and business matters as to be capable of evaluating the merits and risks of an investment in the Acquired Shares, and Subscriber has sought such accounting, legal and tax advice as Subscriber
has considered necessary to make an informed investment decision. 

  
 8 

 (l) Alone, or together with any professional advisor(s), Subscriber represents and
acknowledges that Subscriber has adequately analyzed and fully considered the risks of an investment in the Acquired Shares and determined that the Acquired Shares are a suitable investment for Subscriber and that Subscriber is able at this time and
in the foreseeable future to bear the economic risk of a total loss of Subscriber’s investment in the Issuer. Subscriber acknowledges specifically that a possibility of total loss exists. 

(m) Subscriber understands and agrees that no federal or state agency has passed upon or endorsed the merits of the offering of the Acquired
Shares or made any findings or determination as to the fairness of this investment. 
 (n) Subscriber represents and warrants that Subscriber
is not (i) a person or entity named on the List of Specially Designated Nationals and Blocked Persons, the Executive Order 13599 List, the Foreign Sanctions Evaders List, or the Sectoral Sanctions Identification List, each of which is
administered by the U.S. Treasury Department’s Office of Foreign Assets Control (“OFAC”), or any other Executive Order issued by the President of the United States and administered by OFAC (collectively “OFAC
Lists”), (ii) owned or controlled by, or acting on behalf of, a person, that is named on an OFAC List; (iii) organized, incorporated, established, located, resident or born in, or a citizen, national, or the government, including any
political subdivision, agency, or instrumentality thereof, of, Cuba, Iran, North Korea, Syria, the Crimea region of Ukraine, or any other country or territory embargoed or subject to substantial trade restrictions by the United States, (iv) a
Designated National as defined in the Cuban Assets Control Regulations, 31 C.F.R. Part 515, or (v) a non-U.S. shell bank or providing banking services indirectly to a
non-U.S. shell bank (collectively, a “Prohibited Investor”). Subscriber represents that if it is a financial institution subject to the Bank Secrecy Act (31 U.S.C. section 5311 et seq.) (the
“BSA”), as amended by the USA PATRIOT Act of 2001 (the “PATRIOT Act”), and its implementing regulations (collectively, the “BSA/PATRIOT Act”), that Subscriber maintains policies and procedures
reasonably designed to comply with applicable obligations under the BSA/PATRIOT Act. Subscriber also represents that, to the extent required by applicable laws, it maintains policies and procedures reasonably designed to ensure compliance with
OFAC-administered sanctions programs, including for the screening of its investors against the OFAC Lists. Subscriber further represents and warrants that, to the extent required by applicable laws, it maintains policies and procedures reasonably
designed to ensure that the funds held by Subscriber and used to purchase the Acquired Shares were legally derived. 
 (o) If Subscriber is
or is acting on behalf of (i) an employee benefit plan that is subject to Title I of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”), (ii) a plan, an individual retirement account or other
arrangement that is subject to section 4975 of the Code, (iii) an entity whose underlying assets are considered to include “plan assets” of any such plan, account or arrangement described in clauses (i) and (ii) (each, an
“ERISA Plan”), or (iv) an employee benefit plan that is a governmental plan (as defined in section 3(32) of ERISA), a church plan (as defined in section 3(33) of ERISA), a non-U.S. plan
(as described in section 4(b)(4) of ERISA) or other plan that is not subject to the foregoing clauses (i), (ii) or (iii) but may be subject to provisions under any other federal, state, local, non-U.S. or
other laws or regulations that are similar to such provisions of ERISA or the Code (collectively, “Similar Laws”, and together with ERISA Plans, “Plans”) (iv) , Subscriber represents and warrants that (i) neither
Issuer, nor any of its respective affiliates (the 

  
 9 

 
“Transaction Parties”) has provided investment advice or has otherwise acted as the Plan’s fiduciary, with respect to its decision to acquire and hold the Acquired Shares,
and none of the Transaction Parties shall at any time be the Plan’s fiduciary with respect to any decision to acquire, continue to hold, transfer or otherwise dispose of the Acquired Shares; (ii) the decision to invest in the Acquired
Shares has been made at the recommendation or direction of a fiduciary (for purposes of ERISA and/or section 4975 of the Code, or any applicable Similar Law) with respect to Subscriber’s investment in the Acquired Shares who is
(A) independent of the Transaction Parties; (B) acknowledges that none of the Transaction Parties will not provide impartial investment advice, or to give advice in a fiduciary capacity, in connection with Subscriber’s investment in
the Acquired Shares and (C) its purchase of Acquired Shares will not result is non-exempt prohibited transaction under Section 406 of ERISA or Section 4975 of the Code, or any applicable Similar
Law. 
 (p) Subscriber has, and at the Subscription Closing will have, sufficient funds to pay the Purchase Price pursuant to
Section 2(a) of this Subscription Agreement. 
 (p) The purchase of the Acquired Shares by Subscriber will not
subject the Issuer to any of the “Bad Actor” disqualifications described in Rule 506(d) under the Securities Act. 
 5.
[Reserved]. 
 6. Termination. This Subscription Agreement shall terminate and be void and of no further force and effect, and
all rights and obligations of the parties hereunder shall terminate without any further liability on the part of any party in respect thereof, upon the earlier to occur of (a) such date and time as the Business Combination Agreement is
terminated in accordance with its terms, (b) upon the mutual written agreement of each of the parties hereto to terminate this Subscription Agreement, (c) if any of the conditions to Subscription Closing set forth in
Section 2 of this Subscription Agreement are not satisfied on or prior to the Subscription Closing and, as a result thereof, the transactions contemplated by this Subscription Agreement are not consummated at the
Subscription Closing and (d) the End Date (as defined in the Business Combination Agreement); provided, that nothing herein will relieve any party from liability for any willful breach hereof prior to the time of termination, and each
party will be entitled to any remedies at law or in equity to recover losses, liabilities or damages arising from such breach. The Issuer shall promptly notify Subscriber of the termination of the Business Combination Agreement. 

7. Trust Account Waiver. Subscriber acknowledges that the Issuer is a blank check company with the powers and privileges to effect a
merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination involving the Issuer and one or more businesses. Subscriber further acknowledges that, as described in the Issuer’s prospectus relating to
its initial public offering dated September 15, 2016, available at www.sec.gov, substantially all of the Issuer’s assets consist of the cash proceeds of the Issuer’s initial public offering and private placements of its securities,
and substantially all of those proceeds have been deposited in a trust account (the “Trust Account”) for the benefit of the Issuer, its public shareholders and the underwriters of the Issuer’s initial public offering. For and
in consideration of the Issuer entering into this Subscription Agreement, the receipt and sufficiency of which are hereby acknowledged, Subscriber, on behalf of itself and its affiliates and representatives, hereby

  
 10 

 
irrevocably waives any and all right, title and interest, or any claim of any kind they have or may have in the future as a result of, or arising out of, this Subscription Agreement, in or to any
monies held in the Trust Account, and agrees not to seek recourse or make or bring any action, suit, claim or other proceeding against the Trust Account as a result of, or arising out of, this Subscription Agreement, the transactions contemplated
hereby or the Acquired Shares, regardless of whether such claim arises based on contract, tort, equity or any other theory of legal liability. Subscriber acknowledges and agrees that it shall not have any redemption rights with respect to the
Acquired Shares pursuant to the Issuer’s organizational documents in connection with the Transactions or any other business combination, any subsequent liquidation of the Trust Account or the Issuer or otherwise. In the event Subscriber has any
claim against the Issuer as a result of, or arising out of, this Subscription Agreement, the transactions contemplated hereby or the Acquired Shares, it shall pursue such claim solely against the Issuer and its assets outside the Trust Account and
not against the Trust Account or any monies or other assets in the Trust Account. 
 8. [Reserved]. 

9. Miscellaneous. 
 (a)
Subscriber acknowledges that the Issuer and others will rely on the acknowledgments, understandings, agreements, representations and warranties contained in this Subscription Agreement. Prior to the Subscription Closing, Subscriber agrees to
promptly notify the Issuer if any of the acknowledgments, understandings, agreements, representations and warranties set forth herein are no longer accurate in all material respects. 

(b) Each of the Issuer and Subscriber is entitled to rely upon this Subscription Agreement and is irrevocably authorized to produce this
Subscription Agreement or a copy hereof to any interested party in any administrative or legal proceeding or official inquiry with respect to the matters covered hereby. 

(c) Neither this Subscription Agreement nor any rights that may accrue to Subscriber hereunder (other than the Acquired Shares acquired
hereunder, if any) may be transferred or assigned. Neither this Subscription Agreement nor any rights that may accrue to the Issuer hereunder may be transferred or assigned. 

(d) All the agreements, representations and warranties made by each party hereto in this Subscription Agreement shall survive the Subscription
Closing. 
 (e) The Issuer may request from Subscriber such additional information as the Issuer may deem reasonably necessary to evaluate
the eligibility of Subscriber to acquire the Acquired Shares, and Subscriber shall provide such information as may be reasonably requested, to the extent readily available and to the extent consistent with its internal policies and procedures. 

(f) This Subscription Agreement may not be modified, waived or terminated except by an instrument in writing, signed by the party against whom
enforcement of such modification, waiver, or termination is sought. 

  
 11 

 (g) This Subscription Agreement constitutes the entire agreement, and supersedes all other
prior agreements, understandings, representations and warranties, both written and oral, between the parties, with respect to the subject matter hereof. 

(h) Except as otherwise provided herein, this Subscription Agreement shall be binding upon, and inure to the benefit of the parties hereto and
their heirs, executors, administrators, successors, legal representatives, and permitted assigns, and the agreements, representations, warranties, covenants and acknowledgments contained herein shall be deemed to be made by, and be binding upon,
such heirs, executors, administrators, successors, legal representatives and permitted assigns. Notwithstanding anything to the contrary in this Agreement, the Panavision Holder Representative is an express third-party beneficiary of this Agreement
and shall be entitled to seek and obtain equitable relief, without proof of actual damages, including an injunction or injunctions or order for specific performance to prevent breaches of this Agreement and to enforce specifically the terms and
provisions of this Agreement to cause Issuer to cause, or directly cause, Subscriber to fund the Purchase Price and cause the Subscription Closing to occur if the conditions in Section 2(b) have been satisfied or, to the extent permitted by
applicable law, waived. Each party hereto further agrees that the Panavision Holder Representative shall not be required to obtain, furnish or post any bond or similar instrument in connection with or as a condition to obtaining any remedy referred
to in this Section 9(h), and each party hereto irrevocably waives any right it may have to require the obtaining, furnishing or posting of any such bond or similar instrument. 

(i) If any provision of this Subscription Agreement shall be invalid, illegal or unenforceable, the validity, legality or enforceability of the
remaining provisions of this Subscription Agreement shall not in any way be affected or impaired thereby and shall continue in full force and effect. 

(j) This Subscription Agreement may be executed in two (2) or more counterparts (including by electronic means), all of which shall be
considered one and the same agreement and shall become effective when signed by each of the parties and delivered to the other parties, it being understood that all parties need not sign the same counterpart. 

(k) Subscriber shall pay all of its own expenses in connection with this Subscription Agreement and the transactions contemplated herein. 

(l) Notices. Any notice or communication required or permitted hereunder shall be in writing and either delivered personally, emailed or
telecopied, sent by overnight mail via a reputable overnight carrier, or sent by certified or registered mail, postage prepaid, and shall be deemed to be given and received (i) when so delivered personally, (ii) upon receipt of an
appropriate electronic answerback or confirmation when so delivered by telecopy (to such number specified below or another number or numbers as such person may subsequently designate by notice given hereunder), (iii) when sent, with no mail
undeliverable or other rejection notice, if sent by email, or (iv) five (5) business days after the date of mailing to the address below or to such other address or addresses as such person may hereafter designate by notice given
hereunder: 

  
 12 

 (i) if to Subscriber, to such address or addresses set forth on the signature page hereto;

 (ii) if to the Issuer, to: 

Saban Capital Acquisition Corp. 

10100 Santa Monica Boulevard, 26th Floor 

Los Angeles, California 90067 

Attention:         Adam Chesnoff 

Email: achesnoff@sabanac.com 
 with a required
copy to (which copy shall not constitute notice): 
 Skadden, Arps, Slate, Meagher & Flom LLP 

300 South Grand Avenue, Suite 3400 

Los Angeles, CA 90071 
 Attention:
       Jeffrey H. Cohen 
   David C. Eisman 

E-mail:            jeffrey.cohen@skadden.com

  david.eisman@skadden.com 

(m) This Subscription Agreement, and any claim or cause of action hereunder based upon, arising out of or related to this Subscription
Agreement (whether based on law, in equity, in contract, in tort or any other theory) or the negotiation, execution, performance or enforcement of this Subscription Agreement, shall be governed by and construed in accordance with the Laws of the
State of New York. 
 THE PARTIES HERETO IRREVOCABLY SUBMIT TO THE EXCLUSIVE JURISDICTION OF THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT
OF NEW YORK, THE SUPREME COURT OF THE STATE OF NEW YORK AND THE FEDERAL COURTS OF THE UNITED STATES OF AMERICA LOCATED IN THE STATE OF NEW YORK SOLELY IN RESPECT OF THE INTERPRETATION AND ENFORCEMENT OF THE PROVISIONS OF THIS SUBSCRIPTION AGREEMENT
AND THE DOCUMENTS REFERRED TO IN THIS SUBSCRIPTION AGREEMENT AND IN RESPECT OF THE TRANSACTIONS CONTEMPLATED HEREBY, AND HEREBY WAIVE, AND AGREE NOT TO ASSERT, AS A DEFENSE IN ANY ACTION, SUIT OR PROCEEDING FOR INTERPRETATION OR ENFORCEMENT HEREOF
OR ANY SUCH DOCUMENT THAT IS NOT SUBJECT THERETO OR THAT SUCH ACTION, SUIT OR PROCEEDING MAY NOT BE BROUGHT OR IS NOT MAINTAINABLE IN SAID COURTS OR THAT VENUE THEREOF MAY NOT BE APPROPRIATE OR THAT THIS SUBSCRIPTION AGREEMENT OR ANY SUCH DOCUMENT
MAY NOT BE ENFORCED IN OR BY SUCH COURTS, AND THE PARTIES HERETO IRREVOCABLY AGREE THAT ALL CLAIMS WITH RESPECT TO SUCH ACTION, SUIT OR PROCEEDING SHALL BE HEARD AND DETERMINED BY SUCH A NEW YORK STATE OR FEDERAL COURT. THE PARTIES HEREBY CONSENT TO
AND GRANT ANY SUCH COURT JURISDICTION OVER THE PERSON OF SUCH PARTIES AND OVER THE 

  
 13 

 
SUBJECT MATTER OF SUCH DISPUTE AND AGREE THAT MAILING OF PROCESS OR OTHER PAPERS IN CONNECTION WITH SUCH ACTION, SUIT OR PROCEEDING IN THE MANNER PROVIDED IN SECTION 9(l) OF THIS
SUBSCRIPTION AGREEMENT OR IN SUCH OTHER MANNER AS MAY BE PERMITTED BY LAW SHALL BE VALID AND SUFFICIENT SERVICE THEREOF. 
 EACH PARTY ACKNOWLEDGES
AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS SUBSCRIPTION AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE EACH SUCH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY
WAIVES ANY RIGHT SUCH PARTY MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS SUBSCRIPTION AGREEMENT OR THE TRANSACTIONS CONTEMPLATED BY THIS SUBSCRIPTION AGREEMENT. EACH PARTY
CERTIFIES AND ACKNOWLEDGES THAT (I) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER;
(II) SUCH PARTY UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF THE FOREGOING WAIVER; (III) SUCH PARTY MAKES THE FOREGOING WAIVER VOLUNTARILY AND (IV) SUCH PARTY HAS BEEN INDUCED TO ENTER INTO THIS SUBSCRIPTION AGREEMENT BY, AMONG
OTHER THINGS, THE MUTUAL WAIVER AND CERTIFICATIONS IN THIS SECTION 9(m). 
 (n) The Issuer shall, by 9:00 a.m., New York City
time, on the first (1st) business day immediately following the date of this Subscription Agreement, issue one or more press releases or file with the Commission a Current Report on Form 8-K (collectively, the “Disclosure Document”) disclosing all material terms of the transactions contemplated hereby, the Transactions and any other material, nonpublic information that the Issuer
has provided to Subscriber at any time prior to the filing of the Disclosure Document. From and after the issuance of the Disclosure Document, to the Issuer’s knowledge, Subscriber shall not be in possession of any material, non-public information received from the Issuer or any of its officers, directors or employees. 

[Signature pages follow.] 

  
 14 

 IN WITNESS WHEREOF, each of the Issuer and Subscriber has executed or caused this Subscription
Agreement to be executed by its duly authorized representative as of the date set forth below. 
  

			
	SABAN CAPITAL ACQUISITION CORP.
		
	By:	 	  

		 	Name:
		 	Title:

 [Signature Page to Subscription Agreement] 

 SUBSCRIBER: 

Saban Sponsor II LLC 
  

			
	By:                                   
                 
	Name:
	Title:
	(Please print. Please indicate name and
	capacity of person signing above)
		
	Business Address:	 	  

		 	  

	Facsimile:	 	  

	Email:	 	  

	Attention:	 	  

	EIN:	 	  

Dated:                        
, 2018 
 Aggregate Number of Acquired Shares subscribed for:
$                          

Aggregate Purchase Price:
$                                         
             
 Name in which securities are to be registered (if different):Common
Shares:                                 

You must pay the Purchase Price by wire transfer of United States dollars in immediately available funds to the account specified by the Issuer in the
Closing Notice. 

 SCHEDULE A 

ELIGIBILITY REPRESENTATIONS OF SUBSCRIBER 

This page should be completed by Subscriber 

and constitutes a part of the Subscription Agreement. 

A. QUALIFIED INSTITUTIONAL BUYER STATUS 
 (Please check the
applicable subparagraphs): 
  

	 	1.	 ☐ We are a “qualified institutional buyer” (as defined in Rule 144A under the Securities Act (a
“QIB”)). 

  

	 	2.	 ☐ We are subscribing for the Acquired Shares as a fiduciary or agent for one or more investor accounts,
and each owner of such account is a QIB. 

 B. INSTITUTIONAL ACCREDITED INVESTOR STATUS 

(Please check the applicable subparagraphs): 
  

	 	1.	 ☐ We are an “accredited investor” (within the meaning of Rule 501(a) under the Securities Act)
or an entity in which all of the equity holders are accredited investors within the meaning of Rule 501(a) under the Securities Act, and have marked and initialed the appropriate box on the following page indicating the provision under which we
qualify as an “accredited investor.” 

  

	 	2.	 ☐ We are not a natural person. 

C. AFFILIATE STATUS 
 (Please check the applicable box) 

SUBSCRIBER: 
  

	 	☐	 is: 

  

	 	☐	 is not: 

an “affiliate” (as defined in Rule 144 under the Securities Act) of the Issuer or acting on behalf of an affiliate of the Issuer. 

Rule 501(a), in relevant part, states that an “accredited investor” shall mean any person who comes within any of the below listed categories, or
who the issuer reasonably believes comes within any of the below listed categories, at the time of the sale of the securities to that person. Subscriber has indicated, by marking and initialing the appropriate box below, the provision(s) below which
apply to Subscriber and under which Subscriber accordingly qualifies as an “accredited investor.” 
 ☐ Any bank as defined in section
3(a)(2) of the Securities Act, or any savings and loan association or other institution as defined in section 3(a)(5)(A) of the Securities Act whether acting in its individual or fiduciary capacity; 

 ☐ Any broker or dealer registered pursuant to section 15 of the Securities Exchange Act of 1934; 

☐ Any insurance company as defined in section 2(a)(13) of the Securities Act; 

☐ Any investment company registered under the Investment Company Act of 1940 or a business development company as defined in section 2(a)(48) of that
Act; 
 ☐ Any Small Business Investment Company licensed by the U.S. Small Business Administration under section 301(c) or (d) of the Small
Business Investment Act of 1958; 
 ☐ Any plan established and maintained by a state, its political subdivisions, or any agency or instrumentality of a
state or its political subdivisions, for the benefit of its employees, if such plan has total assets in excess of $5,000,000; 
 ☐ Any employee benefit
plan within the meaning of the Employee Retirement Income Security Act of 1974 if the investment decision is made by a plan fiduciary, as defined in section 3(21) of such act, which is either a bank, savings and loan association, insurance company,
or registered investment adviser, or if the employee benefit plan has total assets in excess of $5,000,000 or, if a self-directed plan, with investment decisions made solely by persons that are accredited investors; 

☐ Any private business development company as defined in section 202(a)(22) of the Investment Advisers Act of 1940; 

☐ Any organization described in section 501(c)(3) of the Internal Revenue Code, corporation, Massachusetts or similar business trust, or partnership, not
formed for the specific purpose of acquiring the securities offered, with total assets in excess of $5,000,000; or 
 ☐ Any trust, with total assets in
excess of $5,000,000, not formed for the specific purpose of acquiring the securities offered, whose purchase is directed by a sophisticated person as described in § 230.506(b)(2)(ii). 

 Exhibit A 

THIS SECURITY HAS BEEN ACQUIRED FOR INVESTMENT AND WITHOUT A VIEW TO DISTRIBUTION AND HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF
1933 (THE “ACT”), OR UNDER STATE SECURITIES LAWS. NO TRANSFER, SALE, ASSIGNMENT, PLEDGE, HYPOTHECATION OR OTHER DISPOSITION OF THIS SECURITY OR ANY INTEREST OR PARTICIPATION THEREIN MAY BE MADE EXCEPT (A) PURSUANT TO AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT OR (B) PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS AND, IN THE CASE OF CLAUSE (B), UNLESS THE ISSUER RECEIVES AN OPINION OF COUNSEL IN FORM AND
SUBSTANCE SATISFACTORY TO THE ISSUER TO THE EFFECT THAT REGISTRATION IS NOT REQUIRED UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS. IN ADDITION, ANY SUCH TRANSFER OR OTHER DISPOSITION IS SUBJECT TO THE CONDITIONS CONTAINED IN A SUBSCRIPTION
AGREEMENT, DATED SEPTEMBER 13, 2018. A COPY OF SUCH CONDITIONS WILL BE PROVIDED TO THE HOLDER HEREOF UPON REQUEST. 
 Any transferee of
this Security or any interest therein, by its acceptance thereof, shall be deemed to have made the representations set forth in Section 4 of the Subscription Agreement. The Issuer shall not be required to register the
transfer of any Security to any transferee unless the Issuer receives from the proposed transferee a written instrument in form and substance reasonably satisfactory to the Issuer in which such transferee makes the representations and warranties set
forth in Section 4 of the Subscription Agreement and, if the Issuer so requests, an opinion of counsel in form and substance reasonably satisfactory to the Issuer to the effect that registration under the Securities Act is
not required in connection with such transfer. 

 Annex A 

[See attached]EX-10.5

 Exhibit 10.5 

EXECUTION VERSION 

DIRECTOR COMPOSITION AND STANDSTILL AGREEMENT 

This Director Composition and Standstill Agreement (this “Agreement”) is made as of September 13, 2018, by and
among Saban Capital Acquisition Corp., a Cayman Islands exempted company limited by shares (which shall domesticate as a Delaware corporation prior to the Closing) (“Acquiror”), Saban Sponsor LLC, a Delaware limited liability
company (the “Saban Sponsor”), Saban Sponsor II LLC, a Delaware limited liability company (“Saban Sponsor II”), the Persons party hereto set forth on Schedule I attached hereto (the
“Key Panavision Stockholders”), and, solely in its capacity as the initial Panavision Holder Representative, Cerberus PV Representative, LLC, a Delaware limited liability company (the “Panavision Holder
Representative”). All of the capitalized terms used but not otherwise defined herein shall have the meanings ascribed to them in the Business Combination Agreement. 

WHEREAS, pursuant to that certain Business Combination Agreement, dated as of the date hereof (as amended, restated, supplemented or
otherwise modified from time to time in accordance with its terms, the “Business Combination Agreement”), by and among Acquiror, Panavision Acquisition Sub, Inc., SIM Acquisition Sub, Inc., Panavision Inc., SIM Video
International Inc., each of the shareholders of SIM party thereto, solely in its capacity as the initial Panavision Holder Representative thereunder, the Panavision Holder Representative, and, in its capacity as the initial SIM Holder Representative
thereunder and as a SIM Seller, Granite Film and Television Rentals Inc., Acquiror has agreed, inter alia, pursuant to Section 9.7 thereof, to take all such action as may be necessary or appropriate such that immediately following the
Effective Time the Acquiror Board consists of nine (9) directors determined in accordance with Section 9.7(c) of the Business Combination Agreement and this Agreement; 

WHEREAS, the parties hereto desire to supplement Section 9.7 of the Business Combination Agreement to more fully set forth the
covenants and agreements of the parties with respect to the Acquiror Board and certain other governance matters with respect to Acquiror; and 

WHEREAS, subject to, and conditioned upon, the occurrence of the Effective Time, each of the Key Panavision Stockholders and the Saban
Sponsor agree to not take certain actions described in Section 4 and Section 5 of this Agreement, respectively, on the terms and subject to the conditions set forth herein. 

NOW, THEREFORE, in consideration of the mutual covenants contained herein and other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the parties to this Agreement hereby agree as follows: 
 Section 1. Panavision
Directors. 
 (a) At least two (2) Business Days prior to the filing with the SEC of the Shareholder Meeting Proxy Statement
pursuant to Section 10.1(a)(ii) of the Business Combination Agreement, the Panavision Holder Representative shall specify in writing to Acquiror and the Saban Sponsor (i) the individuals to serve as Class III directors and, as
applicable, a Class II director of the Acquiror Board immediately following the Effective Time based on the number of directors that the Panavision Holder Representative is entitled to 

 
designate as directors pursuant to Section 1(c) immediately following the Effective Time (the “Designated Initial Panavision Designees”) (it
being understood and agreed that the Panavision Holder Representative may specify directors to serve in circumstances in which it is entitled to designate two (2), three (3) and four (4) directors pursuant to
Section 1(c)), (ii) the Designated Initial Panavision Designee that will serve as a member and the chairman of the nominating committee of the Acquiror Board (the “Nominating Committee”) and
(iii) the Designated Initial Panavision Designee that will serve as a member of the compensation committee of the Acquiror Board (the “Compensation Committee”) (it being understood and agreed that (x) if the
Panavision Holder Representative does not specify in writing the Designated Initial Panavision Designees pursuant to this Section 1(a), then the Class III directors and, as applicable, the Class II director of the
Acquiror Board that the Panavision Holder Representative is entitled to designate and appoint to the Acquiror Board immediately following the Effective Time (as determined pursuant to Section 1(c)) shall be the individuals
set forth on Schedule II, (y) if the Panavision Holder Representative does not specify in writing the Designated Initial Panavision Designee that will serve as a member and the chairman of the Nominating Committee, then the individual
set forth on Schedule III shall be the individual that initially serves as a member and the chairman of the Nominating Committee on behalf of the Panavision Holder Representative and (z) if the Panavision Holder Representative does not
specify in writing the Designated Initial Panavision Designee that will serve as a member of the Compensation Committee, then the individual set forth on Schedule III shall be the individual that initially serves as a member of the
Compensation Committee on behalf of the Panavision Holder Representative). The directors of the Acquiror Board designated pursuant to this Section 1(a) shall be referred to as the “Initial Panavision
Designees”. 
 (b) At and prior to the Effective Time, each of Acquiror and the Saban Sponsor shall take all necessary and
desirable actions such that, immediately following the Effective Time, (i) if the Panavision Holder Representative is entitled to designate two (2) or three (3) directors to the Acquiror Board pursuant to
Section 1(c) immediately after the Effective Time, each of the Initial Panavision Designees determined pursuant to Section 1(a) are Class III directors of Acquiror with a term ending at the
2022 annual meeting of Acquiror’s stockholders, (ii) if the Panavision Holder Representative is entitled to designate four (4) directors to the Acquiror Board pursuant to Section 1(c) immediately after the
Effective Time, three (3) of the Initial Panavision Designees determined pursuant to Section 1(a) are Class III directors of Acquiror with a term ending at the 2022 annual meeting of Acquiror’s stockholders
and one (1) of the Initial Panavision Designees determined pursuant to Section 1(a) is a Class II director of Acquiror with a term ending at the 2021 annual meeting of Acquiror’s stockholders, (iii) the
applicable Initial Panavision Designee determined pursuant to Section 1(a) is a member and the chairman of the Nominating Committee, (iv) the applicable Initial Panavision Designee determined pursuant to
Section 1(a) is a member of the Compensation Committee and (v) any Initial Panavision Designee requested by the Panavision Holder Representative to be a member of any committee of the Acquiror Board (other than the
Nominating Committee or Compensation Committee) pursuant to Section 1(g) at least two (2) Business Days prior to the filing with the SEC of the Shareholder Proxy Statement pursuant to Section 10(a)(ii) of the
Business Combination Agreement shall be a member of such committee of the Acquiror Board (it being understood and agreed that, unless otherwise agreed by the Panavision Holder Representative in writing or unless such designation would violate any
legal restriction on such committee’s composition or the rules and regulations of Nasdaq, Craig Chobor shall be appointed to the audit (or similar) committee of the Acquiror Board pursuant to Section 1(g) immediately
following the Effective Time). 

  
 2 

 (c) Upon the terms and subject to the conditions of this Agreement, from and after the
Effective Time, Acquiror will take all necessary and desirable actions within its control (including, without limitation, calling special meetings of the Acquiror Board and the stockholders and recommending, supporting and soliciting proxies), such
that (i) from and after any time that the Panavision Stockholders and their Affiliates, in the aggregate, beneficially own 32.50% or more of the issued and outstanding Acquiror Common Shares, for so long as the Panavision Stockholders and their
Affiliates, in the aggregate, beneficially own 25.00% or more of the issued and outstanding Acquiror Common Shares, the Panavision Holder Representative shall have the right, but not the obligation, to designate up to (x) three (3) individuals
to be appointed or nominated, as the case may be, as Class III directors (or a comparable class of directors) and one (1) individual to be appointed or nominated, as the case may be, as a Class II director (or a comparable class of
directors) or (y) if the Acquiror Board does not contain classes of directors, four (4) individuals to be appointed or nominated, as the case may be, as directors; (ii) if the Panavision Holder Representative is not entitled to
designate directors pursuant to clause (i) of this Section 1(c) at any determination time, then from and after any time that the Panavision Stockholders and their Affiliates, in the aggregate, beneficially own 27.50%
or more of the issued and outstanding Acquiror Common Shares, for so long as the Panavision Stockholders and their Affiliates, in the aggregate, beneficially own 17.50% or more of the issued and outstanding Acquiror Common Shares, the Panavision
Holder Representative shall have the right, but not the obligation, to designate up to three (3) individuals to be appointed or nominated, as the case may be, as Class III directors (or a comparable class of directors) or, if the Acquiror
Board does not contain classes of directors, as directors; (iii) if the Panavision Holder Representative is not entitled to designate directors pursuant to clause (i) or (ii) of this Section 1(c) at any
determination time and the Panavision Stockholders and their Affiliates, in the aggregate, beneficially own 7.50% or more of the issued and outstanding Acquiror Common Shares as of such time, then the Panavision Holder Representative shall have the
right, but not the obligation, to designate up to two (2) individuals to be appointed or nominated, as the case may be, as Class III directors (or a comparable class of directors) or, if the Acquiror Board does not contain classes of
directors, as directors; and (iv) if the Panavision Holder Representative is not entitled to designate directors pursuant to clause (i), (ii) or (iii) of this Section 1(c) as of any determination time and the
Panavision Stockholders and their Affiliates, in the aggregate, beneficially own 5.00% or more of the issued and outstanding Acquiror Common Shares as of such time, then the Panavision Holder Representative shall have the right, but not the
obligation, to designate one (1) individual to be appointed or nominated, as the case may be, as a Class III director (or a comparable class of directors) or, if the Acquiror Board does not contain classes of directors, as a director. For
the avoidance of doubt, from and after the time that the Panavision Stockholders and their Affiliates, in the aggregate, beneficially own less than 5.00% of the issued and outstanding Acquiror Common Shares, the Panavision Holder Representative
shall not have the right to designate any individual to be appointed or nominated, as the case may be, as a director of the Acquiror Board. For purposes of determining the percentage of the issued and outstanding Acquiror Common Shares owned by the
Panavision Stockholders under this Section 1(c), all Contingent Shares (as defined in the Business Combination Agreement) shall be excluded from such calculation unless and until such Contingent Shares become vested
in accordance with Section 3.16 of the Business Combination Agreement. Notwithstanding 

  
 3 

 
anything to the contrary in this Agreement, if the Panavision Holder Representative is entitled to designate an additional individual to the Acquiror Board for appointment or nomination, as
applicable, pursuant to clause (i) of this Section 1(c), then Acquiror and the Panavision Holder Representative shall agree as to, or failing agreement within three (3) Business Days the Panavision Holder
Representative shall designate, a non-Saban Director (other than the Chief Executive Officer of Acquiror) to be removed from the Acquiror Board, and Acquiror shall promptly take all necessary actions in order
for such non-Saban Director to be removed from the Acquiror Board, such director position to be filled with such individual in accordance with this Section 1(c) and for any
adjustments to the classes of the directors to be made such that the individual appointed in accordance with this Section 1(c) is a Class III director or a Class II director, as applicable. 

(d) If a vacancy on the Acquiror Board occurs because of the death, disability, disqualification, resignation, or removal of any Panavision
Director, any Panavision Director ceases to be on the Acquiror Board for any other reason or the Panavision Holder Representative is entitled to designate an additional individual to the Acquiror Board for appointment or nomination pursuant to
Section 1(c), the Panavision Holder Representative shall, so long as the Panavision Holder Representative is entitled to designate an individual to such director position for appointment or nomination, as applicable,
pursuant to Section 1(c), be entitled to designate an individual to fill such director position by giving written notice to Acquiror, and Acquiror shall, within ten (10) days of such designation, take all necessary and
desirable actions in order for such director position to be filled with such individual designated in writing pursuant to this Section 1(d). Notwithstanding anything to the contrary in this Agreement, the Business
Combination Agreement or the Governing Documents of Acquiror, (i) subject to Section 1(e), neither the Acquiror Board nor any other Person (other than the Panavision Holder Representative pursuant to this
Section 1(d)) may appoint, elect or designate any Person to fill any such director position unless, in the case of a vacant director position, the Panavision Holder Representative fails to designate a director to fill such
director position pursuant to this Section 1(d) within thirty (30) days after such vacancy on the Acquiror Board occurs, in which case such vacant director position shall be filled by the remaining directors on the
Acquiror Board in accordance with the Governing Documents of Acquiror with, unless the Panavision Holder Representative otherwise agrees in writing, an individual that qualifies as “independent” pursuant to the listing standards of Nasdaq,
and (ii) in the event that the Panavision Stockholders and their Affiliates, in the aggregate, beneficially own less than an applicable ownership threshold of the issued and outstanding Acquiror Common Shares specified in
Section 1(c), then the requisite number of Panavision Directors shall, upon request of a majority of the directors of the Acquiror Board (excluding the Panavision Directors), resign from the Acquiror Board pursuant to a
director resignation letter, in a form to be mutually agreed by Acquiror, the Panavision Holder Representative and the Saban Sponsor prior to the Closing (the “Director Resignation Letter”), and, solely with respect to such
resigning Panavision Director(s) and not any other then remaining Panavision Director(s) (if any), the provisions of this Section 1(d) shall not apply (provided that the foregoing does not limit, restrict or otherwise
affect the ability of the Panavision Holder Representative to designate additional individuals to the Acquiror Board pursuant to Section 1(c) if an applicable ownership threshold is subsequently satisfied and that the
Panavision Directors that will resign pursuant to this clause (ii) shall be determined by the Panavision Holder Representative). 

  
 4 

 (e) If an individual designated by the Panavision Holder Representative is not appointed,
nominated or elected pursuant to Section 1(a), 1(b), 1(c) or 1(d) or this Section 1(e) because of such person’s death, disability, disqualification or withdrawal as a
designee or nominee or for any other reason, then the Panavision Holder Representative shall be entitled to designate a replacement to fill such director position by giving written notice to Acquiror, and Acquiror will, within ten (10) days of
such designation, take all necessary and desirable actions in order for such director position to be filled with such person designated in writing pursuant to this Section 1(e). Notwithstanding anything to the contrary in
this Agreement, the Business Combination Agreement or the Governing Documents of Acquiror, neither the Acquiror Board nor any other Person (other than the Panavision Holder Representative pursuant to this Section 1(e)) may
appoint, elect or designate any Person to fill any such director position unless, in the case of a vacant director position, the Panavision Holder Representative fails to designate a replacement director to fill such vacant director position
pursuant to this Section 1(e) within thirty (30) days after such failure of appointment or election to the Acquiror Board occurs, in which case such vacant director position shall be filled by the remaining directors
on the Acquiror Board in accordance with the Governing Documents of Acquiror with, unless the Panavision Holder Representative otherwise agrees in writing, an individual that qualifies as “independent” pursuant to the listing standards of
Nasdaq. 
 (f) As promptly as reasonably practicable following the request of any Panavision Director, Acquiror shall enter into an
indemnification agreement with such Panavision Director, in the form entered into with the other members of the Acquiror Board. Acquiror shall pay the reasonable, documented and
out-of-pocket expenses incurred by any Panavision Director related to his or her service to Acquiror, including attending meetings of the Acquiror Board or any committee
or sub-committee thereof (including, to the extent applicable, the Nominating Committee) or events attended on behalf of Acquiror or any of its Subsidiaries at Acquiror’s request. 

(g) In accordance with the Bylaws, the Acquiror Board may from time to time by resolution establish and maintain one or more committees of the
Acquiror Board, each committee to consist of one or more directors. Acquiror shall notify the Key Panavision Stockholders in writing of any committee (other than the Nominating Committee or the Compensation Committee) of the Acquiror Board to be
established as promptly as practicable (but in any event at least five (5) Business Days) prior to the effective establishment of such committee. Without limiting the other rights of the Panavision Holder Representative and the Key Panavision
Holders under this Agreement (including pursuant to Section 1(h) and Section 1(i)), if requested by the Panavision Holder Representative in writing, Acquiror shall promptly take all necessary and
desirable actions to cause at least one (1) Panavision Director to be appointed as a member of each such committee (it being understood and agreed that, unless the Panavision Holder Representative otherwise agrees in writing, Craig Chobor shall
be a member of the audit (or similar) committee of the Acquiror Board immediately after the Effective Time) unless such designation would violate any legal restriction on such committee’s composition or the rules and regulations of Nasdaq. 

  
 5 

 (h) At any time the Panavision Stockholders and their Affiliates, in the aggregate,
beneficially own 5.00% or more of the issued and outstanding Acquiror Common Shares, if a vacancy on the Nominating Committee occurs because of the death, disability, disqualification, resignation or removal of a Panavision Director or any
Panavision Director ceases to be on the Nominating Committee for any other reason (including the end of the term of such director), then the Panavision Holder Representative shall be entitled to designate a replacement to fill such vacant committee
chairman position with another Panavision Director by giving written notice to Acquiror, and Acquiror will, within ten (10) days of such designation, take all necessary and desirable actions such that such vacant committee chairman position
will be filled with such person. Notwithstanding anything to the contrary in this Agreement, the Business Combination Agreement, the Governing Documents of Acquiror or the Nominating Committee charter or any other similar applicable documents,
(i) neither the Acquiror Board nor any other Person (other than the Panavision Holder Representative pursuant to this Section 1(h)) may appoint, elect or designate any Person to fill any such vacant committee chairman
position unless the Panavision Holder Representative fails to designate a director to fill such vacant committee chairman position pursuant to this Section 1(h) within the later of (A) forty-five (45) days after
such vacancy on the Nominating Committee occurs and (B) the date on which a Panavision Director is appointed pursuant to Sections 1(d) or 1(e), as applicable, in which case such vacant committee chairman
position shall be filled with a then-remaining Panavision Director or, if no Panavision Director is then serving on the Acquiror Board, in accordance with the Governing Documents of Acquiror and the Nominating Committee charter or other applicable
documents, and (ii) in the event that any action or meeting of the Nominating Committee occurs prior to the designation of a Person to fill such vacant committee chairman position pursuant to this Section 1(h), then,
so long as any Panavision Director is then serving on the Acquiror Board, at least one (1) Panavision Director shall be entitled to participate in such action or meeting and such other rights (including any notice or similar rights) as if a
member of the Nominating Committee. 
 (i) At any time the Panavision Stockholders and their Affiliates, in the aggregate, beneficially own
5.00% or more of the issued and outstanding Acquiror Common Shares, if a vacancy on the Compensation Committee occurs because of the death, disability, disqualification, resignation or removal of a Panavision Director or any Panavision Director
ceases to be on the Compensation Committee for any other reason (including the end of the term of such director), then the Panavision Holder Representative shall be entitled to designate a replacement to fill such vacant committee position with
another Panavision Director by giving written notice to Acquiror, and Acquiror will, within ten (10) days of such designation, take all necessary and desirable actions such that such vacant committee position will be filled with such person.
Notwithstanding anything to the contrary in this Agreement, the Business Combination Agreement, the Governing Documents of Acquiror or the Compensation Committee charter or any other similar applicable documents, (i) neither the Acquiror Board
nor any other Person (other than the Panavision Holder Representative pursuant to this Section 1(i)) may appoint, elect or designate any Person to fill any such vacant committee position unless the Panavision Holder
Representative fails to designate a director to fill such vacant committee position pursuant to this Section 1(i) within the later of (A) forty-five (45) days after such vacancy on the Compensation Committee
occurs and (B) the date on which a Panavision Director is appointed pursuant to Sections 1(d) or 1(e), as applicable, in which case such vacant committee position shall be filled with a then-remaining Panavision
Director or, if no Panavision Director is then serving on the Acquiror Board, in accordance with the Governing Documents of Acquiror and the Compensation Committee charter or other applicable documents, and (ii) in the event that any action or
meeting of the Compensation Committee occurs prior to the designation of a Person to 

  
 6 

 
fill such vacant committee position pursuant to this Section 1(i), then, so long as any Panavision Director is then serving on the Acquiror Board, at least one
(1) Panavision Director shall be entitled to participate in such action or meeting and such other rights (including any notice or similar rights) as if a member of the Compensation Committee. 

(j) For so long as any Panavision Director serves as a director of Acquiror, Acquiror shall not amend, alter or repeal any right to
indemnification or exculpation covering or benefiting any director designated pursuant to this Agreement as and to the extent consistent with applicable law, including but not limited to Article Sixth of the Certificate of Incorporation and Article
VII of the Bylaws (whether such right is contained in the Certificate of Incorporation, the Bylaws or another document) (except to the extent such amendment or alteration permits Acquiror to provide broader indemnification or exculpation rights on a
retroactive basis than permitted prior thereto). 
 (k) Subject to compliance with the listing standards of Nasdaq, the Panavision Directors
may, but do not need to, qualify as “independent” pursuant to the listing standards of Nasdaq. Unless otherwise agreed in writing by the Panavision Holder Representative, all other directors of the Acquiror Board (other than the Chief
Executive Officer of Acquiror and the Saban Directors) shall qualify as “independent” pursuant to the listing standards of Nasdaq. 

(l) At any time the Panavision Stockholders and their Affiliates, in the aggregate, beneficially own 5.00% or more of the issued and
outstanding Acquiror Common Shares, (i) if the Cerberus Holders and their Affiliates, in the aggregate, beneficially own at least 2.00% of the issued and outstanding Acquiror Common Shares, then the Cerberus Holders and their Affiliates that
beneficially own a majority of the Acquiror Common Shares beneficially owned by the Cerberus Holders and their Affiliates as of such time (the “Majority Cerberus Holders”) shall be entitled to appoint one (1) individual
that is a Cerberus Related Person (a “Cerberus Board Observer”) who shall be entitled to attend all meetings of the Acquiror Board in a non-voting capacity by giving written notice to
the Acquiror Board, and (ii) if the Solus Holders and their Affiliates, in the aggregate, beneficially own at least 2.00% of the issued and outstanding Acquiror Common Shares, then the Solus Holders and their Affiliates that beneficially own a
majority of the Acquiror Common Shares beneficially owned by the Solus Holders and their Affiliates as of such time (the “Majority Solus Holders”) shall be entitled to appoint one (1) individual that is a Solus Related
Person (a “Solus Board Observer”, and together with the Cerberus Board Observer, collectively, the “Board Observers”) who shall be entitled to attend all meetings of the Acquiror Board in a non-voting capacity by giving written notice to the Acquiror Board. Acquiror shall simultaneously give the Board Observers copies of all notices, consents, minutes and other materials (financial or otherwise), which
Acquiror provides to the Acquiror Board; provided, however, that (A) if a Board Observer has not, upon the request of Acquiror, before receiving such information, executed and delivered to Acquiror an agreement to abide by all
Acquiror policies applicable to members of the Acquiror Board and a confidentiality agreement reasonably acceptable to Acquiror (it being understood and agreed that any Board Observer shall not be required to execute and deliver more than one
agreement to abide by all Acquiror policies applicable to members of the Acquiror Board or more than one confidentiality agreement pursuant to this proviso, except to the extent that any such agreement is being updated or replaced for members of the
Acquiror Board), such Board Observer may be excluded from access to any information if the Acquiror Board determines in good faith that 

  
 7 

 
such exclusion is reasonably necessary to protect confidential proprietary information of Acquiror or confidential proprietary information of third parties that Acquiror is required to hold in
confidence, or for other similar reasons, and (B) the Acquiror Board shall have the right to withhold any information or exclude a Board Observer from any such meeting or any portion thereof if on the advice of counsel, access to such
information or attendance at, or such portion of, the meeting would reasonably be expected to result in the loss of attorney-client or similar privilege, and a Board Observer shall not be entitled to receive, and Acquiror may screen a Board Observer
from, information to the extent related to any matter that is reasonably expected to involve a conflict of interest between Acquiror and/or one or more of its Subsidiaries, on the one hand, and the Panavision Holder Representative, Cerberus, Solus
or one of their respective Affiliates, as applicable, on the other hand, due to such Persons being on opposite sides of such dispute, transaction or contract negotiation, amendment or modification or other situation. A Cerberus Board Observer may be
removed and/or, subject to the ownership thresholds required to appoint a Cerberus Board Observer pursuant to this Section 1(l), replaced at any time by the Majority Cerberus Holders by giving written notice to the Acquiror
Board of the same, and a Solus Board Observer may be removed and/or, subject to the ownership thresholds required to appoint a Solus Board Observer pursuant to this Section 1(l), replaced at any time by the Majority Solus
Holders by giving written notice to the Acquiror Board of the same. 
 Section 2. Saban Directors. 

(a) At least two (2) Business Days prior to the filing with the SEC of the Shareholder Meeting Proxy Statement pursuant to
Section 10.1(a)(ii) of the Business Combination Agreement, the Saban Sponsor shall specify in writing to Acquiror and the Panavision Holder Representative (i) one (1) individual to serve as a Class II director of the Acquiror and one
(1) individual to serve as a Class III director of the Acquiror Board (if the Panavision Holder Representative is entitled to designate two (2) Initial Panavision Designees) or two (2) individuals to serve as Class II
directors (if the Panavision Holder Representative is entitled to designate three (3) or four (4) Initial Panavision Designees) of the Acquiror Board, in each case, immediately following the Effective Time (the “Designated
Initial Saban Designees”), (ii) the Designated Initial Saban Designee that will serve as a member of the Nominating Committee and (iii) the Designated Initial Saban Designee that will serve as a member of the Compensation Committee
(it being understood and agreed that if the Saban Sponsor does not specify in writing the Designated Initial Saban Designees pursuant to this Section 2(a), then (x) the Class III director and Class II
director or (y) Class II directors, as applicable, that the Saban Sponsor is entitled to designate and appoint to the Acquiror Board immediately following the Effective Time (as determined pursuant to
Section 2(c)) shall be the individuals set forth on Schedule IV). The directors of the Acquiror Board designated pursuant to this Section 2(a) shall be referred to as the “Initial
Saban Designees”. 
 (b) At and prior to the Effective Time, Acquiror shall take all necessary and desirable actions such that,
immediately following the Effective Time, (i) if the Panavision Holder Representative is entitled to designate two (2) directors to the Acquiror Board pursuant to Section 1(c) immediately after the Effective Time,
one of the Initial Saban Designees determined pursuant to Section 2(a) is a Class III director of Acquiror with a term ending at the 2022 annual meeting of Acquiror’s stockholders and one of the Initial Saban
Designees determined pursuant to Section 2(a) is a Class II director of Acquiror with a term ending at the 2021 annual meeting 

  
 8 

 
of Acquiror’s stockholders, (ii) if the Panavision Holder Representative is entitled to designate three (3) or four (4) directors to the Acquiror Board pursuant to
Section 1(c) immediately after the Effective Time, each of the Initial Saban Designees determined pursuant to Section 2(a) is a Class II director of Acquiror with a term ending at the 2021
annual meeting of Acquiror’s stockholders, (iii) the applicable Initial Saban Designee determined pursuant to Section 2(a) is a member of the Nominating Committee and (iv) the applicable Initial Saban
Designee determined pursuant to Section 2(a) is a member of the Compensation Committee. 
 (c) Upon the terms and
subject to the conditions of this Agreement, from and after the Effective Time, Acquiror will take all necessary and desirable actions within its control (including, without limitation, calling special meetings of the Acquiror Board and the
stockholders and recommending, supporting and soliciting proxies), such that (i) from and after any time that the Saban Sponsor and its Affiliates, in the aggregate, beneficially own 7.50% or more of the issued and outstanding Acquiror Common
Shares, the Saban Sponsor shall have the right, but not the obligation, (A) if the Panavision Holder Representative is, as of such time, entitled to designate less than three (3) individuals to the Acquiror Board pursuant to
Section 1(c), to designate up to one (1) individual to be appointed or nominated, as the case may be, as a Class III director (or a comparable class of directors) and one (1) individual to be appointed or
nominated, as the case may be, as a Class II director (or a comparable class of directors) or, if the Acquiror Board does not contain classes of directors, two (2) individuals to be appointed or nominated, as the case may be, as directors
or (B) if the Panavision Holder Representative is, as of such time or immediately following the Effective Time, entitled to designate three (3) or more individuals to the Acquiror Board pursuant to Section 1(c),
to designate up to two (2) individuals to be appointed or nominated, as the case may be, as Class II directors (or a comparable class of directors) or, if the Acquiror Board does not contain classes of directors, as directors; and
(ii) if the Saban Sponsor is not entitled to designate directors pursuant to clause (i) of this Section 2(c) at any determination time that the Saban Sponsor and its Affiliates, in the aggregate, beneficially own
5.00% or more of the issued and outstanding Acquiror Common Shares as of such time, then the Saban Sponsor shall have the right, but not the obligation, to designate one (1) individual to be appointed or nominated, as the case may be, as a
Class II director (or a comparable class of directors) or, if the Acquiror Board does not contain classes of directors, as a director. For the avoidance of doubt, from and after the time that the Saban Sponsor and its Affiliates, in the
aggregate, beneficially own less than 5.00% of the issued and outstanding Acquiror Common Shares, the Saban Sponsor shall not have the right to designate any individual to be appointed or nominated, as the case may be, as a director of the Acquiror
Board. For purposes of determining the percentage of the issued and outstanding Acquiror Common Shares owned by the Saban Sponsor and its Affiliates under this Section 2(c), all Contingent Shares (as defined in the Business
Combination Agreement) shall be excluded from such calculation unless and until such Contingent Shares become vested in accordance with Section 3.16 of the Business Combination Agreement. Notwithstanding anything to the contrary in this
Agreement, if the Saban Sponsor is entitled to designate an additional individual to the Acquiror Board for appointment or nomination, as applicable, pursuant to this Section 2(c), then Acquiror and the Saban Sponsor shall
agree as to, or failing agreement within three (3) Business Days the Saban Sponsor shall designate, a non-Panavision Director (other than the Chief Executive Officer of Acquiror) to be removed from the
Acquiror Board, and Acquiror shall promptly take all necessary actions in order for such non-Panavision Director to be removed from the Acquiror Board, such director position to be filled with such individual
in accordance with this Section 2(c) and for any adjustments to the classes of the directors to be made such that the individual appointed in accordance with this Section 2(c) is a Class III director or
Class II director, as applicable. 

  
 9 

 (d) If a vacancy on the Acquiror Board occurs because of the death, disability,
disqualification, resignation, or removal of any Saban Director or any Saban Director ceases to be on the Acquiror Board for any other reason, the Saban Sponsor shall, so long as the Saban Sponsor is entitled to designate an individual to such
director position for appointment or nomination, as applicable, pursuant to Section 2(c), be entitled to designate an individual to fill such director position by giving written notice to Acquiror, and Acquiror shall,
within ten (10) days of such designation, take all necessary and desirable actions in order for such director position to be filled with such individual designated in writing pursuant to this Section 2(d).
Notwithstanding anything to the contrary in this Agreement, the Business Combination Agreement or the Governing Documents of Acquiror, (i) subject to Section 2(e), neither the Acquiror Board nor any other Person (other
than the Saban Sponsor pursuant to this Section 2(d)) may appoint, elect or designate any Person to fill any such director position unless, in the case of a vacant director position, the Saban Sponsor fails to designate a
director to fill such director position pursuant to this Section 2(d) within thirty (30) days after such vacancy on the Acquiror Board occurs, in which case such vacant director position shall be filled by the
remaining directors on the Acquiror Board in accordance with the Governing Documents of Acquiror with, unless the Panavision Holder Representative otherwise agrees in writing, an individual that qualifies as “independent” pursuant to the
listing standards of Nasdaq, and (ii) in the event that the Saban Sponsor and its Affiliates, in the aggregate, beneficially own less than an applicable ownership threshold of the issued and outstanding Acquiror Common Shares specified in
Section 2(c), then the requisite number of Saban Directors shall, upon request of a majority of the directors of the Acquiror Board (excluding the Saban Directors), resign from the Acquiror Board pursuant to a Director
Resignation Letter and, solely with respect to such resigning Saban Director(s) and not the other then remaining Saban Director (if any), the provisions of this Section 2(d) shall not apply (provided that the foregoing does
not limit, restrict or otherwise affect the ability of the Saban Sponsor to designate additional individuals to the Acquiror Board pursuant to Section 2(c) if an applicable ownership threshold is subsequently satisfied and
that the Saban Directors that will resign pursuant to this clause (ii) shall be determined by the Saban Sponsor). 
 (e) If an
individual designated by the Saban Sponsor is not appointed, nominated or elected pursuant to Section 2(a), 2(b), 2(c) or 2(d) or this Section 2(e) because of such
person’s death, disability, disqualification or withdrawal as a designee or nominee or for any other reason, then the Saban Sponsor shall be entitled to designate a replacement to fill such director position by giving written notice to
Acquiror, and Acquiror will, within ten (10) days of such designation, take all necessary and desirable actions in order for such director position to be filled with such person designated in writing pursuant to this
Section 2(e). Notwithstanding anything to the contrary in this Agreement, the Business Combination Agreement or the Governing Documents of Acquiror, neither the Acquiror Board nor any other Person (other than the Saban
Sponsor pursuant to this Section 2(e)) may appoint, elect or designate any Person to fill any such director position unless, in the case of a vacant director position, the Saban Sponsor fails to designate a director to fill
such vacant director position pursuant to this Section 2(e) within thirty (30) days after such failure of appointment or election to the Acquiror Board occurs, in which case such vacant director position shall be
filled by the remaining directors on the Acquiror Board in accordance with the Governing Documents of Acquiror with, unless the Panavision Holder Representative otherwise agrees in writing, an individual that qualifies as “independent”
pursuant to the listing standards of Nasdaq. 

  
 10 

 (f) As promptly as reasonably practicable following the request of any Saban Director,
Acquiror shall enter into an indemnification agreement with such Saban Director, in the form entered into with the other members of the Acquiror Board. Acquiror shall pay the reasonable, documented and out-of-pocket expenses incurred by any Saban Director related to his or her service to Acquiror, including attending meetings of the Acquiror Board or any committee or
sub-committee thereof (including, to the extent applicable, the Nominating Committee) or events attended on behalf of Acquiror or any of its Subsidiaries at Acquiror’s request. 

(g) In accordance with the Bylaws, the Acquiror Board may from time to time by resolution establish and maintain one or more committees of the
Acquiror Board, each committee to consist of one or more directors. Acquiror shall notify the Saban Sponsor in writing of any committee (other than the Nominating Committee or the Compensation Committee) of the Acquiror Board to be established at
least fifteen (15) days prior to the effective establishment of such committee. Without limiting the other rights of the Saban Sponsor under this Agreement (including pursuant to Section 2(h) and
Section 2(i)), if requested by the Saban Sponsor in writing, Acquiror shall promptly take all necessary and desirable actions to cause at least one (1) Saban Director to be appointed as a member of each such committee
unless such designation would violate any legal restriction on such committee’s composition or the rules and regulations of Nasdaq. 

(h) At any time the Saban Sponsor and its Affiliates, in the aggregate, beneficially own 5.00% or more of the issued and outstanding Acquiror
Common Shares, if a vacancy on the Nominating Committee occurs because of the death, disability, disqualification, resignation or removal of a Saban Director or any Saban Director ceases to be on the Nominating Committee for any other reason
(including the end of the term of such director), then the Saban Sponsor shall be entitled to designate a replacement to fill such vacant committee position with another Saban Director by giving written notice to Acquiror, and Acquiror will, within
ten (10) days of such designation, take all necessary and desirable actions such that such vacant committee position will be filled with such person. Notwithstanding anything to the contrary in this Agreement, the Business Combination
Agreement, the Governing Documents of Acquiror or the Nominating Committee charter or any other similar applicable documents, (i) neither the Acquiror Board nor any other Person (other than the Saban Sponsor pursuant to this
Section 2(h)) may appoint, elect or designate any Person to fill any such vacant committee position unless the Saban Sponsor fails to designate a director to fill such vacant committee position pursuant to this
Section 2(h) within the later of (A) forty-five (45) days after such vacancy on the Nominating Committee occurs and (B) the date on which a Saban Director is appointed pursuant to
Sections 2(d) and 2(e), in which case such vacant committee position shall be filled with the then-remaining Saban Director or, if no Saban Director is then serving on the Acquiror Board, in accordance with the
Governing Documents of Acquiror and the Nominating Committee charter or other applicable documents, and (ii) in the event that any action or meeting of the Nominating Committee occurs prior to the designation of a Person to fill such vacant
committee position pursuant to this Section 2(h), then, so long as any Saban Director is then serving on the Acquiror Board, at least one (1) Saban Director shall be entitled to participate in such action or meeting
and such other rights (including any notice or similar rights) as if a member of the Nominating Committee. 

  
 11 

 (i) At any time the Saban Sponsor and its Affiliates, in the aggregate, beneficially own
5.00% or more of the issued and outstanding Acquiror Common Shares, if a vacancy on the Compensation Committee occurs because of the death, disability, disqualification, resignation or removal of a Saban Director or any Saban Director ceases to be
on the Compensation Committee for any other reason (including the end of the term of such director), then the Saban Sponsor shall be entitled to designate a replacement to fill such vacant committee position with another Saban Director by giving
written notice to Acquiror, and Acquiror will, within ten (10) days of such designation, take all necessary and desirable actions such that such vacant committee position will be filled with such person. Notwithstanding anything to the contrary
in this Agreement, the Business Combination Agreement, the Governing Documents of Acquiror or the Compensation Committee charter or any other similar applicable documents, (i) neither the Acquiror Board nor any other Person (other than the
Saban Sponsor pursuant to this Section 2(i)) may appoint, elect or designate any Person to fill any such vacant committee position unless the Saban Sponsor fails to designate a director to fill such vacant committee
position pursuant to this Section 2(i) within the later of (A) forty-five (45) days after such vacancy on the Compensation Committee occurs and (B) the date on which a Saban Director is appointed pursuant to
Sections 2(d) and 2(e), in which case such vacant committee position shall be filled with a then-remaining Saban Director or, if no Saban Director is then serving on the Acquiror Board, in accordance with the Governing Documents of
Acquiror and the Compensation Committee charter or other applicable documents, and (ii) in the event that any action or meeting of the Compensation Committee occurs prior to the designation of a Person to fill such vacant committee position
pursuant to this Section 2(i), then, so long as any Saban Director is then serving on the Acquiror Board, at least one (1) Saban Director shall be entitled to participate in such action or meeting and such other rights
(including any notice or similar rights) as if a member of the Compensation Committee. 
 (j) For so long as any Saban Director serves as a
director of Acquiror, Acquiror shall not amend, alter or repeal any right to indemnification or exculpation covering or benefiting any director designated pursuant to this Agreement as and to the extent consistent with applicable law, including but
not limited to Article Sixth of the Certificate of Incorporation and Article VII of the Bylaws of Acquiror (whether such right is contained in the Certificate of Incorporation, the Bylaws or another document) (except to the extent such amendment or
alteration permits Acquiror to provide broader indemnification or exculpation rights on a retroactive basis than permitted prior thereto). 

(k) Subject to compliance with the listing standards of Nasdaq, the Saban Directors may, but do not need to, qualify as “independent”
pursuant to the listing standards of Nasdaq. Unless otherwise agreed in writing by the Saban Sponsor, all other directors of the Acquiror Board (other than the Chief Executive Officer of Acquiror and the Panavision Directors) shall qualify as
“independent” pursuant to the listing standards of Nasdaq. 

  
 12 

 Section 3. Independent Directors. At least two (2) Business Days prior to
the filing with the SEC of the Shareholder Meeting Proxy Statement pursuant to Section 10.1(a)(ii) of the Business Combination Agreement, the Panavision Holder Representative and the Saban Sponsor collectively shall specify in writing to
Acquiror the mutually agreed upon individuals to serve as the Designated Independent Directors immediately following the Effective Time. 

Section 4. Panavision Stockholders Standstill. 

(a) Subject to Sections 4(b), 4(c) and 4(d), from and after the Effective Time, each of the Key
Panavision Stockholders agrees that it shall not, directly or indirectly, alone or in concert with others, without the prior written consent of Acquiror and the Saban Sponsor: 

(i) engage in any “solicitation” of “proxies” (as such terms are used in Regulation 14 of the Exchange Act) to vote or
consents to vote, or seek to advise or influence any Person with respect to the voting of, any voting securities of Acquiror or any of its Subsidiaries in opposition of any individual nominated or designated for appointment or election to the
Acquiror Board by the Saban Sponsor pursuant to this Agreement or otherwise in opposition of any Saban Director (including by “solicitation” of “proxies” in favor of any opposing nominee of any such individual); 

(ii) form, join or in any way participate in a “group” (as defined in Section 13(d)(3) of the Exchange Act) in connection with
any action contemplated by clause (i) of this Section 4(a); 
 (iii) enter into any arrangements,
understanding or agreements (whether written or oral) with, or advise, finance, assist or knowingly encourage, any other Person in connection with any of the foregoing; 

(iv) make any public disclosure inconsistent with clauses (i) through (iii) of this Section 4(a), or take any
action that would reasonably be expected to require Acquiror to make any public disclosure with respect to the matters set forth in clauses (i) through (iii) of this Section 4(a); or 

(v) take any action challenging the validity or enforceability of this Section 4. 

(b) Notwithstanding anything herein to the contrary, nothing in this Section 4 or elsewhere in this Agreement shall
be deemed to in any way restrict, limit or prevent (i) any Key Panavision Stockholder, any of its Affiliates or any of their respective agents or representatives from, directly or indirectly, discussing any matter (including a Company Sale)
with Acquiror, the Acquiror Board (or any of its members) or any member of Acquiror’s or any of its Subsidiaries’ management or exercising its voting rights with respect to any matter brought before the stockholders of Acquiror or any of
its Subsidiaries in any manner it chooses, (ii) any Key Panavision Stockholder, any of its Affiliates or any of their respective agents or representatives from, directly or indirectly, negotiating, entering into an agreement with respect to, or
consummating, a Company Sale (including as to the composition of the Acquiror Board in connection with any such Company Sale), (iii) the Key Panavision Stockholders or their Affiliates from (A) bringing litigation to enforce the provisions of
this Agreement, the Business 

  
 13 

 
Combination Agreement or the Governing Documents of Acquiror or (B) making counterclaims with respect to any proceeding initiated by, or on behalf of, Acquiror against any Panavision
Stockholder with respect to this Agreement, the Business Combination Agreement or the Governing Documents of Acquiror, or (iv) any Panavision Director from taking any action consistent with such director’s fiduciary duties under applicable
law in connection with such role. 
 (c) Notwithstanding anything in this Agreement to the contrary, the provisions of
Section 4(a) shall be suspended if: 
 (i) any Person or “group” (as defined in Section 13(d)(3) of
the Exchange Act): (A) executes a definitive agreement with Acquiror providing for (or the Acquiror Board approves) a transaction or series of related transactions involving a Company Sale, provided that Section 4(a) will
be reinstated if Acquiror publicly states that any such process has been irrevocably terminated; (B) commences, or announces an intention to commence, a tender offer or exchange offer that, if consummated, would result in the acquisition of
beneficial ownership of more than 50.00% of Acquiror’s issued and outstanding voting securities and, in the case of this clause (B), the Acquiror Board recommends, or publicly discloses an intention to recommend, that Acquiror’s
shareholders tender their Acquiror Common Shares into such offer or fails to recommend against its shareholders tendering their Acquiror Common Shares into such offer within ten (10) Business Days after the commencement of such offer or at any
time thereafter at which it publicly takes a position with respect to such offer, provided that Section 4(a) will be reinstated if any such tender offer or exchange offer is irrevocably withdrawn or terminated; or
(C) commences any “solicitation” of “proxies” (as such terms are defined in the rules of the SEC) to elect and/or remove a majority of the Acquiror Board, provided that Section 4(a) will be
reinstated if any such solicitation is irrevocably terminated; or 
 (ii) Acquiror publicly discloses that it has authorized a process for
the solicitation of offers or indications of interest with respect to a Company Sale, and fails to invite the Key Panavision Stockholders to participate in the process on substantially the same terms as apply to other participants, provided that
Section 4(a) will be reinstated if Acquiror publicly states that any such process has been irrevocably terminated. 

(d) The provisions set forth in this Section 4 shall be effective subject to, and conditioned upon, the occurrence of
the Effective Time and shall remain in full force and effect for the period commencing at the Effective Time and ending on the earliest to occur of: (i) the date on which the Saban Sponsor and its Affiliates, in the aggregate, beneficially own
less than 5.00% of the issued and outstanding Acquiror Common Shares; (ii) the date on which the Panavision Holder Representative no longer has the right to designate any Panavision Director to the Acquiror Board pursuant to this Agreement;
(iii) written notice by the Panavision Holder Representative in the event that Acquiror fails to comply in any material respect with Section 1 or, to the extent applicable, Section 7 or the
Saban Sponsor fails to comply in any material respect with Section 5; and (iv) the mutual written consent of the Panavision Holder Representative and the Saban Sponsor to terminate this
Section 4. 

  
 14 

 Section 5. Saban Sponsor Standstill. 

(a) Subject to Sections 5(b), 5(c) and 5(d), from and after the Effective Time, each of the Saban
Sponsor and Saban Sponsor II agrees that it shall not, directly or indirectly, alone or in concert with others, without the prior written consent of Acquiror and the Panavision Holder Representative: 

(i) engage in any “solicitation” of “proxies” (as such terms are used in Regulation 14 of the Exchange Act) to vote or
consents to vote, or seek to advise or influence any Person with respect to the voting of, any voting securities of Acquiror or any of its Subsidiaries in opposition of any individual nominated or designated for appointment or election to the
Acquiror Board by the Panavision Holder Representative pursuant to this Agreement or otherwise in opposition of any Panavision Director (including by “solicitation” of “proxies” in favor of any opposing nominee of any such
individual); 
 (ii) form, join or in any way participate in a “group” (as defined in Section 13(d)(3) of the Exchange Act)
in connection with any action contemplated by clause (i) of this Section 5(a); 
 (iii) enter into any
arrangements, understanding or agreements (whether written or oral) with, or advise, finance, assist or knowingly encourage, any other Person in connection with any of the foregoing; 

(iv) make any public disclosure inconsistent with clauses (i) through (iii) of this Section 5(a), or take any
action that would reasonably be expected to require Acquiror to make any public disclosure with respect to the matters set forth in clauses (i) through (iii) of this Section 5(a); or 

(v) take any action challenging the validity or enforceability of this Section 5. 

(b) Notwithstanding anything herein to the contrary, nothing in this Section 5 or elsewhere in this Agreement shall
be deemed to in any way restrict, limit or prevent (i) the Saban Sponsor, any of its Affiliates (including Saban Sponsor II) or any of their respective agents or representatives from, directly or indirectly, discussing any matter (including a
Company Sale) with Acquiror, the Acquiror Board (or any of its members) or any member of Acquiror’s or any of its Subsidiaries’ management or exercising its voting rights with respect to any matter brought before the stockholders of
Acquiror or any of its Subsidiaries in any manner it chooses, (ii) subject to Section 7, the Saban Sponsor, any of its Affiliates (including Saban Sponsor II) or any of their respective agents or representatives from,
directly or indirectly, negotiating, entering into an agreement with respect to, or consummating, a Company Sale (including as to the composition of the Acquiror Board in connection with any such Company Sale), (iii) the Saban Sponsor or its
Affiliates (including Saban Sponsor II) from (A) bringing litigation to enforce the provisions of this Agreement, the Business Combination Agreement or the Governing Documents of Acquiror or (B) making counterclaims with respect to any
proceeding initiated by, or on behalf of, Acquiror against the Saban Sponsor with respect to this Agreement, the Business Combination Agreement or the Governing Documents of Acquiror, or (iv) any Saban Director from taking any action consistent
with such director’s fiduciary duties under applicable law in connection with such role. 

  
 15 

 (c) Notwithstanding anything in this Agreement to the contrary, the provisions of
Section 5(a) shall be suspended if: 
 (i) any Person or “group” (as defined in Section 13(d)(3) of
the Exchange Act): (A) executes a definitive agreement with Acquiror providing for (or the Acquiror Board approves) a transaction or series of related transactions involving a Company Sale, provided that Section 5(a) will
be reinstated if Acquiror publicly states that any such process has been irrevocably terminated; (B) commences, or announces an intention to commence, a tender offer or exchange offer that, if consummated, would result in the acquisition of
beneficial ownership of more than 50.00% of Acquiror’s issued and outstanding voting securities and, in the case of this clause (B), the Acquiror Board recommends, or publicly discloses an intention to recommend, that Acquiror’s
shareholders tender their Acquiror Common Shares into such offer or fails to recommend against its shareholders tendering their Acquiror Common Shares into such offer within ten (10) Business Days after the commencement of such offer or at any
time thereafter at which it publicly takes a position with respect to such offer, provided that Section 5(a) will be reinstated if any such tender offer or exchange offer is irrevocably withdrawn or terminated; or
(C) commences any “solicitation” of “proxies” (as such terms are defined in the rules of the SEC) to elect and/or remove a majority of the Acquiror Board, provided that Section 5(a) will be
reinstated if any such solicitation is irrevocably terminated; or 
 (ii) Acquiror publicly discloses that it has authorized a process for
the solicitation of offers or indications of interest with respect to a Company Sale, and fails to invite the Saban Sponsor to participate in the process on substantially the same terms as apply to other participants, provided that
Section 5(a) will be reinstated if Acquiror publicly states that any such process has been irrevocably terminated. 

(d) The provisions set forth in this Section 5 shall be effective subject to, and conditioned upon, the occurrence of
the Effective Time and shall remain in full force and effect for the period commencing at the Effective Time and ending on the earliest to occur of: (i) the date on which the Panavision Stockholders and their Affiliates, in the aggregate,
beneficially own less than 5.00% of the issued and outstanding Acquiror Common Shares; (ii) the date on which the Saban Sponsor no longer has the right to designate any Saban Director to the Acquiror Board pursuant to this Agreement;
(iii) written notice by the Saban Sponsor in the event that Acquiror fails to comply in any material respect with Section 2 or, to the extent applicable, Section 8 or the Key Panavision
Stockholders fail to comply in any material respect with Section 4; and (iv) the mutual written consent of the Panavision Holder Representative and the Saban Sponsor to terminate this
Section 5. 
 Section 6. Chair of the Board. The individual who initially will serve as the chair of
the Acquiror Board (the “Chair of the Board”) shall be Kimberly Snyder. If a vacancy in the role of Chair of the Board occurs because of the death, disability, disqualification, resignation or removal of any such Chair of the
Board, then, (a) so long as (i) the Panavision Holder Representative is entitled to designate an individual to a director position pursuant to Section 1(c)(ii) and (ii) the Saban Sponsor is entitled to
designate an individual to a director position pursuant to Section 2(c)(ii), the Panavision Holder Representative and the Saban Sponsor shall mutually agree on the replacement Chair of the Board and the Acquiror Board shall
elect the replacement Chair of the Board in accordance with the Governing Documents of Acquiror; 

  
 16 

 
provided, that if the Panavision Holder Representative and the Saban Sponsor fail to mutually agree on such replacement Chair of the Board within one week of such vacancy, a majority of
the Acquiror Board shall elect the replacement Chair of the Board from the then current members of the Acquiror Board; and (b) in all other cases, a majority of the Acquiror Board shall elect the replacement Chair of the Board in accordance
with the Governing Documents of Acquiror. 
 Section 7. Actions Requiring Special Approval of the Panavision Holder
Representative.
 (a) From and after the Effective Time at any time that the Panavision Stockholders and their Affiliates beneficially
own, in the aggregate, at least 5.00% of the issued and outstanding Acquiror Common Shares, Acquiror shall not, and shall cause each of its Subsidiaries not to, in each case, without the prior written consent of the Panavision Holder Representative,
except in connection with a Company Sale: 
 (i) amend, waive, rescind or otherwise modify any provision of the Governing Documents of
Acquiror or any of its Subsidiaries in a manner that adversely affects any of the express rights of the Panavision Stockholders or the Panavision Holder Representative under the Governing Documents of Acquiror or this Agreement or any of the
covenants, agreements or obligations of Acquiror or the Saban Sponsor under this Agreement; 
 (ii) liquidate or dissolve, except
(A) in connection with a reorganization, restructuring or similar transaction or series of related transactions approved by the Acquiror Board that is consummated in a manner that preserves in all material respects the same rights and
obligations immediately following such transaction or series of related transactions as the parties hereto had under this Agreement immediately prior to such transaction or series of related transactions or (B) for the liquidation or
dissolution of any Subsidiary that does not affect the rights and obligations of the parties hereto under this Agreement; 
 (iii) enter
into or consummate, directly or indirectly, any transaction or agreement with (A) any Affiliate of Acquiror (other than, in the case of Acquiror, any of its Subsidiaries or, in the case of any Subsidiary of Acquiror, Acquiror or another
Subsidiary of Acquiror), (B) the Saban Sponsor or any of its Affiliates, (C) any Person that is part of a “group” that beneficially owns at least 5.00% of the issued and outstanding Acquiror Common Shares, (D) any Representative
of any Person described in the foregoing clauses (A) through (C) and (E) any parent, child, sibling or spouse who resides with, or is a dependent of, any Person described in the foregoing clauses (A) through (D), in each case other
than (x) those transactions entered into on arm’s-length terms that are approved in accordance with Acquiror’s “Related Party Policy” or such successor policy, (y) (1)
transactions expressly permitted or required by this Agreement, the Business Combination Agreement or any of the Ancillary Agreements, (2) ordinary course director compensation and expense reimbursement as permitted by the Governing Documents
of Acquiror or any of its Subsidiaries and this Agreement, (3) officer compensation approved by the Compensation Committee and (4) director and officer indemnification agreements and the rights of indemnification and exculpation provided
to directors and officers pursuant to the Governing Documents of Acquiror or any of its Subsidiaries or the Business Combination Agreement and (z) any agreement with Solus Alternative Asset Management LP or any of its Affiliates in connection
with, or related to, the Debt Financing (including the Debt Commitment Letter, the Debt Documents and any agreements or contracts entered into after the date hereof in connection with any of the foregoing); or 

  
 17 

 (iv) (A) except for any increase to the size of the Acquiror Board that is approved by
the Acquiror Board in connection with an acquisition of any Person or any assets, properties or rights of any Person (provided that any such increase shall not otherwise affect the rights and obligations of the parties hereto under this Agreement),
increase or decrease the size of the Acquiror Board or (B) except as required by this Agreement, change the classes on which the Acquiror Board members serve. 

(b) In addition to the rights granted pursuant to Section 7(a), from and after the Effective Time at any time that
the Panavision Stockholders and their Affiliates beneficially own, in the aggregate, at least 20.00% of the Acquiror Common Shares until such time that the Panavision Stockholders and their Affiliates beneficially own, in the aggregate, at least
10.00% of the issued and outstanding Acquiror Common Shares, Acquiror shall not, and shall cause each of its Subsidiaries not to, in each case, without the prior written consent of the Panavision Holder Representative, except in connection with a
Company Sale: 
 (i) issue (by reclassification or otherwise) or enter into any agreement providing for the issuance (contingent or
otherwise) of any new class or series of Equity Securities (including any notes or debt securities convertible into or exchangeable for any Equity Securities) that is senior in ranking to the Acquiror Common Shares; 

(ii) except as may be required to give effect to any changes contemplated by Section 7(a)(iv), enter into any
equityholders, voting or similar agreement relating to or affecting the ownership or voting of the Equity Securities of Acquiror or the governance of Acquiror; or 

(iii) issue Equity Securities to employees of Acquiror and its Subsidiaries in an amount that is in excess of 7.00% of the fully diluted
capital stock of Acquiror during any five (5)-year period commencing after the Effective Time. 
 (c) In addition to the rights granted
pursuant to Sections 7(a) and 7(b), from and after the Effective Time at any time that the Panavision Stockholders and their Affiliates beneficially own, in the aggregate, at least 27.50% of the Acquiror Common
Shares until such time that the Panavision Stockholders and their Affiliates cease to beneficially own, in the aggregate, at least 17.50% of the issued and outstanding Acquiror Common Shares, Acquiror shall not, and shall cause each of its
Subsidiaries not to, in each case, without the prior written consent of the Panavision Holder Representative: 
 (i) enter into any
definitive agreement to effect, or effect, any business combination, acquisition, disposition or merger or any transaction or series of transactions relating to the sale, lease or disposition of (but excluding liens upon) any assets, properties or
intellectual property rights of Acquiror or any of its Subsidiaries or any third party(ies), in any such case, involving (A) the acquisition, disposition, sale, lease or transfer, directly or indirectly,

  
 18 

 
of assets, properties and/or rights of Acquiror or any of its Subsidiaries or of any third party(ies) with an aggregate value in excess of $62,500,000, (B) an aggregate enterprise value in excess
of $62,500,000 or (C) consideration to or from Acquiror and/or any of its Subsidiaries with an aggregate value in excess of $62,500,000, in each case, such value to be determined in good faith by the Acquiror Board; 

(ii) materially alter or change the businesses of Acquiror and its Subsidiaries or enter into any material line of business that is unrelated
to any line of business conducted by Acquiror or any of its Subsidiaries as of immediately following the Effective Time; or 
 (iii) incur,
assume or otherwise become liable for any indebtedness for borrowed money or guarantee the indebtedness for borrowed money of any other Person in excess of $62,500,000 in the aggregate, except for (A) any indebtedness incurred under the
“revolving” credit facility to be entered into on the Closing Date or in connection with any acquisition that is entered into in accordance with this Section 7 (including a Company Sale), (B) any amendment to the
“revolving” credit facility to be entered into on the Closing Date that does not (1) increase the total principal amount of the then outstanding indebtedness of Acquiror on a consolidated basis, excluding any fees associated
therewith, and any subsequent incurrence thereunder, or (2) increase the total principal amount that may be borrowed thereunder, or (C) the refinancing of existing indebtedness that does not (1) increase the total principal amount of
the then outstanding indebtedness of Acquiror on a consolidated basis, excluding any fees associated therewith, and any subsequent incurrence thereunder, or (2) increase the total principal amount that may be borrowed thereunder. 

(d) In addition to the rights granted pursuant to Sections 7(a), 7(b) and
Section 7(c), from and after the Effective Time at any time that the Panavision Stockholders and their Affiliates beneficially own, in the aggregate, at least 32.50% of the Acquiror Common Shares until such time that the
Panavision Stockholders and their Affiliates cease to beneficially own, in the aggregate, at least 25.00% of the issued and outstanding Acquiror Common Shares, Acquiror shall not, and shall cause each of its Subsidiaries not to, without the prior
written consent of the Panavision Holder Representative, enter into any definitive agreement to effect, or effect, a Company Sale. 
 (e) At
least quarterly and otherwise in connection with any action to be taken by Acquiror or any of its Subsidiaries, as applicable, pursuant to this Section 7 that may require the prior written consent of the Panavision Holder
Representative, the Key Panavision Stockholders and Acquiror shall reasonably cooperate with each other to determine and identify any Affiliates of the Panavision Stockholders that hold Acquiror Common Shares for purposes of determining satisfaction
of the applicable beneficial ownership threshold set forth in this Section 7 with respect to the Panavision Holder Representative’s consent right over such proposed action (it being understood and agreed that only the
Affiliates so identified shall be included for such purpose). The Key Panavision Holders and Acquiror shall mutually agree to institute reasonable procedures to determine and identify Affiliates pursuant to the immediately preceding sentence. 

  
 19 

 Section 8. Actions Requiring Special Approval of the Saban Sponsor.

(a) From and after the Effective Time at any time that the Saban Sponsor and its Affiliates beneficially own, in the aggregate, at least 5.00%
of the issued and outstanding Acquiror Common Shares, Acquiror shall not, and shall cause each of its Subsidiaries not to, in each case, without the prior written consent of the Saban Sponsor, except in connection with a Company Sale: 

(i) amend, waive, rescind or otherwise modify any provision of the Governing Documents of Acquiror or any of its Subsidiaries in a manner that
adversely affects any of the express rights of the Saban Sponsor under the Governing Documents of Acquiror or this Agreement or any of the covenants, agreements or obligations of Acquiror or the Panavision Holder Representative under this Agreement;

 (ii) liquidate or dissolve, except (A) in connection with a reorganization, restructuring or similar transaction or series of
related transactions approved by the Acquiror Board that is consummated in a manner that preserves in all material respects the same rights and obligations immediately following such transaction or series of related transactions as the parties
hereto had under this Agreement immediately prior to such transaction or series of related transactions or (B) for the liquidation or dissolution of any Subsidiary that does not affect the rights and obligations of the parties hereto under this
Agreement; 
 (iii) enter into or consummate, directly or indirectly, any transaction or agreement with (A) any Affiliate of Acquiror
(other than, in the case of Acquiror, any of its Subsidiaries or, in the case of any Subsidiary of Acquiror, Acquiror or another Subsidiary of Acquiror), (B) any Principal Panavision Holder or any of their Affiliates, (C) any Person that is
part of a “group” that beneficially owns at least 5.00% of the issued and outstanding Acquiror Common Shares, (D) any Representative of any Person described in the foregoing clauses (A) through (C) and (E) any parent, child,
sibling or spouse who resides with, or is a dependent of, any Person described in the foregoing clauses (A) through (D), in each case other than (x) those transactions entered into on
arm’s-length terms that are approved in accordance with Acquiror’s “Related Party Policy” or such successor policy, (y) (1) transactions expressly permitted or required by this
Agreement, the Business Combination Agreement or any of the Ancillary Agreements, (2) ordinary course director compensation and expense reimbursement as permitted by the Governing Documents of Acquiror or any of its Subsidiaries and this
Agreement, (3) officer compensation approved by the Compensation Committee and (4) director and officer indemnification agreements and the rights of indemnification and exculpation provided to directors and officers pursuant to the
Governing Documents of Acquiror or any of its Subsidiaries or the Business Combination Agreement and (z) any agreement with Solus Alternative Asset Management LP or any of its Affiliates in connection with, or related to, the Debt Financing
(including the Debt Commitment Letter, the Debt Documents and any agreements or contracts entered into after the date hereof in connection with any of the foregoing); or 

(iv) (A) except for any increase to the size of the Acquiror Board that is approved by the Acquiror Board in connection with an
acquisition of any Person or any assets, properties or rights of any Person (provided that any such increase shall not otherwise affect the rights and obligations of the parties hereto under this Agreement), increase or decrease the size of the
Acquiror Board or (B) except as required by this Agreement, change the classes on which the Acquiror Board members serve. 

  
 20 

 (b) In addition to the rights granted pursuant to Section 8(a),
from and after the Effective Time at any time that the Saban Sponsor and its Affiliates beneficially own, in the aggregate, at least 20.00% of the Acquiror Common Shares until such time that the Saban Sponsor and its Affiliates beneficially own, in
the aggregate, at least 10.00% of the issued and outstanding Acquiror Common Shares, Acquiror shall not, and shall cause each of its Subsidiaries not to, in each case, without the prior written consent of the Saban Sponsor, except in connection with
a Company Sale: 
 (i) issue (by reclassification or otherwise) or enter into any agreement providing for the issuance (contingent or
otherwise) of any new class or series of Equity Securities (including any notes or debt securities convertible into or exchangeable for any Equity Securities) that is senior in ranking to the Acquiror Common Shares; 

(ii) except as may be required to give effect to any changes contemplated by Section 8(a)(iv), enter into any
equityholders, voting or similar agreement relating to or affecting the ownership or voting of the Equity Securities of Acquiror or the governance of Acquiror; or 

(iii) issue Equity Securities to employees of Acquiror and its Subsidiaries in an amount that is in excess of 7.00% of the fully diluted
capital stock of Acquiror during any five (5)-year period commencing after the Effective Time. 
 (c) At least quarterly and otherwise in
connection with any action to be taken by Acquiror or any of its Subsidiaries, as applicable, pursuant to this Section 8 that may require the prior written consent of the Saban Sponsor, the Saban Sponsor and Acquiror shall
reasonably cooperate with each other to determine and identify any Affiliates of the Saban Sponsor that hold Acquiror Common Shares for purposes of determining satisfaction of the applicable beneficial ownership threshold set forth in this
Section 8 with respect to the Saban Sponsor’s consent right over such proposed action (it being understood and agreed that only the Affiliates so identified shall be included for such purpose). The Saban Sponsor and
Acquiror shall mutually agree to institute reasonable procedures to determine and identify Affiliates pursuant to the immediately preceding sentence. 

Section 9. Panavision Information Rights. 

(a) The Key Panavision Stockholders shall be entitled to receive (i) any information received by any Panavision Director; provided,
however, that the Key Panavision Stockholders shall not be entitled to receive information provided to a Panavision Director if the Acquiror Board (or a committee thereof) determines in good faith, based on the advice of Acquiror’s
counsel, that such omission may be necessary in order to preserve Acquiror’s attorney-client or similar privilege, and the Key Panavision Stockholders shall not be entitled to receive, and Acquiror may screen a Panavision Director from,
information related to any matter that involves any dispute, transaction or contract negotiation, amendment or modification, or other situation that is reasonably expected to involve a conflict of interest between Acquiror

  
 21 

 
and/or one or more of its Subsidiaries, on the one hand, and a Key Panavision Stockholder and/or one or more of its Affiliates, on the other hand, due to such Persons being on opposite sides of
such dispute, transaction or contract negotiation, amendment or modification or other situation; provided, further, that if a Key Panavision Stockholder does not, upon the request of Acquiror, before receiving such information, execute
and deliver to Acquiror an agreement to abide by all Acquiror policies applicable to members of the Acquiror Board and a confidentiality agreement reasonably acceptable to Acquiror, such Key Panavision Stockholder may be excluded from access to any
information if the Acquiror Board determines in good faith that such exclusion is reasonably necessary to protect confidential proprietary information of Acquiror or confidential proprietary information of third parties that Acquiror is required to
hold in confidence, or for other similar reasons, and (ii) such other information and data as a Key Panavision Stockholder may reasonably request in connection with its ownership of Acquiror Common Shares, including any information necessary to
assist such Key Panavision Stockholder in preparing its tax, regulatory or other similar filings or as otherwise required for administrative purposes. Any information pursuant to clause (i) of this Section 9(a) may be
provided to the Key Panavision Stockholders by Acquiror or a Panavision Director. Any Key Panavision Stockholder, in its sole discretion, may decline to receive any information pursuant to clause (i) of this
Section 9(a) upon written notice to Acquiror (it being understood and agreed that if a Key Panavision Stockholder declines any such information it shall in no way affect or limit another Key Panavision Stockholder’s
right to receive the same information pursuant to this Section 9(a)). Notwithstanding the foregoing, Acquiror shall not be required to provide, and a Panavision Director shall not provide on behalf of Acquiror pursuant to
this Section 9(a), any information that would reasonably be expected to violate any confidentiality obligations owing to third Persons or Law to which Acquiror or any of its Subsidiaries is subject; provided, that if
any information is withheld pursuant to this sentence, Acquiror will (A) inform such Key Panavision Stockholder as to the general nature of what is being withheld and (B) use its commercially reasonable efforts (at the cost and expense of
the requesting party) to accommodate any request from such Key Panavision Stockholder for information pursuant to this Section 9(a) in a manner that does not result in such a violation. 

(b) Acquiror will deliver, or will cause to be delivered, the following to the Key Panavision Stockholders (unless a Key Panavision Stockholder
has informed Acquiror in writing that it does not wish to receive any such information) (it being understood and agreed that if a Key Panavision Stockholder declines any such information it shall in no way affect or limit another Key Panavision
Stockholder’s right to receive the same information pursuant to this Section 9(b)): 
 (i) to the extent that
such information is provided to the Acquiror Board, as soon as available after each month and in any event within fifteen (15) days after the date on which such information is delivered in final form to the Acquiror Board, unaudited
consolidated monthly financial reports of Acquiror and its consolidated Subsidiaries prepared in accordance with GAAP; and 
 (ii) to the
extent that such information is provided to the Acquiror Board, as soon as available and in any event within fifteen (15) days after the date on which such information is delivered to the Acquiror Board, the annual business plan (including
operating budget and capital expenditures presented on a monthly basis). 

  
 22 

 (c) Acquiror shall, and shall cause its Subsidiaries to, upon the written request of a Key
Panavision Stockholder, provide the following to such Key Panavision Stockholder: 
 (i) reasonable access to appropriate officers and
directors of Acquiror and its Subsidiaries at such reasonable times during normal business hours as may be requested by such Key Panavision Stockholder for consultation with such Key Panavision Stockholder with respect to matters relating to the
business and affairs of Acquiror or any of its Subsidiaries (provided that no such access or consultation shall be required to the extent related to any dispute, transaction or contract negotiation, amendment or modification, or other situation that
is reasonably expected to involve a conflict of interest between Acquiror and/or one or more of its Subsidiaries, on the one hand, and the Panavision Holder Representative, such Key Panavision Stockholder and/or one or more of its Affiliates, on the
other hand, due to such Persons being on opposite sides of such dispute, transaction or contract negotiation, amendment or modification or other situation); and 

(ii) a reasonably detailed overview of any material information with respect to any significant corporate actions, including, without
limitation, extraordinary dividends, stock redemptions or repurchases, mergers, acquisitions or dispositions of assets, issuances of significant amounts of debt or equity and material amendments to the Acquiror Governing Documents or the
organizational documents of any of Acquiror’s Subsidiaries, and to provide such Key Panavision Stockholder with the opportunity to reasonably consult with Acquiror and its Subsidiaries with respect to such actions (provided that no such
information or consultation shall be required (A) with respect to any dispute, transaction or contract negotiation, amendment or modification, or other situation that is reasonably expected to involve a conflict of interest between Acquiror
and/or one or more of its Subsidiaries, on the one hand, and the Panavision Holder Representative, a Key Panavision Stockholder and/or one or more of its Affiliates, on the other hand, due to such Persons being on opposite sides of such dispute,
transaction or contract negotiation, amendment or modification or other situation and (B) to the extent that the Acquiror Board (or a committee thereof) determines in good faith, based on the advice of Acquiror’s counsel, that such
omission may be necessary in order to preserve Acquiror’s attorney-client or similar privilege). 
 (d) Acquiror shall, and shall cause
its Subsidiaries to, provide each Key Panavision Stockholder reasonable access, during normal business hours and with prior written notice, in such manner as to not unreasonably interfere with the normal operation of Acquiror and its Subsidiaries,
to the books, records, policies and procedures, internal audit and compliance reports, and to officers, personnel, accountants and other representatives of Acquiror and its Subsidiaries and their respective businesses, whether located in the United
States or outside the United States, including, without limitation, the right to audit any such books, records, policies and procedures, and reports and to make copies therefrom. Without limiting the generality of the foregoing, Acquiror shall not
be required to provide (or cause to be provided) (and each of the following shall be deemed to be “unreasonable access” pursuant to the immediately preceding sentence): (i) any information that the Acquiror Board (or a committee thereof)
determines in good faith, based on the advice of Acquiror’s counsel, that such omission may be necessary in order to preserve Acquiror’s attorney-client or similar privilege; (ii) any information with respect to any dispute,
transaction or contract negotiation, amendment or modification, or other situation that is reasonably expected to involve a conflict of interest between Acquiror and/or one or more 

  
 23 

 
of its Subsidiaries, on the one hand, and the Panavision Holder Representative, a Key Panavision Stockholder and/or one or more of its Affiliates, on the other hand, due to such Persons being on
opposite sides of such dispute, transaction or contract negotiation, amendment or modification or other situation; and (iii) any information that would reasonably be expected to violate any confidentiality obligations owing to third Persons or
Law to which Acquiror or any of its Subsidiaries is subject; provided, that if any information is withheld pursuant to this sentence, Acquiror will (A) inform such Key Panavision Stockholder as to the general nature of what is being
withheld and (B) use its commercially reasonable efforts (at the cost and expense of the requesting party) to accommodate any request from Acquiror for information pursuant to this Section 9(d) in a manner that does
not result in such a violation. 
 (e) The provisions set forth in Sections 9(a), 9(b), 9(c) and
9(d) shall be effective subject to, and conditioned upon, the occurrence of the Effective Time and shall remain in full force and effect for the period commencing at the Effective Time and ending on the earliest to occur of: (i) with
regard to all Key Panavision Stockholders, the date on which the Panavision Stockholders and their Affiliates, in the aggregate, beneficially own less than 5.00% of the issued and outstanding Acquiror Common Shares; and (ii) (A) with regard to
only the Cerberus Holders, the date on which the Cerberus Holders and their Affiliates, in the aggregate, beneficially own less than 2.00% of the issued and outstanding Acquiror Common Shares, and (B) with regard to only the Solus Holders, the
date on which the Solus Holders and their Affiliates, in the aggregate, beneficially own less than 2.00% of the issued and outstanding Acquiror Common Shares. 

(f) The Key Panavision Stockholders hereby acknowledge that they are aware that the United States securities laws prohibit any person who has
material, non-public information concerning a company from purchasing or selling securities of such company or from communicating such information to any other person under circumstances in which it is
reasonably foreseeable that such person is likely to purchase or sell such securities. 
 (g) The Key Panavision Stockholders shall maintain
the confidentiality of any confidential and proprietary information of Acquiror or any of its Subsidiaries received pursuant to Sections 9(a), 9(b), 9(c) and 9(d) (“Panavision Proprietary
Information”) using the same standard of care as it applies to its own confidential information, except for any Panavision Proprietary Information which is publicly available or a matter of public knowledge generally. Nothing herein
shall prevent any of the Key Panavision Stockholders from (i) using Panavision Proprietary Information to enforce its rights under this Agreement, the Business Combination Agreement and/or any of the Ancillary Agreements or the rights granted
to it as a holder of Acquiror Common Shares contained in Acquiror’s Governing Documents, (ii) disclosing Panavision Proprietary Information to its attorneys, accountants, consultants, and other advisors, to the extent necessary to obtain
their services in connection with monitoring and managing the Key Panavision Stockholders’ investment in Acquiror or otherwise in connection with this Agreement, the Business Combination Agreement and/or any of the Ancillary Agreements or the
rights granted to it as a holder of Acquiror Common Shares contained in Acquiror’s Governing Documents, so long as such advisors are obligated to maintain the confidentiality of the same; provided that the Key Panavision Stockholders shall be
responsible for any breach of such confidentiality obligations by any such attorneys, accountants, consultants, and other advisors, or (iii) disclosing Panavision Proprietary Information as may otherwise be required by law, if such

  
 24 

 
Key Panavision Stockholder promptly notifies Acquiror of such disclosure and takes reasonable steps to minimize the extent of any such required disclosure. The foregoing shall not be considered
Panavision Proprietary Information and shall not prohibit the use by any of the Key Panavision Stockholders of any such information received pursuant to this Section 9(g) if and solely to the extent such information
(w) is or becomes generally available to or known by the public other than as a result of a breach of the confidentiality provisions of this Agreement, including the confidentiality obligations as required by this Agreement that apply to
Persons not party to this Agreement to whom the Key Panavision Stockholders have disclosed such information as permitted hereunder, (x) was available to such Key Panavision Stockholder or any of its Affiliates, or a Panavision Director, as
applicable, prior to Acquiror’s disclosure to any such person, (y) is or becomes available to such Key Panavision Stockholder or any of its Affiliates, or a Panavision Director, as applicable, from a source other than Acquiror, or
(z) has already been, or is hereafter, independently developed by any of the Key Panavision Stockholders or any of their Affiliates without reference to, incorporation of or other use of the Panavision Proprietary Information; provided,
however, that, in the case of clauses (x) and (y), such information was not actually known by such Key Panavision Stockholder to be disclosed by the source of such information in violation of a confidentiality obligation (whether by
agreement, duty or otherwise) to Acquiror with respect to such information. Notwithstanding anything in this Section 9 or this Agreement to the contrary, the parties hereto agree that the Key Panavision Stockholders are
affiliated with private equity, hedge or similar funds and that each Key Panavision Stockholder may provide general information about the subject matter of this Agreement and the transactions contemplated hereby in connection with normal fund
raising and related marketing or informational or reporting activities. 
 Section 10. Saban Information Rights. 

(a) The Saban Sponsor shall be entitled to receive (i) any information received by any Saban Director; provided, however,
that the Saban Sponsor shall not be entitled to receive information provided to a Saban Director if the Acquiror Board (or a committee thereof) determines in good faith, based on the advice of Acquiror’s counsel, that such omission may be
necessary in order to preserve Acquiror’s attorney-client or similar privilege, and the Saban Sponsor shall not be entitled to receive, and Acquiror may screen a Saban Director from, information related to any matter that involves any dispute,
transaction or contract negotiation, amendment or modification, or other situation that is reasonably expected to involve a conflict of interest between Acquiror and/or one or more of its Subsidiaries, on the one hand, and the Saban Sponsor and/or
one or more of its Affiliates, on the other hand, due to such Persons being on opposite sides of such dispute, transaction or contract negotiation, amendment or modification or other situation; provided, further, that if the Saban
Sponsor does not, upon the request of Acquiror, before receiving such information, execute and deliver to Acquiror an agreement to abide by all Acquiror policies applicable to members of the Acquiror Board and a confidentiality agreement reasonably
acceptable to Acquiror, the Saban Sponsor may be excluded from access to any information if the Acquiror Board determines in good faith that such exclusion is reasonably necessary to protect confidential proprietary information of Acquiror or
confidential proprietary information of third parties that Acquiror is required to hold in confidence, or for other similar reasons, and (ii) such other information and data as the Saban Sponsor may reasonably request in connection with its
ownership of Acquiror Common Shares, including any information necessary to assist the Saban Sponsor in preparing its tax, regulatory or other similar 

  
 25 

 
filings or as otherwise required for administrative purposes. Any information pursuant to clause (i) of this Section 10(a) may be provided to the Saban Sponsor by
Acquiror or a Saban Director. The Saban Sponsor, in its sole discretion, may decline to receive any information pursuant to clause (i) of this Section 10(a) upon written notice to Acquiror. Notwithstanding the
foregoing, Acquiror shall not be required to provide, and a Saban Director shall not provide on behalf of Acquiror pursuant to this Section 10(a), any information that would reasonably be expected to violate any
confidentiality obligations owing to third Persons or Law to which Acquiror or any of its Subsidiaries is subject; provided, that if any information is withheld pursuant to this sentence, Acquiror will (A) inform the Saban Sponsor as to
the general nature of what is being withheld and (B) use its commercially reasonable efforts (at the cost and expense of the requesting party) to accommodate any request from the Saban Sponsor for information pursuant to this
Section 10(a) in a manner that does not result in such a violation. 
 (b) Acquiror will deliver, or will cause to
be delivered, the following to the Saban Sponsor (unless it has informed Acquiror in writing that it does not wish to receive any such information): 

(i) to the extent that such information is provided to the Acquiror Board, as soon as available after each month and in any event within
fifteen (15) days after the date on which such information is delivered in final form to the Acquiror Board, unaudited consolidated monthly financial reports of Acquiror and its consolidated Subsidiaries prepared in accordance with GAAP; and

 (ii) to the extent that such information is provided to the Acquiror Board, as soon as available and in any event within fifteen
(15) days after the date on which such information is delivered to the Acquiror Board, the annual business plan (including operating budget and capital expenditures presented on a monthly basis). 

(c) Acquiror shall, and shall cause its Subsidiaries to, upon the written request of the Saban Sponsor, provide the following to the Saban
Sponsor: 
 (i) reasonable access to appropriate officers and directors of Acquiror and its Subsidiaries at such reasonable times during
normal business hours as may be requested by the Saban Sponsor for consultation with the Saban Sponsor with respect to matters relating to the business and affairs of Acquiror or any of its Subsidiaries (provided that no such access or consultation
shall be required to the extent related to any dispute, transaction or contract negotiation, amendment or modification, or other situation that is reasonably expected to involve a conflict of interest between Acquiror and/or one or more of its
Subsidiaries, on the one hand, and the Saban Sponsor and/or one or more of its Affiliates, on the other hand, due to such Persons being on opposite sides of such dispute, transaction or contract negotiation, amendment or modification or other
situation); and 
 (ii) a reasonably detailed overview of any material information with respect to any significant corporate actions,
including, without limitation, extraordinary dividends, stock redemptions or repurchases, mergers, acquisitions or dispositions of assets, issuances of significant amounts of debt or equity and material amendments to the Acquiror Governing Documents
or the organizational documents of any of Acquiror’s Subsidiaries, and to 

  
 26 

 
provide the Saban Sponsor with the opportunity to reasonably consult with Acquiror and its Subsidiaries with respect to such actions (provided that no such information or consultation shall be
required (A) with respect to any dispute, transaction or contract negotiation, amendment or modification, or other situation that is reasonably expected to involve a conflict of interest between Acquiror and/or one or more of its Subsidiaries,
on the one hand, and the Saban Sponsor and/or one or more of its Affiliates, on the other hand, due to such Persons being on opposite sides of such dispute, transaction or contract negotiation, amendment or modification or other situation and
(B) to the extent that the Acquiror Board (or a committee thereof) determines in good faith, based on the advice of Acquiror’s counsel, that such omission may be necessary in order to preserve Acquiror’s attorney-client or similar
privilege). 
 (d) Acquiror shall, and shall cause its Subsidiaries to, provide the Saban Sponsor reasonable access, during normal business
hours and with prior written notice, in such manner as to not unreasonably interfere with the normal operation of Acquiror and its Subsidiaries, to the books, records, policies and procedures, internal audit and compliance reports, and to officers,
personnel, accountants and other representatives of Acquiror and its Subsidiaries and their respective businesses, whether located in the United States or outside the United States, including, without limitation, the right to audit any such books,
records, policies and procedures, and reports and to make copies therefrom. Without limiting the generality of the foregoing, Acquiror shall not be required to provide (or cause to be provided) (and each of the following shall be deemed to be
“unreasonable access” pursuant to the immediately preceding sentence): (i) any information that the Acquiror Board (or a committee thereof) determines in good faith, based on the advice of Acquiror’s counsel, that such omission may be
necessary in order to preserve Acquiror’s attorney-client or similar privilege; (ii) any information with respect to any dispute, transaction or contract negotiation, amendment or modification, or other situation that is reasonably
expected to involve a conflict of interest between Acquiror and/or one or more of its Subsidiaries, on the one hand, and the Saban Sponsor and/or one or more of its Affiliates, on the other hand, due to such Persons being on opposite sides of such
dispute, transaction or contract negotiation, amendment or modification or other situation; and (iii) any information that would reasonably be expected to violate any confidentiality obligations owing to third Persons or Law to which Acquiror
or any of its Subsidiaries is subject; provided, that if any information is withheld pursuant to this sentence, Acquiror will (A) inform the Saban Sponsor as to the general nature of what is being withheld and (B) use its
commercially reasonable efforts (at the cost and expense of the requesting party) to accommodate any request from Acquiror for information pursuant to this Section 10(d) in a manner that does not result in such a violation.

 (e) The provisions set forth in Sections 10(a), 10(b), 10(c) and 10(d) shall be effective subject to, and
conditioned upon, the occurrence of the Effective Time and shall remain in full force and effect for the period commencing at the Effective Time and ending on the date on which the Saban Sponsor and its Affiliates, in the aggregate, beneficially own
less than 5.00% of the issued and outstanding Acquiror Common Shares. 
 (f) The Saban Sponsor hereby acknowledges that it is aware that the
United States securities laws prohibit any person who has material, non-public information concerning a company from purchasing or selling securities of such company or from communicating such information to
any other person under circumstances in which it is reasonably foreseeable that such person is likely to purchase or sell such securities. 

  
 27 

 (g) The Saban Sponsor shall maintain the confidentiality of any confidential and proprietary
information of Acquiror or any of its Subsidiaries received pursuant to Sections 10(a), 10(b), 10(c) and 10(d) (“Saban Proprietary Information”) using the same standard of care as it applies to its
own confidential information, except for any Saban Proprietary Information which is publicly available or a matter of public knowledge generally. Nothing herein shall prevent the Saban Sponsor from (i) using Saban Proprietary Information to
enforce its rights under this Agreement, the Business Combination Agreement and/or any of the Ancillary Agreements or the rights granted to it as a holder of Acquiror Common Shares contained in Acquiror’s Governing Documents,
(ii) disclosing Saban Proprietary Information to its attorneys, accountants, consultants, and other advisors, to the extent necessary to obtain their services in connection with monitoring and managing the Saban Sponsor’s investment in
Acquiror or otherwise in connection with this Agreement, the Business Combination Agreement and/or any of the Ancillary Agreements or the rights granted to it as a holder of Acquiror Common Shares contained in Acquiror’s Governing Documents, so
long as such advisors are obligated to maintain the confidentiality of the same; provided that the Saban Sponsor shall be responsible for any breach of such confidentiality obligations by any such attorneys, accountants, consultants, and other
advisors, or (iii) disclosing Saban Proprietary Information as may otherwise be required by law, if the Saban Sponsor promptly notifies Acquiror of such disclosure and takes reasonable steps to minimize the extent of any such required
disclosure. The foregoing shall not be considered Saban Proprietary Information and shall not prohibit the use by the Saban Sponsor of any such information received pursuant to this Section 10(g) if and solely to the extent
such information (w) is or becomes generally available to or known by the public other than as a result of a breach of the confidentiality provisions of this Agreement, including the confidentiality obligations as required by this Agreement
that apply to Persons not party to this Agreement to whom the Saban Sponsor has disclosed such information as permitted hereunder, (x) was available to the Saban Sponsor or any of its Affiliates, or a Saban Director, as applicable, prior to
Acquiror’s disclosure to any such person, (y) is or becomes available to the Saban Sponsor or any of its Affiliates, or a Saban Director, as applicable, from a source other than Acquiror, or (z) has already been, or is hereafter,
independently developed by the Saban Sponsor or any of its Affiliates without reference to, incorporation of or other use of the Saban Proprietary Information; provided, however, that, in the case of clauses (x) and (y), such
information was not actually known by the Saban Sponsor to be disclosed by the source of such information in violation of a confidentiality obligation (whether by agreement, duty or otherwise) to Acquiror with respect to such information.
Notwithstanding anything in this Section 10 or this Agreement to the contrary, the parties hereto agree that the Saban Sponsor is affiliated with private equity, hedge or similar funds and that the Saban Sponsor may provide
general information about the subject matter of this Agreement and the transactions contemplated hereby in connection with normal fund raising and related marketing or informational or reporting activities. 

Section 11. D&O Insurance. Acquiror shall (i) purchase directors’ and officers’ liability insurance in an
amount determined by the Acquiror Board to be reasonable and customary and (ii) for so long as any director designated pursuant to the terms of this Agreement serves as a director of the Acquiror Board, maintain such coverage with respect to
such director; provided, that upon removal or resignation of such director for any reason, Acquiror shall take all actions reasonably necessary to extend such directors’ and officers’ liability insurance coverage for a period
of not less than six (6) years from any such event in respect of any act or omission occurring at or prior to such event. 

  
 28 

 Section 12. Pre-Closing Transaction
Support. 
 (a) From the date hereof until the earlier of (i) the Closing and (ii) the termination of the Business Combination
Agreement in accordance with its terms, the Saban Sponsor hereby unconditionally and irrevocably agrees that at any duly called meeting of the stockholders of Acquiror (or any adjournment or postponement thereof), and in any action by written
consent of the stockholders of Acquiror requested by the Acquiror Board or undertaken as contemplated by the transactions contemplated by the Business Combination Agreement, the Saban Sponsor shall, and shall cause its Affiliates to, if a meeting is
held, appear at the meeting, in person or by proxy, or otherwise cause its Equity Securities in Acquiror to be counted as present thereat for purposes of establishing a quorum, and it shall vote or consent (or cause to be voted or consented), in
person or by proxy, all of its Equity Securities (a) in favor of the Acquiror Extension Approval and the Transaction Proposals, (b) against any action, proposal, transaction or agreement that would result in a breach in any respect of any
covenant, representation or warranty or any other obligation or agreement of Acquiror contained in the Business Combination Agreement, (c) in favor of the election of the nominees to become members of the Acquiror Board, as well as the
composition of the classes and committees thereof, in each case as determined in accordance with this Agreement and the Business Combination Agreement, and (e) except as set forth in the Proxy Statement, against the following actions or
proposals (other than the transactions contemplated by the Business Combination Agreement): (i) any Acquisition Proposal or any proposal in opposition to approval of the Business Combination Agreement or any other Transaction Proposal or in
competition with or materially inconsistent with the Business Combination Agreement or any other Transaction Proposal; and (ii) (A) any material change in the present capitalization of Acquiror or any amendment of the Acquiror Governing
Documents; (B) any change in Acquiror’s corporate structure or business; or (C) any other action or proposal involving Acquiror or any of its Subsidiaries that is intended, or would reasonably be expected, to prevent, impede,
interfere with, delay, postpone or adversely affect in any material respect the transactions contemplated by the Business Combination Agreement or would reasonably be expected to result in any of the conditions to Acquiror’s obligations under
the Business Combination Agreement not being fulfilled, except in the case of each of clause (A), (B) and (C), as contemplated by this Agreement or the Business Combination Agreement. The Saban Sponsor agrees not to, and shall cause its Affiliates
not to, enter into any agreement, commitment or arrangement with any Person the effect of which would be inconsistent with or violative of the provisions and agreements contained in this Section 12. 

(b) Nothing in this Section 12 shall be construed to impose any obligation or limitation on votes or actions taken by
any director, officer, employee, agent or other representative of the Saban Sponsor, in each case, in his or her capacity as a director or officer of Acquiror. 

Section 13. Definitions and Interpretation. 

(a) As used herein, the following terms shall have the following meanings: 

  
 29 

 “Acquiror” has the meaning set forth in the preamble. 

“Affiliate” shall have the meaning set forth in Rule 12b-2 promulgated by the
SEC under the Exchange Act and shall include all Persons that at any time during the term of this Agreement become Affiliates of any Person referred to in this Agreement. 

“Agreement” has the meaning set forth in the preamble. 

“beneficially own” has the meaning ascribed to it in Section 13(d) of the Exchange Act. 

“Board Observers” has the meaning set forth in Section 1(l). 

“Business Combination Agreement” has the meaning set forth in the recitals. 

“Bylaws” means Acquiror’s Bylaws, as the same may be amended from time to time. 

“Cerberus Board Observer” has the meaning set forth in Section 1(l). 

“Cerberus Holders” means Cerberus Series Four Holdings, LLC and Cerberus Institutional Partners V, L.P. 

“Certificate of Incorporation” means Acquiror’s Certificate of Incorporation, as the same may be amended from
time to time. 
 “Chair of the Board” has the meaning set forth in Section 6. 

“Company Sale” means an acquisition by any Person or “group” (as defined in Section 13(d)(3) of the
Exchange Act) of any Equity Securities (or beneficial ownership thereof), including rights or options to acquire such ownership, tender or exchange offer, merger, consolidation, amalgamation, scheme of arrangement, business combination, issuance,
recapitalization, restructuring, liquidation, dissolution or other extraordinary transaction with or involving Acquiror or any of its Affiliates, in each case as a result of which such Person or “group” would beneficially own securities
representing more than 50.00% of the Equity Securities (by voting power or economic rights, including upon exercise, exchange or conversion of any other security) of Acquiror. 

“Compensation Committee” has the meaning set forth in Section 1(a). 

“Designated Independent Directors” means (i) if there are three (3) or four (4) Initial Panavision
Designees, three (3) independent directors, one (1) of which will serve as a Class II director and two (2) of which will serve as Class I directors, and (ii) if there are two (2) Initial Panavision Designees, four
(4) independent directors, two (2) of which will serve as Class II directors and two (2) of which will serve as Class I directors. 

“Designated Initial Panavision Designees” has the meaning set forth in Section 1(a). 

“Designated Initial Saban Designees” has the meaning set forth in Section 2(a). 

“Director Resignation Letter” has the meaning set forth in Section 1(d). 

  
 30 

 “Equity Securities” means, as applicable, (a) any capital
stock, membership interests or other share or equity capital, (b) any securities directly or indirectly convertible into or exchangeable for any capital stock, membership interests or other share or equity capital or containing any profit
participation features, (c) any rights or options directly or indirectly to subscribe for or to purchase any capital stock, membership interests, other share or equity capital or securities containing any profit participation features or to
subscribe for or to purchase any securities directly or indirectly convertible into or exchangeable for any capital stock, membership interests, other share or equity capital or securities containing any profit participation features, (d) any
share appreciation rights, phantom share rights or other similar rights, or (e) any Equity Securities issued or issuable with respect to the securities referred to in clauses (a) through (d) above in connection with a combination of
shares, recapitalization, merger, consolidation or other reorganization. 
 “Governing Documents” means the legal
document(s) by which any Person (other than an individual) establishes its legal existence or which govern its internal affairs. For example, the “Governing Documents” of a corporation are its certificate of incorporation and bylaws, the
“Governing Documents” of a limited partnership are its limited partnership agreement and certificate of limited partnership and the “Governing Documents” of a limited liability company are its operating agreement and certificate
of formation. 
 “Initial Panavision Designees” has the meaning set forth in Section 1(a).

 “Initial Saban Designees” has the meaning set forth in Section 2(a). 

“Key Panavision Stockholders” has the meaning set forth in the preamble. 

“Majority Cerberus Holders” has the meaning set forth in Section 1(l). 

“Majority Solus Holders” has the meaning set forth in Section 1(l). 

“Nominating Committee” has the meaning set forth in Section 1(a). 

“Panavision Directors” means, collectively, the Initial Panavision Designees and any other individual elected or
appointed to the Acquiror Board that has been designated by the Panavision Holder Representative pursuant to this Agreement. 

“Panavision Holder Representative” has the meaning set forth in the preamble. 

“Panavision Proprietary Information” has the meaning set forth in Section 9(g). 

“Panavision Stockholders” means, for purposes of this Agreement, each of the Key Panavision Holders, Anthem Inc,
Credit Suisse Securities (USA) LLC, Morgan Stanley & Co. LLC, Sunrise Partners Limited Partnership, Whippoorwill Associates, Inc. Profit Sharing Plan, Whippoorwill Distressed Opportunity Fund, L.P., Whippoorwill Institutional Partners LP
and Whippoorwill Offshore Distressed Opportunity Fund, Ltd. 
 “Related Person” means, with respect to any Person,
any employee, officer, director, manager, equity holder or partner of such Person or of any of its Affiliates. 

  
 31 

 “Saban Directors” means, collectively, the Initial Saban Designees
and any other individual elected or appointed to the Acquiror Board that has been designated by the Saban Sponsor pursuant to this Agreement. 

“Saban Proprietary Information” has the meaning set forth in Section 10(g). 

“Saban Sponsor” has the meaning set forth in the preamble. 

“Saban Sponsor II” has the meaning set forth in the preamble. 

“Solus Board Observer” has the meaning set forth in Section 1(l). 

“Solus Holders” means SOLA LTD, Solus Senior High Income Fund LP, Solus Opportunities Fund 3 LP, Solus Opportunities
Fund 5 LP, Ultra Master LTD and Ultra NB LLC. 
 (b) Unless the context of this Agreement otherwise requires, (i) words of any gender
include each other gender; (ii) words using the singular or plural number also include the plural or singular number, respectively; (iii) the terms “hereof,” “herein,” “hereby,” “hereto” and
derivative or similar words refer to this entire Agreement; (iv) the terms “Section,” “Exhibit” or “Schedule” refer to the specified Section, Exhibit or Schedule of this Agreement; (v) the word
“including” shall mean “including, without limitation”; (vi) the word “or” shall mean “and/or”; (vii) references to any Contract are to that Contract as amended, modified or supplemented from time to
time; (viii) references to any Person include the successors and permitted assigns of that Person; and (ix) the words “writing”, “written” and comparable terms refer to printing, typing and other means of reproducing
words (including e-mail and electronic media) in a visible form. 
 (c) Unless the context of this
Agreement otherwise requires, references to statutes shall include all regulations promulgated thereunder and references to statutes or regulations shall be construed as including all statutory and regulatory provisions consolidating, amending or
replacing the statute or regulation. 
 (d) The language used in this Agreement shall be deemed to be the language chosen by the parties to
express their mutual intent and no rule of strict construction shall be applied against any party. 
 (e) Whenever this Agreement refers to a
number of days, such number shall refer to calendar days unless Business Days are specified. 
 (f) Unless the context of this Agreement
otherwise requires, all references herein to ownership of the Acquiror Common Shares shall mean the Acquiror Common Shares determined on a non-fully diluted basis without taking into account any Contingent
Shares unless and until any such Contingent Shares become vested pursuant to the Business Combination Agreement or Equity Securities of the type described in clauses (b) through (d) of the definition of Equity Securities unless and until any
such Equity Securities are converted into or exchanged for Acquiror Common Shares. Any reference to the Acquiror Common Shares shall be deemed for all purposes under this Agreement to refer to the Equity Securities into which the Acquiror Common
Shares are converted in connection with the Domestication, as the context so requires. 

  
 32 

 (g) References to “$” shall mean U.S. dollars, unless otherwise indicated herein.

 (h) The headings contained in this Agreement are inserted for convenience only and shall not affect in any way the meaning or
interpretation of this Agreement. 
 Section 14. Essential Consideration. The parties hereto acknowledge and agree that the
rights and obligations of the parties hereunder, including under Sections 1 through 12, are given in consideration for the rights and obligations undertaken under the Business Combination Agreement and the Ancillary
Agreements, and without limiting the generality of the foregoing, constitute essential and integral consideration to the parties hereto for their execution or authorization of, as applicable, the Business Combination Agreement and the Ancillary
Agreements. 
 Section 15. Assignment; Benefit of Parties; Transfer. No party may assign this Agreement or any of its rights or
obligations hereunder and any assignment hereof will be null and void, except that any of the Key Panavision Stockholders or the Saban Sponsor may assign, in whole, but not in part, this Agreement as part of a transfer of its Acquiror Common Shares
to an Affiliate and provided that the assignee executes a joinder agreement pursuant to which such assignee agrees to be bound by the terms hereof. This Agreement shall be binding upon and shall inure to the benefit of the parties hereto and their
respective successors, legal representatives and assignees for the uses and purposes set forth and referred to herein. Nothing herein contained shall confer or is intended to confer on any third party or entity that is not a party to this Agreement
any rights under this Agreement. 
 Section 16. Remedies. The parties hereto agree that irreparable damage for which monetary
damages, even if available, would not be an adequate remedy, would occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that
the parties shall be entitled to an injunction or injunctions to prevent breaches of this Agreement and to specific enforcement of the terms and provisions of this Agreement, in addition to any other remedy to which any party is entitled at Law or
in equity. In the event that any Action shall be brought in equity to enforce the provisions of this Agreement, no party shall allege, and each party hereby waives the defense, that there is an adequate remedy at Law, and each party agrees to waive
any requirement for the securing or posting of any bond in connection therewith. 
 Section 17. Notices. All notices and other
communications among the parties shall be in writing and shall be deemed to have been duly given (x) on the date of delivery if delivered in person, (y) on the date sent by e-mail if sent on or prior
to 5:00 p.m. (Pacific Time), and on the next Business Day if sent after 5:00 p.m. (Pacific Time), or (z) three (3) Business Days after deposit with an internationally recognized express courier service to the respective parties hereto at the
following addresses (or at such other address for a party as shall be specified in a notice given in accordance with this Section 17): 

  
 33 

	 	(a)	 If to Acquiror, to: 

Saban Capital Acquisition Corp. 

10100 Santa Monica Boulevard, 26th Floor 

Los Angeles, CA 90067 

Attention:    Adam Chesnoff 

                    Niveen S. Tadros, Esq.

 E-mail:        achesnoff@sabanac.com 

                    ntadros@sabanac.com

 including, if after the Closing, to: 

Panavision Inc. 
 6101 Variel
Avenue 
 Woodland Hills, CA 91367 

Attention:    Kim Snyder 

                    Mara Morner-Ritt, Esq.

 E-mail:        kim.snyder@panavision.com 

                    
mara.morner-ritt@panavision.com 
 in each case, with copies to (which shall not constitute notice): 

Skadden, Arps, Slate, Meagher & Flom LLP 

300 South Grand Avenue, Suite 3400 

Los Angeles, CA 90071 

Attention:    Jeffrey H. Cohen 

                    David C. Eisman 

E-mail:        jeffrey.cohen@skadden.com 

                    
david.eisman@skadden.com 
 and 

Kirkland & Ellis LLP 

601 Lexington Avenue 
 New York,
NY 10022 
 Attention:    Douglas Ryder, P.C. 

                    Christian Nagler, P.C.

 E-mail:        douglas.ryder@kirkland.com 

                    cnagler@kirkland.com

  

	 	(b)	 If to the Cerberus Holders, to: 

c/o Cerberus Capital Management, L.P. 

875 Third Avenue 
 New York, NY
10022 
 Attention:    Alexander Benjamin 

                    Marc Millman 

E-mail:        albenjamin@cerberuscapital.com 

                    
mmillman@cerberuscalifornia.com 

  
 34 

 with copies to (which shall not constitute notice): 

Kirkland & Ellis LLP 

601 Lexington Avenue 
 New York,
NY 10022 
 Attention:    Douglas Ryder, P.C. 

                    Christian Nagler, P.C.

 E-mail:        douglas.ryder@kirkland.com 

                    cnagler@kirkland.com

  

	 	(c)	 If to the Solus Holders, to: 

c/o Solus Alternative Asset Management LP 

410 Park Avenue, Floor 11 
 New
York, NY 10022 
 Attention:    Ryan Cremins 

                    Craig Chobor 

E-mail:        rcremins@soluslp.com 

                    cchobor@soluslp.com

 with copies to (which shall not constitute notice): 

Kirkland & Ellis LLP 

601 Lexington Avenue 
 New York,
NY 10022 
 Attention:    Douglas Ryder, P.C. 

                    Christian Nagler, P.C.

 E-mail:        douglas.ryder@kirkland.com 

                    cnagler@kirkland.com

  

	 	(d)	 If to the Panavision Holder Representative, to: 

Cerberus PV Representative, LLC 

c/o Cerberus Capital Management, L.P. 

875 Third Avenue 
 New York, NY
10022 
 Attention:    Alexander Benjamin 

                    Marc Millman 

E-mail:        albenjamin@cerberuscapital.com 

                    
mmillman@cerberuscalifornia.com 

  
 35 

 with copies to (which shall not constitute notice): 

Kirkland & Ellis LLP 

601 Lexington Avenue 
 New York,
NY 10022 
 Attention:    Douglas Ryder, P.C. 

                    Christian Nagler, P.C.

 E-mail:        douglas.ryder@kirkland.com 

                    cnagler@kirkland.com

  

	 	(c)	 If to the Saban Sponsor or Saban Sponsor II, to: 

Saban Capital Acquisition Corp. 

10100 Santa Monica Boulevard, 26th Floor 

Los Angeles, CA 90067 

Attention:    Adam Chesnoff 

                    Niveen S. Tadros, Esq.

 E-mail:        achesnoff@sabanac.com 

                    ntadros@sabanac.com

 with copies to (which shall not constitute notice): 

Skadden, Arps, Slate, Meagher & Flom LLP 

300 South Grand Avenue, Suite 3400 

Los Angeles, CA 90071 

Attention:    Jeffrey H. Cohen 

                    David C. Eisman 

E-mail:        jeffrey.cohen@skadden.com 

                    
david.eisman@skadden.com 
 Copies delivered solely to outside counsel shall not constitute notice. 

Section 18. Adjustments. If, and as often as, there are any changes in the Acquiror Common Shares by way of stock split, stock
dividend, combination or reclassification, or through merger, consolidation, reorganization, recapitalization or sale, or by any other means, appropriate adjustment shall be made in the provisions of this Agreement, as may be required, so that the
rights, privileges, duties and obligations hereunder shall continue with respect to the Acquiror Common Shares as so changed. 

Section 19. No Strict Construction. The language used in this Agreement shall be deemed to be the language chosen by the parties
hereto to express their mutual intent, and no rule of strict construction shall be applied against any party. 
 Section 20. No
Third-Party Beneficiaries. Nothing in this Agreement, express or implied, is intended or shall be construed to confer upon, or give to, any person or entity other than the parties hereto and their respective successors and assigns any remedy or
claim under or by reason of this Agreement or any terms, covenants or conditions hereof, and all of the terms, covenants, conditions, promises and agreements contained in this Agreement shall be for the sole and exclusive benefit of the parties
hereto and their respective successors and assigns. Notwithstanding anything to the contrary in this Agreement, (a) each Panavision Director shall be an express third-party beneficiary of the provisions set forth in
Section 1(f), Section 1(j) and Section 11, and (b) each Saban Director shall be an express third-party beneficiary of the provisions set forth in
Section 2(f), Section 2(j) and Section 11. 

  
 36 

 Section 21. Further Assurances. Each of the parties hereby agrees that it will
hereafter execute and deliver any further document, agreement, instruments of assignment, transfer or conveyance as may be necessary or desirable to effectuate the purposes hereof. 

Section 22. Expenses. Except as otherwise expressly set forth herein, each of the parties hereby agrees that each party shall bear
any fees and expenses incurred by or on behalf of, or paid or payable by, such party as a result of or in connection with this Agreement and the transactions contemplated herein. 

Section 23. Counterparts. This Agreement may be executed in one or more counterparts, and may be delivered by means of facsimile
or electronic transmission in portable document format, each of which shall be deemed to be an original and shall be binding upon the party who executed the same, but all of such counterparts shall constitute the same agreement. 

Section 24. Governing Law. This Agreement, and all Actions based upon, arising out of, or related to this Agreement shall be
governed by, and construed in accordance with, the Laws of the State of Delaware, without giving effect to principles or rules of conflict of Laws to the extent such principles or rules would require or permit the application of Laws of another
jurisdiction. 
 Section 25. Jurisdiction; Waiver of Jury Trial. 

(a) Any Action based upon, arising out of or related to this Agreement or the Transactions must be brought in the Court of Chancery of the
State of Delaware (or, to the extent such court does not have subject matter jurisdiction, the Superior Court of the State of Delaware), or, if it has or can acquire jurisdiction, in the United States District Court for the District of Delaware, and each of the parties irrevocably submits to the exclusive jurisdiction of each such court in any such Action, waives any objection it may now or hereafter have to personal jurisdiction, venue or
inconvenience of forum, agrees that all claims in respect of the Action shall be heard and determined only in any such court, and agrees not to bring any Action arising out of or relating to this Agreement in any other court. Nothing herein
contained shall be deemed to affect the right of any party to serve process in any manner permitted by Law or to commence an Action or otherwise proceed against any other party in any other jurisdiction, in each case, to enforce judgments obtained
in any Action brought pursuant to this Section 25. 
 (b) EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY
WHICH MAY ARISE UNDER THIS AGREEMENT AND THE TRANSACTIONS IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE EACH SUCH PARTY HEREBY IRREVOCABLY, UNCONDITIONALLY AND VOLUNTARILY WAIVES ANY RIGHT SUCH PARTY MAY HAVE TO A TRIAL BY
JURY IN RESPECT OF ANY ACTION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT, THE DEBT FINANCING OR ANY OF THE TRANSACTIONS. 

  
 37 

 Section 26. Complete Agreement; Inconsistent Agreements. This Agreement,
together with the Business Combination Agreement, the Acquiror Governing Documents and the other Ancillary Agreements, represent the complete agreement between the parties hereto as to all matters covered hereby, and supersede any prior agreements
or understandings between the parties. In the event of any conflict between the terms of this Agreement and the Business Combination Agreement, the Acquiror Governing Documents and/or the other Ancillary Agreements, the terms of this Agreement shall
govern and control. 
 Section 27. Severability. If any provision of this Agreement is held invalid or unenforceable by any
court of competent jurisdiction, the other provisions of this Agreement shall remain in full force and effect. The parties further agree that if any provision contained herein is, to any extent, held invalid or unenforceable in any respect under the
Laws governing this Agreement, they shall take any actions necessary to render the remaining provisions of this Agreement valid and enforceable to the fullest extent permitted by Law and, to the extent necessary, shall amend or otherwise modify this
Agreement to replace any provision contained herein that is held invalid or unenforceable with a valid and enforceable provision giving effect to the intent of the parties. 

Section 28. Amendment and Waiver. Except as otherwise provided herein, no modification, amendment or waiver of any provision of
this Agreement shall be effective against any party hereto unless such modification is approved in writing by such party. The failure of any party to enforce any of the provisions of this Agreement shall in no way be construed as a waiver of such
provisions and shall not affect the right of such party thereafter to enforce each and every provision of this Agreement in accordance with its terms. 

Section 29. Termination. This Agreement shall terminate, and be of no further force and effect, upon the earliest to occur of:
(a) the termination of the Business Combination Agreement in accordance with the terms thereof; (b) the consummation of a Company Sale; and (c) mutual written consent of the parties hereto. 

[SIGNATURE PAGES FOLLOW] 

  
 38 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement on the day and year
first written above. 
  

			
	Acquiror:
	
	SABAN CAPITAL ACQUISITION CORP.
		
	By:	 	 /s/ Adam Chesnoff

	Name:	 	Adam Chesnoff
	Title:	 	Authorized Representative

 [Signature Page to Director Composition and Standstill Agreement] 

 
			
	Key Panavision Stockholders:
	
	CERBERUS SERIES FOUR HOLDINGS, LLC
	
	By: Cerberus Institutional Partners, L.P. -Series Four
	Its: Managing Member
	
	By: Cerberus Institutional Associates, L.L.C.
	Its: General Partner
		
	By:	 	 /s/ Alexander D. Benjamin

	Name:	 	Alexander D. Benjamin
	Title:	 	Senior Managing Director
	
	CERBERUS INSTITUTIONAL PARTNERS V, L.P.
	
	By: Cerberus Institutional Associates II, L.L.C.
	Its: General Partner
		
	By:	 	 /s/ Alexander D. Benjamin

	Name:	 	Alexander D. Benjamin
	Title:	 	Senior Managing Director

 [Signature Page to Director Composition and Standstill Agreement] 

 
			
	SOLA LTD
	
	By: Solus Alternative Asset Management LP
	Its: Investment Advisor
		
	By:	 	 /s/ Chris Pucillo

	Name:	 	Chris Pucillo
	Title:	 	CIO
	
	SOLUS SENIOR HIGH INCOME FUND LP
	
	By: Solus Alternative Asset Management LP
	Its: Investment Advisor
		
	By:	 	 /s/ Chris Pucillo

	Name:	 	Chris Pucillo
	Title:	 	CIO
	
	SOLUS OPPORTUNITIES FUND 3 LP
	
	By: Solus Alternative Asset Management LP
	Its: Investment Advisor
		
	By:	 	 /s/ Chris Pucillo

	Name:	 	Chris Pucillo
	Title:	 	CIO
	
	SOLUS OPPORTUNITIES FUND 5 LP
	
	By: Solus Alternative Asset Management LP
	Its: Investment Advisor
		
	By:	 	 /s/ Chris Pucillo

	Name:	 	Chris Pucillo
	Title:	 	CIO

 [Signature Page to Director Composition and Standstill Agreement] 

 
			
	ULTRA MASTER LTD
	
	By: Solus Alternative Asset Management LP
	Its: Investment Advisor
		
	By:	 	 /s/ Chris Pucillo

	Name:	 	Chris Pucillo
	Title:	 	CIO
	
	ULTRA NB LLC
	
	By: Solus Alternative Asset Management LP
	Its: Investment Advisor
		
	By:	 	 /s/ Chris Pucillo

	Name:	 	Chris Pucillo
	Title:	 	CIO

 [Signature Page to Director Composition and Standstill Agreement] 

 
			
	Panavision Holder Representative:
	
	CERBERUS PV REPRESENTATIVE, LLC
		
	By:	 	 /s/ Alexander D. Benjamin

	Name:	 	Alexander D. Benjamin
	Title:	 	Secretary

 [Signature Page to Director Composition and Standstill Agreement] 

 
			
	Saban Sponsor:
	
	SABAN SPONSOR LLC
		
	By:	 	 /s/ Adam Chesnoff

	Name:	 	Adam Chesnoff
	Title:	 	Authorized Representative
	
	Saban Sponsor II:
	
	SABAN SPONSOR II LLC
		
	By:	 	 /s/ Adam Chesnoff

	Name:	 	Adam Chesnoff
	Title:	 	Authorized Representative

 [Signature Page to Director Composition and Standstill Agreement] 

 Schedule I 

Key Panavision Stockholders 
  

	1.	 Cerberus Series Four Holdings, LLC 

 

	2.	 Cerberus Institutional Partners V, L.P. 

 

	3.	 SOLA LTD 

  

	4.	 Solus Senior High Income Fund LP 

 

	5.	 Solus Opportunities Fund 3 LP 

 

	6.	 Solus Opportunities Fund 5 LP 

 

	7.	 Ultra Master LTD 

  

	8.	 Ultra NB LLC 

 Schedule II 

Initial Panavision Designees 
 If
the Panavision Holder Representative is entitled to nominate 2 directors under Section 1(c) immediately after the Effective Time: 
  

	1.	 Craig Chobor (Class III) 

 

	2.	 Marc Millman (Class III) 

If the Panavision Holder Representative is entitled to nominate 3 directors under Section 1(c) immediately after the Effective Time: 

 

	1.	 Craig Chobor (Class III) 

 

	2.	 Marc Millman (Class III) 

 

	3.	 Peter Kirchof (Class III) 

If the Panavision Holder Representative is entitled to nominate 4 directors under Section 1(c) immediately after the Effective Time: 

 

	1.	 Craig Chobor (Class III) 

 

	2.	 Marc Millman (Class III) 

 

	3.	 Peter Kirchof (Class III) 

 

	4.	 Robert Solomon (Class II) 

 Schedule III 

Initial Panavision Designee Positions 

Member and Chairman of the Nominating Committee: Craig Chobor 

Member of the Compensation Committee: Marc Millman 

 Schedule IV 

Initial Saban Designees 
 If the
Panavision Holder Representative is entitled to nominate 2 directors under Section 1(c) immediately after the Effective Time: 
  

	1.	 Adam Chesnoff (Class III) 

 

	2.	 Adam Weene (Class II) 

If the Panavision Holder Representative is entitled to nominate 3 or 4 directors under Section 1(c) immediately after the Effective Time:

  

	1.	 Adam Weene (Class II) 

 

	2.	 Adam Chesnoff (Class II)

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00289-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00289-of-00352.parquet"}]]